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Merrilactone A (1) was isolated in only 0.004% yield from the methanol extracts of 
the pericarps of Illicium merrillianum. Structural elucidation of Merrilactone A 
revealed a compact, cage-like pentacyclic architecture of high molecular complexity, 
featuring seven stereocentres, five of which as contiguous fully substituted carbon 
atoms, two γ-lactones and a central oxetane ring. Merrilactone A also exhibits an 
important neurotrophic activity, significantly promoting neurite outgrowth in the 
primary cultures of foetal rat cortical neurons at very low concentrations. 
 
Structurally, merrilactone A is related to anislactones A and B, a pair of epimeric 
sesquiterpene dilactones discovered ten years earlier by Kouno and co-workers from 
the related Illicium anisatum plant. Fukuyama has shown that anislactone B can be 
converted into merrilactone A using a simple three step sequence, suggesting that the 
anislactones may be biogenetic precursors to merrilactone A.  
Described in this thesis are our research efforts directed towards developing a 
conceptually novel synthetic route enabling regiodivergent total synthesis of both 
anislactone A / B and merrilactone A. Our synthetic route (around 22 steps) features 
several key reactions, which include a [2+2] photo-cycloaddition reaction, 
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1.1 Merrilactone A and Anislactones: Origin, Structure and Biological activity 
The evergreen shrub or tree Illicium is the only genus member of the family 
Illiciaceael[1], of which forty species have been found in eastern North America, 
Mexico, the West Indies and eastern Asia. The highest concentration of this species 
can be found in northern Myanmar and southern China, where almost thirty-five 
species have been documented. The Illicium species provides rich resources of 
neolignans and biosynthetically unique seco-prezizaane-type sesquiterpenes. Most 
importantly, some of these possess distinctive neurotoxic and neurotrophic 
properties[2, 3].  
Based on their carbon skeleton, the Illicium sesquiterpenes have been classified into 
three categories [3,4], a major class of seco-prezizaane-type sesquiterpenes, and two 
smaller classes, anislactone & allo-cedrane type sesquiterpenes. Scheme 1-1 shows 
representative examples of each of the above categories. 
 
Scheme 1-1. Examples of seco-prezizaane-type (3), anislactone B (2b) and 
allo-cedrane type (4) sesquiterpenes. 
Illicium merrillianum, an aboriginal plant of south-western China and Myanmar, 
occupies a significant taxonomical place as the first Illicium plant to yield a number 
of seco-prezizaane-type sesquiterpenes and allo-cedrane-type sesquiterpenes, 
including the biosynthetically essential tashiromin 5, and 11-O-debenzoyltashiromin 
6. More importantly, I. merrillianum can produce a large number of anislactone-type 
compounds such as anislactone A and B (3a and 3b respectively) and merrilactones 
A, B and C (1, 7 and 8 respectively), which possess a distinctive carbon skeleton 
consisting of two consecutive five-membered rings bearing two -lactones[5-7] 
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(Scheme 1-2). They cannot therefore be categorised with the previously known 
seco-prezizaane-type sesquiterpenes. To date, thirty-six structurally novel 













































Scheme 1-2. Illicium sesquiterpenes isolated from I. merrillianum. 
Merrilactone A (1) was isolated in only 0.004% yield from the methanol extracts of 
the pericarps of I. merrillianum. Its structure has been elucidated by means of 
extensive spectroscopic and X-ray crystallographic analysis and the absolute 
configuration established using the modified Mosher’s method. Merrilactone A is a 
pentacyclic anislactone-type sesquiterpene fused with two -lactones and an oxetane 
ring. This densely oxygenated highly compact architecture also contains five 
contiguous quaternary centres and shows a cis-arrangement of the two angular 
methyl groups at the B-C junction, making it an attractive and challenging target for 
synthesis. 
In addition to its attractive structure, merrilactone A also exhibits an important 
neurotrophic activity, significantly promoting neurite outgrowth in the primary 
cultures of foetal rat cortical neurons at very low concentrations from 10 mol/L to 
0.1 mol/L[6]. Thus researchers believe that Merrilactone A may possess therapeutic 
potential in the treatment of neuro-degenerative diseases, such as Alzheimer’s 
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disease and Parkinson's disease[8]. 
1.2 Biosynthesis of Anislactone-type sesquiterpenes  
These compounds originate from the mevalonic acid pathway, which affords 
dimethylallyl diphosphate (DMAPP) from acetyl-CoA. Three DMAPPs, or two IPPs 
(isopentenyl diphosphate) and one DMAPP, are formed into a farnesyl diphosphate 
(FPP), which is the essential precursor of sesquiterpenes. Then the cyclization of 
farnesyl diphosphate is promoted by sesquiterpene cyclase enzymes. The synthesis to 
this step is well studied, though the process after the first cyclization is unclear.  
 
Scheme 1-3. Plausible biosynthetic route of anislactone-type sesquiterpenes.[9] 
After the bond cleavage between C6 and C11 of the molecule, the tricyclic carbon 
skeleton, allo-cedrane A, turns into seco-prezizaanes such as anisatin, pseudoanisatin, 
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miwanensin, pseudomajucin and cycloparvifloralone. As both anislactones and 
majucin possess the same γ-lactone motif, Kouno proposed that anislactones were 
from the majucin-type compound[9]. However this biosynthetic assumption has some 
diffculties explaining some of the configurations and other features found in these 
molecules. Fukuyama proposed an alternative biogenetic pathway which led to 
anislactones from allo-cedrane A as shown in scheme 1-3[5]. The bond breaking 
between C10 and C11 in allo-cedrane A gives rise to a bicyclic carbon skeleton G, 
which repeats the cleavage of the bond between C6 and C7 followed by the 
construction of five-membered ring between C6 and C10, resulting in the formation 
of anislactone-type carbon skeleton H. This newly proposed pathway is expected to 
be able to give a reasonable biosynthetic explanation to all characteristic 
sesquiterpenes in Illicium plants. 
1.3 Chemical conversion of anislactone B to merrilactone A  
Fukuyama and co-workers[6] previously showed that anislactone B, which can be 
obtained from Illicium merrillianum in significant amounts, can be transformed to 
merrilactone A in three steps. At first, a solution of 2b was refluxed in trifluoroacetic 
acid leading to the lactone transposition to the C-4 hydroxyl group. This was 
followed by the dehydration of the C-1 hydroxyl group, which gives rise to 9 in 90% 
yield. Secondly, treatment of 9 with m-chloroperoxybenzoic acid afforded the desired 
epoxidation product 11 in 64% yield, together with a separable-epoxide 10 in 
4% yield. The high stereoselectivity of epoxidation could be rationalized by a 
favorable attack of the peroxyacid from the less hindered convex face of 9. Finally, 
11 was treated with p-toluenesulfonic acid to produce 1 in 78% yield, which was 




Scheme 1-4. Chemical conversion of Anislactone B to Merrilactone A 
1.4 Previous syntheses of Merrilactone A 
Merrilactone A’s intriguing biological properties have attracted the attention of 
several research groups interested in the development of nonpeptidal neurotrophic 
agents. A total synthesis of merrilactone A and possible analogues would provide a 
route by which novel therapeutic agents could be investigated. In addition to its 
novel bioactivity, its unique structure has stimulated extensive efforts leading to 
several publications on its synthesis. Danishefsky[10,11], Hirama[12], and Mehta[13] 
have completed three elegant syntheses of the natural product in the past eight years. 
Fukuyama[14] reported one model study of this natural product. Very recently 
Frontier[15,16] has reported a new synthetic approach. 
Scheme 1-5. Timeline of the different syntheses 
 
2000 isolation   
2002 Samuel Danishefsky  Columbia U, US JACS, 2002, 2018 
2003 Masahiro Hirama  Tohoku U, JP JACS, 2003, 10772 
2006 Goverdhan Mehta India Inst. Of Science, In ACIEE, 2006, 953 
2007 Alison Frontier University of Rochester, US JACS, 2007, 498 




1.4.1 Danishefsky’s total syntheses of Merrilactone A 
1.4.1.1 Racemic total synthesis  
In 2002, the first racemic total synthesis of Merrilactone A was accomplished by 
Danishefsky and Birman successfully[10]. The 20 step synthetic route afforded 
(±)-Merrilactone A in an impressive 10.7% overall yield. However, several problems 
of stereo- and regio- selectivity were encountered along the route. Scheme 1-6 shows 
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Scheme 1-6. Danishefsky’s retrosynthetic analysis of Merrilactone A 
The central oxetane motif in Merrilactone A is synthesized via a known, biomimetic 
homo-Payne-type rearrangement of epoxide 11, which was obtained from the 
exo-olefin 12 via alkene isomerisation and epoxidation[5]. A free radical cyclisation 
from 13 was anticipated to afford tetracycle 12, setting a quaternary centre in a 
highly sterically crowded environment. The γ,δ-unsaturated acid 15 is a key 
intermediate, which could be elaborated into 14 via iodolactonisation reaction. 
Substrate 15 was believed to be obtainable by a Claisen rearrangement via 16, which 
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in turn could be accessible from a ring contraction of bicycle 17. The latter structure 
was a product of a Diels-Alder type reaction of diene 18 and dienophile 19.  
In the forward synthesis of merrilactone A, diene 18 reacts with 2,3-dimethylmaleic 
anhydride 20 at high temperature, affording bicycle 17 in 74% yield (Scheme 1-7) 
with high stereo- and regio-selectivity. Three stereocenters (including two quaternary) 
are created at the same time in this very early step. 
 
a) 165 ℃, mesitylene, 74%; b) NaOMe, MeOH; c) ClCO2Me, THF, then NaBH4, MeOH, -35 ℃; d) aq. 
LiOH; e) LiBHEt3, THF, then TFA, DCM, 78% for 4 steps 
Scheme 1-7. Diels-Alder reaction and regioselective C14 reduction 
Selective reduction of C14 via conventional methods afforded a mixture of products 
due to regio-selectivity problems. Alternatively, a slight longer protocol could be 
applied to produce 21 in a reasonable 78% yield from 20 over four steps (b-e in 




































a) O3, PPh3, DCM/MeOH; b) Bn2NH.TFA, PhH, 65 ℃, 94% over 2 steps; c) NaBH4, DCM, MeOH, -78 ℃, 
quant.; d) MeC(OEt)3, mesitylene, PivOH, 135 ℃, 92%; e)aq. LiOH, MeOH; f) I2, NaHCO3, THF, 59% 26 
and 35% 25 over 2 steps; g) AllylSnBu3, AIBN, PhH, 75%. 
Scheme 1-8. Johnson-ortho-ester reaction and Keck C-allylation. 
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A ring contraction strategy was then employed via a ring opening-closing sequential 
reaction, which was initiated by ozonolysis of 22 followed by subsequent reductive 
workup. Reduction of the aldol condensation product between the resulting 
di-aldehyde produced the ring contracted bicyclic alcohol 16 in excellent yield. An 
ortho-ester Claisen rearrangement was then employed, producing a diastereomeric 
mixture of esters 23a and 23b in a moderate ratio (~1.8:1). The resulting ester 
mixture was hydrolysed into the corresponding acids which were subsequently 
iodolactonised into two chromatographically separable iodolactones 24b and 24a in 
35% and 59% yield respectively. The tricyclic key intermediate 14 was synthesized 
from the desired diastereomer 24a via Keck’s C-allylation protocol[17] of a three 
carbon chain elongation.  
 
a) LHMDS, TMSCl, then PhSeCl; b) PhSeBr, MeCN; c) O3, DCM, 1-hexene, PhH, NEt3, reflux, 77% 
over 3 steps; d) Bu3SnH, AIBN, PhH, 90%; e) TsOH.H2O, PhH, reflux, 98%; f) mCPBA, DCM, 3.5:1 ratio 
of / epoxide, quant.; g) TsOH.H2O, DCM, 71% over 2 stpes. 
Scheme 1-9. Free radical cyclisation and homo-Payne rearrangement 
Selenylation of C10 of 14 via an intermediate silyl ketene acetal, then 
bromoselenylation of the pendant vinyl group, and subsequent concurrent oxidative 
deselenation yielded 25 with good yield over 3 steps. The tetracyclic 12 was then 
accessible from 25 via a radical cyclisation reaction in excellent yield. Subsequent 
isomerisation of the exocyclic methylene group and deprotection of the TBS group 
led to β-alcohol 9. Hydroxyl groups usually act as syn-directing groups in 
epoxidations, however in this case the congested nature of the β-face of the double 
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bond dominates and the epoxidation occurs from the α-face (α/β epoxide = 3.5:1)[18]. 
The total synthesis was then finished by conversion of the epoxidation 11 into 
(±)-Merrilactone A 1 via known homo-Payne rearrangement catalyzed by acid. 
1.4.1.2 Asymmetric formal synthesis  
In 2005, just three years after reporting their first racemic total synthesis of 
(±)-Merrilactone A, Danishefsky and co-workers reported an asymmetric variant. In 
order to resolve the various issues of selectivity in the racemic synthesis, a modified 
approach accessing either enantiomer of Merrilactone A was established.[11] They 
concentrated attention on a stereocontrolled synthesis of key intermediate 24a, since 
the transformation of this advanced intermediate into Merrilactone A had already 
been shown to be concise and high yielding.[10] A substantial redesign of the 
previously racemic synthesis was necessary to tackle several multi-step sequences, 
such as transforming 17 into 21, and lack of selectivity, for example the 
regioselective C14 reduction or the Claisen rearrangement of 16 which yielded a 
mixture of the diastereomeric esters 23a and 23b. 
The starting point for the asymmetric route was the endo-selective Diels-Alder 
reaction at high temperature between the cyclic anhydride 19 and diene 26. 
Deprotonation via lithiation and subsequent stereoselective methylation gave access 
to 27 in an 87% yield over two steps. 27 was then converted to meso-intermediate 28 
efficiently through several standard transformations with an overall 48% yield over 
five steps (Scheme 1-10). 
 
a) 180 ℃,neat, then MeOH, reflux, PhH/MeOH, TMSCHN2. 92%; b) LDA, HMPA, MeI, THF, -78 ℃ to RT, 
95%; c) LiAlH4, THF, reflux,; d) Na, NH3, THF/EtOH, 72% over 2 stpes; e) 2,2-dimethoxypropane, 
acetone, TsOH; f) NaH, (EtO)2POCH2CO2Et, THF, 86% over 2 stpes; g) Mg, MeOH, 77%. 
Scheme 1-10. Endo-Diels Alder and conversion into meso 1,4-diol compound 
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Treatment of meso-compound 29 with dimethyldioxirane gave rise to the 
exo-epoxide 30, setting the stage for the key steps in the asymmetric synthesis – a 
desymmetrisation of the epoxide 30 with Jacobsen’s CoIII(salen) chiral catalyst. The 
desymmetrisation reaction was carried out by treatment of the epoxide 30 with a 
catalytic amount of (S,S)-[CoIII(salen)]-OAc, as described by Jacobsen and 
co-workers[20], successfully affording enantioenriched tricycle 31 in 86% yield and 
86% ee. Similarly, using of the Jacobsen’ catalyst (R,R)-[CoIII(salen)]-OAc afforded 
ent-31, thereby setting up routes to the opposite enantiomer of Merrilactone A. 
Oxidation of resulting diol 31 and subsequent esterification afforded ketoester 32 
which in turn was substrate for Baeyer-Villiger oxidation. Exposure of intermediate 
32 to standard Baeyer-Villiger oxidation condition gave access to carboxylic acid 33 
































a) DMDO, DCM; b) (s,s)-[CoIII(salen)]-OAc, -78 ℃ to -25 ℃, THF, 86% for 2 stpes; c) PDC, DMF; d) 
K2CO3, MeI, acetone, reflux, 70% over 2 stpes; e) MMPP, MeOH, 0 ℃ to RT, 88%  
Scheme 1-11. Regio- and enantio-controlled chemical degradation pathway 
The secondary alcohol 34 was obtained from carboxylic acid 33 in a three-step 
sequence with retention of stereochemistry (Scheme 1-12). Treatment of 34 with 
Lewis acid led to opening of the methoxy-tetrahydrofuran ring, subsequent trapping 
of the masked aldehyde, and lactonisation in a one-pot reaction to afford compound 
35 which was then transformed into diol 36. Selective reaction at the primary alcohol 
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in 36 was achieved by using the methodology developed by Grieco and co-workers 
to provide a transient selenide, which was converted to the desired exocyclic olefin 
37 after oxidative elimination[20]. The ester group of 37 was hydrolysed into 
carboxylic acid which underwent iodolactonisation, affording key intermediate 24a 
(Scheme 1-12).  
 
a) DCC, mCPBA, 0 ℃ to RT, 83%; b) PhH, reflux; c) K2CO3, MeOH, 70% for 2 stpes; d) BF3.OEt2, 
HS(CH2)3SH, DCM, 50%; e) PhI(OCOCF3)2, MeCN/H2O, 50%; f) NaBH4, MeOH, 0 ℃; g) 
o-NO2C6H4SeCN, Bu3P, THF, then 30% H2O2, 86% for 2 steps; h) TBSOTf, Net3, DCM, 76%; i) LiOH, 
H2O/MeOH, then I2, aq. NaHCO3/THF, 75% 
Scheme 1-12. Synthesis of enantioenriched key intermediate 
The enantiopure key intermediate 24a could then be transformed into Merrilactone A 
through the known methodology reported in Danishefsky’s racemic total synthesis of 
Merrilactone A[10]. It is worthy of note that with this redesigned synthetic approach, 
the selectivity issues in the previous racemic route have been resolved successfully 
and for the first time enabled access to either enantiomer of the natural product. The 
key enantioenriched intermediate 24a was achieved via a 21 step synthetic route with 




1.4.2 Hirama’s total syntheses of Merrilactone A  
1.4.2.1 Racemic total synthesis  
In 2003, Hirama and co-workers published the second total synthesis of 
(±)-Merrilactone A.[12] They developed a totally new synthetic methodology for the 
construction of the core of the natural product. The 27 step racemic total synthesis 
was finished with an overall 1% yield. The retro-synthetic approach employed by 

































Scheme 1-13. Hirama’s retrosynthesis of Merrilactone A 
It was proposed that Merrilactone A would be prepared from precursor 11 via the 
known and previously successfully used homo-Payne rearrangement to install the 
oxetane moiety in the final step of the synthesis. Compound 11 was accessible from 
bicyclic compound 38 through a number of straightforward transformations. The key 
cis-bicyclo- [3.3.0]octane core was designed to be accessible via an impressive 
desymmetrisation reaction of the meso-diketone 39 by employing an intramolecular 
aldol reaction. The substrate 39 for this pivotal step would be accessible from a 
double allylation, ring closing metathesis and subsequent ring expansion of 
cyclobutane 40. The latter would in turn be synthesized via a [2+2] photocyclisation 
of di-haloalkene 41 and cyclic anhydride 20. 
In the forward synthesis, the envisioned [2+2] photocyclisation was carried out under 
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irradiation of substrates 41 and 20 in the presence of the photosensitiser 
benzophenone to produce 42 in a stereospecific manner. The cycloadduct was 
subjected to dechlorination, anhydride reduction, di-benzylation of the resulting diol 
and dihydroxylation, affording the meso-diol 40 in a 47% yield over three steps.  
Exposure of cyclobutane 40 to a one-pot Swern oxidation and consecutive double 
cis-allylation afforded 43 as a major product in 78% yield. At this stage the ring 
closing metathesis reaction was applied, giving rise to the bicyclic [4.2.0]octyl 
system 44 effectively. Treatment of 44 with Pb(OAc)4 in situ formed the eight 
membered ring 39 in excellent yield (Scheme 1-14). 
 
a) benzophenone, acetone, hv; b) Zn, TMSCl, Ac2O, toluene, 85 ℃; c) LiAlH4, THF, 47% for 3 stpes; d) 
BnBr,NaH, THF/DMF, 99%; e) OsO4, NMO, tBuOMe/tBuOH/H2O, 94%; f) (COCl)2, DMSO, NEt3, g) 
(PCy3)2Cl2Ru=CHPh, DCM, reflux, then Pb(OAc)4, 95%. 
Scheme 1-14. Synthesis of desymmetrisation substrate 
In the total synthesis’ pivotal step, a base-induced intramolecular transannular aldol 
reaction promoted the desymmetrisation of meso-diketone 39 to afford the 
diastereometric bicycles in favor of desired 45 over undesired 46 in a ratio of 3.1:1 
depending on the reaction condition. Interestingly in this desymmetrisation reaction, 
changing the condition by varying different bases giving access to the other 




a) LHDMS, THF, -100 ℃, 45:56 ratio 3.1:1, 85%. 
Scheme 1-15. Desymmetrisation via intramolecular aldol reaction 
Epoxidation of the resulting aldol product 46 afforded the epoxide, which was 
subsequently opened by treating with DBU and then followed by oxidation to enone 
motif. An α-bromoacetal was introduced to afford 47 as a mixture of acetal 
diastereomers, setting the stage for radical cyclisation. Under standard radical 
conditions, cyclisation of 47 proceeded smoothly to give a 5-exo-trig product in good 
yield. Subsequent silyl enol ether formation followed by treatment with 
Eschenmoser’s salt and mCPBA[21] produced exo-alkene 48. Selective reduction of 
ketone and hydrogenation to remove the benzyl groups led to triol 49 which, upon 
hydration and double Fetizon oxidation[22] of the diol, underwent lactonisation 
yielding intermediate 9 and introducing the ring C in the natural product. Subsequent 
epoxidation afforded 11 and set the stage of final acid promoted Payne-type 
rearrangement to afford Merrilactone A (Scheme 1-16). 
 
a) mCPBA, DCM, 81%; b) DBU, DCM, -40 ℃, 81%; c) IBX, DMSO, 94%; d) BrCH2CHBr(OEt), PhNMe2, 
DCM, -78 ℃ to RT, 62%; e) Bu3SnH, BEt3/O2, toluene, then CSA, EtOH, 71%; f) TMSOTf, DIPEA, DCM, 
-20 ℃; g) Me2NCH2
+I-, DCM; h) mCBPA, DCM, 70% over 3 setps; i) TFA/H2O, 94%; 
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2-Tf2N-5-chloropyridine, -78 ℃, 99%; I) Pd(OAc)2, PPh3, NBu3, HCOOH, DMF, 40 ℃, 89%; m) DIBALH, 
DCM, -78 ℃, 88%; n) Na, NH3, THF/EtOH, -78 ℃, 100%; o) DOWEX 50WX2, THF/H2O; p) Ag2CO3 on 
celite, toluene, 130 ℃, 64 % for 2 steps; q) DMDO, DCM, 96%; r) TsOH, DCM, 81%. 
Scheme 1-16. Completion of Merrilactone A synthesis 
Hirama and co-workers’s total synthesis of Merrilactone A utilized a novel 
desymmetrising intramolecular transannular aldol reaction to install two of the 
central five-membered carbocycles at the same time. As with Danishefsky’s route, 
serious selectivity problems plague the synthesis at several stages, sffording racemic 
Merrilactone A in 27 steps and an overall yield of 1%. 
1.4.2.2 Asymmetric total synthesis  
Three years after their racemic synthesis of Merrilactone A, Hirama and co-workers 
reported an asymmetric version of their total synthesis in 2006[23]. They successfully 
introduced a bulky protecting group to control the stereochemistry of intra-molecular 
aldol reaction, providing access to an enantioenriched analogue of the 
desymmetrisation substrate 39. For preparing an enantioenriched analogue of 39 a 
novel route was developed, in which the two pendant alcohols were protected 
differentially. The new synthetic route began with the partial reduction of dimethyl 
maleic anhydride 20, and consecutive Wittig olfination and esterifcation to afford 50 
in 68% yield over three steps.  
 
a) LiAlH(OtBu)3, DME, -15 ℃ to RT, 85%; b) Ph3PCH3
+Br-, tBuOK, 0 ℃ to RT, 87%; c) MeI, K2CO3, THF, 
50 ℃, 92%; d) AD-mix-, tBuOH/H2O, 0 ℃, 65%, >99% ee after recrystallisation; e) PivCl, pyridine, 
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DMAP, DCM, 99%; f) cis-dichloroethylene, MeCN, -20 ℃, hv; g) Zn, Ac2O, toluene, 120 ℃; h) LiAlH4, 
Et2O, 75% for 3 steps; i) Me2C(OMe)2, TsOH, DCM, 81%; j) BnBr, NaH, THF/DMF; k) 3M HCl, THF, 91% 
for 2 steps; l) Pd(OAc)4, pyridine, DCM, -50 ℃ then DIBALH, -78 ℃ to -50 ℃, 93%; m) BTBBr, KH, 
[18]crown-6, DMF; n) OsO4, NMO, tBuOMe/tBuOH/H2O, 94% over 2 steps; o)SO3.py, DIPEA, DMSO, 
DCM, -15 ℃ then allylmagnesium bromide, -78 ℃, ratio / 2.7:1, 78%; p) [(PCy3)2Cl2Ru=CHPh], DCM, 
reflux then Pb(OAc)4, 97%. 
Scheme 1-17. Asymmetric synthesis of intramolecular aldol substrate 
Sharpless asymmetric dihydroxylation reaction was employed on 50 to provide a diol 
in excellent enantioselectivity, which underwent in situ lactonisation. The resulting 
hydroxy-γ-lactone was protected as the pivaloate ester to afford 51. Photo promoted 
[2+2] addition of 1,2-dichloroethylene and 51 and subsequent zinc mediated 
dechlorination afforded bicycle 52 in good yield. In order to install the anticipated 
differential protecting group pattern, 52 was then reduced and the resulting 1,2-diol 
was protected as its propylidene acetal to furnish 53, and the remaining primary 
alcohol was protected as the benzyl ether. Key intermediate 55 was synthesized after 
removal of the acetal protecting group followed by cleavage of resulting diol and in 
situ reduction to primary alcohol which was subsequently protected as the 
bis-(trifluoromethyl)benzyl (BTB) ether (60). Further conversion of 55 to the aldol 
substrate 56 was achieved through steps similar to those used in the racemic 
synthesis (Scheme 1-17). 
In order to control the regio-selectivity in the pivotal intra-molecular aldol reaction, 
the intermediate 56 was predominantly deprotonated at C9. The preference over C3 
arose from unfavourable long range steric interaction between the base and 
trifluoromethyl substituents on the pendant BTB protecting group. Transannular 
aldol reaction of the resulting of sodium enolate intermediate 58 proceeded smoothly 
with a highly stereoselectivity, constructing the desired [3.3.0]octane system 59 as 




a) NaHMDS, THF, -100 ℃, 97% overall, 75% yield for desired enantiomer 59 
Scheme 1-18. Asymmetric transannular aldol reaction 
With an established synthetic route to the enantiopure 59, the completion of the total 
synthesis closely followed the route developed in Hirama’s racemic synthesis (cf. 
Scheme 1-16). Advanced enantioenriched intermediate 59 was thus converted into 
Merrilactone A in 15 steps as shown in Scheme 1-19. 
 
a) mCPBA, DCM then florisil, DCM, 75%; b) IBX, DMSO, 91%; c) BrCH2CHBr(OEt), PhNMe2, DCM, -78 
℃ to RT, 92%; d) Bu3SnH, AIBN, toluene, 85 ℃, 73%; e) EtOSiMe3, BF3.Et2O, DCM, 72%; f) Me3SiOTf, 
NEt3, DCM, -20 ℃; g) Me2NCH2
+I-, MeCN; h) mCPBA, DCM, 64% over 3 steps; i) mCBPA, BF3.OEt2, 
DCM, 40 ℃, 91%; j)LiBH(sBu)3, 2-Tf2N-5-chloropyridine, THF, -78 ℃, 73%; k) Pd(OAc)2, PPh3, NBu3, 
HCOOH, DMF, 40 ℃, 91%; l) Na, NH3, THF/EtOH, -78 ℃; m) Ag2CO3 on celite, toluene, 130 ℃, 41 % 
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over 2 steps; n) DMDO, DCM, 91%; o) TsOH, DCM, 96%  
Scheme 1-19. Completion of the asymmetric total synthesis 
The second asymmetric route to (-)-Merrilactone A has been achieved by Hirama and 
co-workers in 31 synthetic steps with an overall 1% yield. The long range steric 
effect of a novel bulky protecting group was employed in controlling the regio- and 
stereo-selectivity in their key intramolecular transannular aldol reaction to construct 
enantiopure cis-bicyclo[3.3.0]octane core in Merrilactone A. This methodology 
demonstrated impressive regio- and stereo-selective transformations, allowing the 
synthesis of the key intermediate 59 as a single enantiomer. 
1.4.2.3 Hirama’s total synthesis of ent-(+)-Merrilactone A  
In 2007 Hirama and co-workers reported a modified version of their asymmetric 
synthesis providing access to unnatural enantiomer, ent-(+)-Merrilactone A[24]. 
Compared with their previous methodology, employing differentially protected 
alcohol moieties to induce long range steric effects, this time they developed a novel 
desymmetrisation strategy applying a chiral lithium amide base in the key 
transannular aldol reaction to selectively deprotonate at C9 over C3. In order to avoid 
the requirement for the synthesis of differential protection upon the pendant alcohols, 
which was a long and cumbersome route employed in the previous asymmetric total 
synthesis (cf. Scheme 1-17), the key aldol substrate could be obtained via a similar 
approach to that reported in the racemic total synthesis (cf. Scheme 1-14). 
The synthetic route began with the photochemical [2+2] reaction of 
1,2-dichloroalkene 41 and 2,3-dimethylmaleic anhydride 20. Subsequent 
dechlorination and anhydride reduction afforded diol 63. Then the two hydroxyl 
moieties were protected as 2,6-dichlorobenzyl (DCB) ethers, which was found to 
provide the best selectivity in the key transannular aldol reaction. The 
dihydroxylation of 63 produced diol 64, which was further elaborated into the 
anticipated diastereomer 65 via a one pot Swern oxidation with subsequent allylation 
to the transient 1,2 dione, analogous to the approach employed in the racemic 
synthesis. Ring closing metathesis and subsequent treatment with Pb(OAc)4 then 




a) benzophenone, acetone, hv; b) Zn, TMSCl, Ac2O, toluene, 85 ℃; c) LiAlH4, THF, 57% for 3 steps; d) 
DCBBr, NaH, THF/DMF; e) OsO4, NMO, tBuOMe/tBuOH/H2O, 91% over 2 steps; f) (COCl)2, DMSO, 
NEt3, DCM, -78 ℃ then allylmagnesium bromide, -78 ℃, 70aa/70bb ratio 9:1, 80%; g) 
(PCy3)2Cl2Ru=CHPh, DCM, reflux, then Pb(OAc)4, 95%. DCCB = 2,6-dichlorobenzyl 
Scheme 1-20. Preparation of DCB protected aldol substrate 
The group then focused on the development of novel methodology to enable the 
regio- and enantio-selective transformation of aldol substrate 68. Screening of a 
number of chiral lithium amide bases indicated that 71 could provide the desired 
enantiomer in good regio- and stereoselectivity over the other undesired enantio- and 
diastereomers. The transient intermediate lithium enolate 69, which could be 
obtained via selective deprotonation at C9 over C3 dione 68 when treating it with 
chiral base 71, underwent transannular aldol reaction in a stereoselective fashion to 
provide the enantioenriched 70 in 79% yield and 57% ee. The enantiomeric excess of 
70 could be increased to 99% after a single recrystallisation step with a yield of 53% 
(Scheme 1-21). 
With the enantiopure key intermediate 70 in hand, the total synthesis of 
ent-(+)-Merrilactone A could be achieved in analogy with the substrate preparation 
reported in the racemic total synthesis, outlined in Scheme 1-16 and the asymmetric 
variant described in Scheme 1-19. The conversion of 70 into the unnatural 
enantiomer of Merrilactone A was thereby completed in 16 steps and the total 

































a) 71, LiCl, THF, -78 ℃, 79%; b) recrystallization, 1:1 EtOAc/hexanes, 53%. 
Scheme 1-21. Enantioselective transannular aldol reaction using chiral base 
When the synthesis was finished, they also investigated the unnatural enantiomer’s 
biological activity. Surprisingly, biological experiments revealed that the 
ent-(+)-Merrilactone A displayed similar level to stimulate neurite outgrowth as 
natural merrilactone A. This unexpected result presented an uncommon example of 
similar levels of biological activity being observed in both enantiomers of a natural 
product. Further research into the mechanism of this unexpected biological activity 
was reportedly currently ongoing. 
Hirama’s asymmetric total synthesis of both natural and unnatural enantiomers of 
Merrilactone A represented substantial efforts in developing the novel 
desymmetrisation strategy for the key intramolecular transannular aldol reaction. 
Enantioselective preparation of key intermediates via either selective deprotonation 
relying on the use of chiral bases, or by means of differential protection approach, 
provided a reliable and elegant approach towards the natural product. 
1.4.3 Metha’s racemic total synthesis of Merrilactone A 
In 2005 Singh and Mehta published a model study on a novel synthesis of the core of 
Merrilactone A[13a]. The key steps in the model study subsequently constituted the 
basis of the total synthesis of Merrilactone A, which was published in the following 
year[13b]. As with the previous two total syntheses, the oxetane motif was constructed 
in the final step via the known homo-Payne rearrangement. Scheme 1-22 shows the 
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retrosynthetic approach adopted by Mehta and Singh. 
 
Scheme 1-22. Mehta and co-workers retrosynthesis 
Relying on the acid promoted homo-Payne rearrangement in the final step of the 
synthesis of Merrilactone A, epoxide substrate 11 was anticipated to be accessible 
from 72 via ozonolysis and oxidation. Tetracycle 72 would be obtained from the [2+2] 
photo-addition product 73 by dehalogenation reaction. Compound 74 would be 
synthesized in a pivotal ring closing metathesis reaction of diene 75, which was 
prepared from 76 through a multi-step sequence of deprotection-protection. Further 
analysis revealed that 77 is a suitable starting material for the total synthesis. 
Double hydroxy-methylation of 1,4-dione 77 followed by acetonide protection and 
subsequent Luche reduction produced 78 in 77% yield over three steps. Successive 
allylation and oxidation furnished cyclopentenone 76 in high yield. Exposure of 76 to 
an acetonide deprotection-protection sequence afforded 79 thus setting the pivotal 
stage for the subsequent sequential annulation of carbocycle C and the γ-lactone ring 
D. The deprotection of 76 and reprotection under equilibrating conditions afforded 
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the desired 79 and 76 as a 1:1 mixture, with the latter isomer being readily recycled. 
Oxidation of the primary alcohol in 79 to the aldehyde and a subsequent multi-step 
sequence of methylation, oxidation and methylenation under Wittig conditions, 
afforded 75 in 36% yield over four steps. The key ring closing metathesis reaction on 
exposure to Grubbs’ first generation catalyst was now applied to the cis-orientated 
allyl and propenyl side chains, furnishing bicycle core 74 in a good yield, and set the 


























a) DBU, 40% HCHO, THF, 0 ℃, 95%; b) acetone, MS, Amberlyst-15 then NaBH4, CeCl3, 0 ℃, 83%; c) 
CeCl3, allylmagnesium chloride, -78 ℃, then MnO2, DCM, 81%; d) 2M HCl, THF/H2O, 90%; e) acetone, 
MS, amberlyst-15, 94%; f) PDC, DCM, then MeLi, Et2O, 62%; g) PDC, DCM then Ph3PCH3Br, tBuOK, 
Et2O, 55%; h) Grubbs’ catalyst I, DCM, reflux, 76% 
Scheme 1-23. Synthesis of RCM substrate and metathesis reaction 
The photo [2+2]-cycloaddition reaction of intermediate 74 and 1,2-dichloroethylene 
proceeded in 65% yield, however it only gave a moderate degree of facial selectivity 
in favour of the desired β-face isomer 76 over the undesired diastereomer. After 
separation of the diastereomers, a number of straightforward transformations were 
applied, including reductive dehalogenation, DIBAL-H reduction, protection of the 
resulting alcohol with a TBS group, and subsequent acetonide deprotection to furnish 
the diol 77 in 54% yield over four steps. Conversion of 77 to 78 via a multi-step 
sequence of TPAP oxidation, Wittig methoxymethylenation, and consecutive 
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acid-mediated hydrolysis with simultaneous intramolecular hemiacetal formation and 
subsequent oxidation afforded 78 in good yield. Conversion of the cyclobutene ring 
of 75 into the right-hand γ-lactone ring was promoted by ozonolysis and successive 
in situ sodium borohydride reduction followed by oxidation to furnish the bis-lactone 
79. Elaboration of 79 into Merrilactone A was carried out by means of the well 
known Payne-type rearrangement strategy[5] via deprotection of TBS, epoxidation 




























a) trans-dichloroethylene, hv, / face ratio 1:2. 65%; b) sodium naphthalenide, -60 ℃, 70%; c) DIBALH, 
-78 ℃, 95%; d) TBSOTf, NEt3, DCM, 86%; e) 2M HCl, THF/H2O, 95%; f) TPAP, DCM then 
Ph3PCH3OCH3, tBuOK, THF, 54%; g) HClO4, DCM/THF; h) PCC, DCM, 62% for 2 steps; i) O3, MeOH, 
-78 ℃ then NaBH4, MeOH, -78 ℃, 45%; j) PCC, DCM, 80%; k) TBAF, AcOH, THF, 85%; l) DMDO, 95%; 
m) TsOH, DCM, 80%. 
Scheme 1-24. Elaboration of key intermediate into Merrilactone A 
In summary, Mehta and Singh have developed a route to Merrilactone A which was 
achieved in a 27 step sequence with an overall 0.4% yield. A number of selectivity 
issues may be noted such as the lack of stereoselectivity in the [2+2] photo 
cycloaddition. 
1.4.4 Frontier’s racemic total synthesis of Merrilactone A  
In 2007, Frontier’s group published their total synthesis of (±)-Merrilactone A in 
communication form,[15] and in the following year, a full account of their research 
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was reported describing their completion of the synthesis.[16] Based on the well 
established methodology to install the oxetane in the final step, Frontier’s group 
developed an impressive synthetic route involving a metal-catalyzed Nazarov 
































Scheme 1-25. Frontier’s retrosynthetic analysis 
Outline in Scheme 1-25 is the retrosynthetic approach adopted by Frontier and 
co-workers. Conversion of the advanced intermediate 9 into merrilactone A was to be 
achieved via the known epoxidation and homo-Payne rearrangement approach. The 
construction of the γ-lactone ring C would be achieved from alcohol 80 at a late stage. 
Subsequently, tricycle 80 would be accessible from 81 via a radical cyclisation 
reaction. Bicycle 81 would be prepared from compound 82 via a key Nazarov 
cyclisation reaction. Further analysis indicated that 82 was readily synthesized from 
83 through a number of straightforward transformations. In turn, 84 was a suitable 
starting material for the total synthesis. 
Outlined in Scheme 1-26 is the preparation towards the substrate for the pivotal 
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Nazarov cyclisation reaction. The synthesis began with the organometallic 
1,2-addition reaction of lithiated ethyl propiolate to known aldehyde 84. The 
lactonisation of resulting product proceeded smoothly followed by tin-bromide 
exchange producing the vinyl bromide 83 in excellent yield. Treatment of 83 with 
triethylamine and triisopropylsilyl triflate furnished silyloxyfuran in quantitative 
yield. The alkenyllithium derived from the silyloxyfuran was then added to a solution 
of Weinreb amide 85 to furnish the advanced intermediate 82, the substrate for the 
next key Nazarov cyclization reaction.  
 
a) ethyl propiolate, nBuLi, THF, -78 ℃, 88%; b) Bu3Sn(Bu)(CN)CuLi2, THF/MeOH, -78 ℃, 90%; c) Br2, 
DCM, 93%; d) NEt3, triisopropylsilyl triflate, DCM, -78 ℃ to 0 ℃, quant.; e) tBuLi, Et2O, then XX, 82%. 
Scheme 1-26. Synthesis of key Nazarov substrate 
After careful screening of numerous model compounds closely related to 82 and 
adjusting subtly the structure of catalysts employed in the Nazarov cyclisation, the 
dicationic iridium catalyst - Ir(CO)(Me)(dppe)(DIB)2+ (BArF)-2- emerged as the 
optimal catalyst for this system. Treatment of silyloxyfuran 82 with a dicationic 
iridium catalyst afforded the anticipated bicycle 83 as a single diastereomer - due to 
the conrotatory nature of the 4π electrocyclic pathway of the Nazarov cyclisation C4 










82 83  
a) [Ir(CO)(Me)(dppe)(DIB)]2+-(BArF)-2 (2 mol%), DCM, 87% 
Scheme 1-27. Nazarov cyclisation of silyloxyfuran 
Following the successful Nazarov cyclisation, removal of the trimethylsilyl group of 
the resulting bicycle 83 set the stage for the radical cyclisation reaction. The 
desilylation product was exposed to tributyl tinhydride, followed by subsequent 
global silyl deprotection induced by TBAF to furnish alcohol 84 in excellent yield. 
The right-hand γ-lactone ring D was then constructed through transformation of the 
alcohol into the carbonate followed by an intramolecular nucleophilic lactonisation. 
Subsequently, methenylation, reduction of ketone to secondary alcohol and 
consecutive isomerisation of the exo-alkene provided the advanced common 
intermediate 86a, which was previously transformed into merrilactone A by 































a) AgNO3, KCN, THF/EtOH/H2O, 83%; b) AIBN, Bu3SnH, PhH, reflux then TsOH, 91%; c) TBAF, THF, 
99%; d) pyridine, DMAP, ethylchloroformate, 95%; e) NaH, THF; f) TsOH, PhH, reflux, 90% for 2 steps; 
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g) NaH, MeI, HMPA, THF, 97%; h) NaBH4, MeOH, ration 30a/30b 1.2:1, 93%; i) Dess-Martin 
periodinane, DCM, 98%; j) TsOH, PhH, reflux, 92%; k)mCPBA, DCM, l) TsOH, DCM, 68% over 2 steps. 
Scheme 1-28. Completion of the total synthesis 
The stereoselective reduction at C7 proved to be somewhat problematic as it only 
gave moderate facial selectivity for desired 86a over undesired product 86b in a 
1.2:1 ratio. The two diastereoisomers could be separated by column chromatography 
and the undesired isomer could be recycling by re-oxidation to ketone thus making 
the overall synthesis more efficient. The final established two steps were then carried 
out in analogy with all previous total syntheses; stereoselective epoxidation and 
homo-Payne rearrangement to furnish racemic merrilactone A (Scheme 1-28). 
The efficient and elegant total synthesis of Merrilactone A involving a dicationic 
iridium catalyst promoting pivotal Nazarov cyclisation disclosed by Frontier and 
co-workers in only 17 steps presented a highly impressive overall yield of 10% and 
the research towards the asymmetric total synthesis with chiral catalyst is reportedly 
ongoing in the same group. 
1.4.5 Greaney’s model study 
In 2005 Greaney and co-workers reported a conceptually different approach towards 
the synthesis of the core of Merrilactone A based on an intramolecular [2+2] 
Paternò-Büchi photoaddition strategy[26]. In all previously reported total syntheses of 
Merrilactone A the central oxetane motif was constructed relying on a homo-Payne 
type rearrangement as the final step, However Greaney and co-workers employed an 
intramolecular [2+2] Paternò-Büchi photoaddition to create this key oxa-[3.3.3] 
structural motif 91 in a very high 93% yield. In addition, this work demonstrated a 
novel methodology to install the γ-lactone A ring via a tandem oxy-carbopalladation 




a) tBuLi, Et2O, -78 ℃, 89%; b)TBAF, THF; c) PDC, DCM, 62% over 2 steps; d) Pd(OAc)2, CH2=CHOEt, 
65%; e) OsO4, NaIO4,THF/H2O, 47%; f) hv, MeCN 93%. 
Scheme 1-29. Paternò-Büchi photoaddition in the synthesis of the core of 
Merrilactone A 
1.4.5.1 Unpublished work within Greaney’s group 
The development of the Paterno-Buchi approach to Merrilactone A in the Greaney 
group proved ultimately unsuccessful[27], but did lay the groundwork for a successful 
synthesis via alternative chemistry (vide infra). Our initial efforts at extending the 
Paterno-Buchi route focused on the installation of the two key cis-methyl quaternary 
centres using the [2+2] photocylcoaddition route shown in Scheme 1-30. The two 
quaternary centres are set via photocycloaddition reaction between 20 and 92 in the 
very first step in the synthesis (Scheme 9-30). 
The cyclobutane 93 is then taken through several standard transformations to afford 
94, where a key Tiffeneau-Demjanov ring expansion reaction had been employed to 
produce the cyclopentenone 95. Critically, this reaction was found to be highly 
regioselective with the least-substituted carbon centre migrating. Exchange of benzyl 
for ethoxymethyl protecting groups was then necessary because benzyl groups were 
found to quench subsequent photocycloaddition reactions[27]. Stereoselective 1, 
2-addition of alkyllithium to cyclopentenone 96 proved to be very successful, 
proceeding in good selectivity (6 : 1) and excellent yield. Attempts at further 
manipulation of 95, however, were unsuccessful due to the facile elimination of the 
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tertiary alcohol. Both the stereoselectivity of 1,2-addition to ketones such as 96, and 
the instability of tertiary allylic alcohols such as 97, proved to be major issues in the 
synthesis, and shaped all subsequent attempts at a stereocontrolled assembly of the 
central cyclopentane B ring.  
a) a) hv, MeCN, acetone, 98%; b) LiAlH4, Et2O; c) NaH, BnBr, THF; d) H2SO4, H2O, MeCN, 71% over 3 
steps; e) N2CHCO2Et, BF3.OEt2, f) MgCl2.6H2O, DMSO, 54% over 2 steps; g) H2, Pd/C; h) EMOCl, NaH, 
THF; i) PhSeBr, LDA, then H2O2, H2O, DCM, 40% over 3 steps; j) tBuli, Et2O, -78 ℃. 
Scheme 1-30. Paternò-Büchi photoaddition in the synthesis of Merrilactone A 
In the Paterno-Buchi regime, the addition of the propargyllithium derived from 9 led 
to propargyl alcohol 100 that had no elimination mechanism available, representing a 
more tractable intermediate. Oxidation and Lindlar hydrogenation then afforded the 
cis-enone, a highly pre-organised substrate 101 for Paternò-Büchi 
photocycloaddition (Scheme 1-31). Unfortunately, all attempts at [2+2] cycloaddition 
failed. It appeared that the change of functional group in substrate 101 relative to the 
simpler model 90 (Scheme 1-29; enone in sidechain, alkene in ring v ketone in side 
























a) tBuLi, Et2O, then HCl work up; b) PDC, DCM; c) Lindlar, H2; d) EOMCl, NEt3; e) hv 
Scheme 1-31. Paternò-Büchi photoaddition in the synthesis of Merrilactone A 
The aim of this PhD project is build on the foundations in previous years to finish the 
total synthesis of merrilactone A. Work will initially focus on the development of the 
methodology appropriate for 1) In corporation of C10 and C11 via Pd-catalyzed 
decarboxylation- dehydrogenation reaction, 2) construction of the bicyclic BC core 
via titanium(III) mediated radical epoxide opening and cyclization strategy. Finally 
regiodivergent synthesis of both anislactones and merrilactone A will be achieved by 
orthogonal lactonization sequences. 
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2 Total synthesis of (±)-Merrilactone A  
Merrilactone A’s intriguing biological activity combined with its unique and 
challenging structure has made it a highly attractive target for total synthesis. Even 
though several fantastic and concise synthetic routes have been published in the 
leading journals[1-9], its structure still challenges chemists to solve problems of C-C 
bond formation in stereochemically complex architectures. 
2.1 Retrosynthesis analysis  
The general features of our synthesis of Merrilactone A are based on the 
retrosynthetic analysis outlined in Scheme 2-1. We hoped to develop a synthetic 
route that could access both Merrilactone A and the related Anislactone structure. 
The core oxetane ring in Merrilactone A is generated from 243 via several well 
established procedures: the biomimetic homo-Payne rearrangement, selective 
epoxidation and isomerisation of the exo-alkene. Both γ-lactone rings A and D in (1) 
are disconnected by lactonization from 232. The bicyclic BC core in 232 containing a 
highly congested C9 quaternary stereocentre would be installed via a pivotal 
titanium(III)-mediated reductive ring opening of epoxide and radical cyclization onto 
the pendant alkyne in 223. This robust and efficient methodology will be the focus of 
a simple model study (vide infra). The tertiary alcohol at C4 would be constructed 
via a stereoselective 1,2-addition of an organometallic to the ketone in 219. The alkyl 
chain in cyclopentenone 219 would be incorporated via a Pd-catalyzed 
decarboxylation-dehydrogenation reaction from cyclopentenone 179, which would 
be prepared by transesterification and alkylation from 144. The five-membered C 
ring at the core of natural product would be accessible by means of a key 
Tiffeneau-Demjanov ring expansion reaction from cyclobutane 94. The cis-methyl 
quaternary centres in cyclobutane would be installed using a [2+2] 







































































Anislactone A, 2a. R1 = H, R2 = OH




















Scheme 2-1. Retrosynthesis for Merrilactone A and Anislactones 
2.2 Synthesis of simple model system  
In order to investigate the feasibility of the envisaged synthetic route, a simple model 
system was designed and carried out in which several key transformations were 
included (Scheme 2-2). Key amongst them was a Tsuji-Trost approach to the 
incorporation of C10 and C11, and the central reductive epoxide cyclisation reaction 
to install C9. The model system synthesis started with commercially available ethyl 
2-oxocyclopentanecarboxylate 103. After several attempts, it was discovered that by 
simply heating the substrate with allyl alcohol without any catalyst[10-12], allylic 
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-keto ester 104 could be readily prepared from ethyl 2-oxocyclopentanecarboxylate 
103 in very high yield on 20g scale. The toluene and excess allyl alcohol were 
evaporated under reduced pressure and the crude allyl 2-oxocyclopentanecarboxylate 
104 was subjected to the next step without further purification. An alkylation of the 
-ketoester is required to install C10 and C11 of the natural product. The alkylation 
reaction proceeded slowly with TBS-protected 2-bromoethanol in refluxing acetone 
for 10 h producing 106 in 50% yield after two steps. Then it was ready for the next 
step: Tsuji-Trost reaction[13-15]. Cyclopentanone 106 was treated with Pd(OAc)2 and 
PPh3 (1:1 ratio) in acetonitrile and the reaction mixture was heated to 70 ℃ under 
argon. TLC analysis indicated that reaction was normally completed in 1-2 hours, 
then a filtration though a short silica column to remove palladium furnished clean 








































a) allyl alcohol, toluene, reflux; b) K2CO3, acetone, reflux, 46 % over 2 steps; c) Pd(OAc)2, PPh3, MeCN, 
reflux, 77 % yield; d) H2O2, NaOH, MeOH, 88 % yield; e) t-Buli, Et2O, -78 ℃; f) K2CO3, MeOH, 40 % 
over 2 steps, g) TiCp2Cl2, Zn, THF, 88 % yield. 
Scheme 2-2. Model system for the constructions of AB ring in merrilactone A 
Exposure of cyclopentanone 107 to H2O2 in MeOH gave the desired epoxide in good 
yield. 1,2-Addition was then carried out at -78 ℃ in diethyl ether where the 
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cyclopentenone 108 was treated with the organolithium compound generated in situ 
from (4-iodobut-1-ynyl)-trimethylsilane 109 and t-butyllithium[16]. This afforded the 
tertiary alcohol in 30 min. Removal of TMS group using methanolic KOH[17-19] 
afforded the epoxide product 110 in high yield, the substrate for the key radical 
cyclisation.  
Background and mechanism of Ti(III) induced radical reaction. The utility of 
epoxide building blocks has received extensive attention, since they are highly 
versatile intermediates in the synthesis of natural products and biologically active 
compounds. With the rapid development of radical chemistry, the selective 
one-electron reduction of an epoxide to a radical intermediate represents a very 
useful synthetic tool, in which the generated radical intermediate could be trapped in 
subsequent reactions (Scheme 2-3).[20-22] 
 
Scheme 2-3. One electron reduction of epoxide 
Compared to reactions involving polar intermediates, another advantage of radical 
chemistry is the functional group tolerance. Sensitive functional groups such as 
esters, acetals, nitriles and ketone are tolerant to radical conditions while allylic 
ethers and aldehydes lead to reduced yields. Additionally, it should be expected that 
the product distribution will be different from those of classical reactions of epoxides. 
The regio- and stereochemistry of the epoxide opening via C-O homolysis is 
controlled by the relative stability of the intermediate radicals, which is affected by 
both substitution patterns (for example, tertiary > secondary > primary) and 
stereoelectronic factors.  
In 1972 Green and co-workers first reported bis(cyclopentadienyl) titanium(III) 
chloride,[23] which in the solid state existed as a chloride-bridged dimer. In the 
presence of donor solvent such as THF, however, the dimer dissociates to produce 
the monomer species. The titanium(III) regent was found to be able to promote the 
homolytic cleavage of epoxides with remarkable selectivity under room 
temperature.[18-21]  Isolation and purification of bis-(cyclopentadienyl)titanium(III) 
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chloride species was not necessary as the active reagent could be generated in situ by 
means of stirring a solution of the inexpensive, commercially available titanocene 
dichloride (red in THF) with activated powered zinc metal (solution becomes green) 
(Scheme 2-4). 
 
Scheme 2-4. Generation of titanium(III) species 
Titanium(III)-Mediated Epoxyolefin Cyclization. Titanium (III)-promoted radical 
carbon-carbon bond forming reactions have been investigated intensively since the 
5-hexenyl radical cyclization is known to be a rapid and efficient process.[24,25] 
 
a) Cp2TiCl/THF/rt. b) D3O
+. c) workup, H3O
+ 
Scheme 2-5. Mechanism fot the Ti(III) induced radical cyclization 
In the case of intramolecular radical cyclization, 2 molar equivalents of Cp2TiCl in 
THF was added to a solution of 6,7-epoxy-1-heptene 115 in THF, the green color of 
the titanium(III) species being rapidly discharged to a red color when subjected to the 
epoxide. Quenching the mixture with D2SO4 in D2O afforded 2-methylcyclo- 
pentanemethanol 119 which was >85% monodeuterated at the methyl group in 
around 70% yield. This result suggested that hexenyl radical cyclization does indeed 




a) THF-d8, RT; b) THF, RT; c) D2O/D
+.; d) Workup (H2O/H
+) 
Scheme 2-6. Mechanism fot the Ti(III) induced radical cyclization  
In contrast to these results, cyclization of 6,7-epoxy-1-heptyne 120 followed by 
deuterolysis afforded 2-methylenecyclopenanemethanol 120 containing no deuterium 
as the methylene group (Scheme 2-6). The initially formed vinyl radical would 
abstract a hydrogen atom from the THF solvent immediately due to its high reactivity. 
Using THF-d8 as the solvent for the reaction, only one deuterated olefin 122 was 
obtained even after work up with H2O. This further confirmed the free radical nature 
of the intermediates involved in these transformations. 
Radical cyclization in natural products synthesis. Clive and co-workers applied 
this methodology in their total synthesis of (±)-ceratopicanol 128 (Scheme 2-7) [26,27]. 
Exposure of the tricyclic epoxide 123 to Cp2TiCl solution in THF led to 
regioselective, radical epoxide opening, affording the more substituted carbon radical 
126. Subsequent 5-exo-dig cyclisation of the radical 126 with the tethered terminal 
alkyne constructed a new carbon-carbon bond, resulting in intermediate radical 127. 
Radical 127 was then quenched with a second equivalent of the titanocene reagent 
affording 124. Finally acidic workup furnished the desired product 125 in 82% yield. 

































Scheme 2-7. Radical cyclization in the synthesis of Ceratopicanol 
Toyota and co-workers also published another example employing the radical 
epoxide opening methodology in cyclisations with alkynes in the study towards the 
synthesis of andrastins A–D (Scheme 2-8)[28,29]. In this work, a highly stereoselective 
sequence of radical epoxide opening of the tricyclic epoxide 129 was followed by 
subsequent 5-exo-dig cyclization, affording the densely functionalised tricycle 130 as 
the sole product in 80% yield. Interestingly, under the reaction conditions the 
methoxymethyl ether group was removed.  
 
Scheme 2-8. Toyota and Roy’s examples of radical epoxide opening methodology 
As the examples of the application of titanium(III) mediated radical reaction in 
natural products synthesis demonstrate, there is some literature precedent for the 
formation of 5-membered carbocycles cotaining exo-alkenes. However, for the 
reaction related to the compounds similar to our substrates 110, bearing a tertiary 
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alcohol adjacent to the carbon radical to be formed, no literature precedent could be 
found.  
Radical cyclization in model system. At this stage we attempted the titanium(III) 
mediated reductive ring opening of epoxide and radical cyclization reaction[20] on 
substrate 110. It was expected that the more stable tertiary radical would be 
generated at C9, that would then undergo cyclisation to form the 5, 5 bicyclic system. 
The titanium(III) reagent was prepared by stirring a red THF solution of 
commercially available titanocene dichloride with activated powered zinc metal. 
After 30 min, the red solution turned to lime green indicating formation of 
titanium(III). The clear green solution of titanium(III) was then transferred via 
cannula to the THF solution of compound 110. In principle, the stability of the 
carbon radical generated in the reaction will be determined by the substitution pattern, 
for example, tertiary > secondary > primary. As expected, subjecting 110 to the 
solution of titanium(III) in THF led to selective scission of the C-O bond to form the 
more stable tertiary radical (Scheme 2-9). This was followed by 5-exo-dig cyclization 
onto the pendant alkyne furnishing bicyclic product 111 in 82% yield. The initially 
formed vinyl radical 132 abstracted a hydrogen atom from the THF solvent 
immediately. 
Scheme 2-9. Proposed mechanism for the Ti(III) induced radical cyclization 
Following this successful model radical cyclization reaction, the methodology was 
applied to the advanced intermediate 133 by co-worker Karsten Meyer (see Meyer, K. 
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PhD Thesis, University of Edinburgh, 2008). The reaction proceeded smoothly and 
the desired cyclisation product 134 was achieved in 51% yield. However further 
elaboration of 134 into the target natural product was unsuccessful as the OBn 




Nevertheless, the successful radical cyclization reaction constituted an important 
milestone in our route for the total synthesis of merrilactone A. Once this 
methodology had been effectively demonstrated we decided to prepare the key 
intermediate cyclobutane 94 in order to carry out the real total synthesis towards 
Merrilactone A (Scheme 2-11). 
2.3 Synthesis of cyclopentanone 
2.3.1 Photochemical [2+2] route to cyclobutanone 
The commercially available compounds 2,3-dimethylmaleic anhydride 20 and 
dimethyl ketene acetal 135 were envisaged as the starting materials to undertake the 
synthesis of the sub-target cyclobutane through the strategy depicted in Scheme 2-11. 
Our plan involved four main transformations: (i) construction of cyclobutane 136 by 
a [2+2] photocycloaddition[30] of 20 and 135, (ii) reduction of anhydride 136 to diol 
137, (iii) subsequent protection of diols as their benzyl ethers 138, (iv) deprotection 



























135 20 136 137
13894  
a) hv, MeCN, acetone, benzophenone, 94%; b) LiAlH4, Et2O; c)BnBr, NaH, Bu4NI,  THF; d) H2SO4, 
H2O, 82% over 3 steps 
Scheme 2-11. [2+2] photocycloaddition reaction 
The [2+2] photocycloaddition reaction[30] was performed via the irradiation of a 
solution of 2,3-dimethylmaleic anhydride 20 and dimethylketene acetal 135 in a 
solvent of acetone and acetonitrile using a 400 W medium pressure mercury lamp 
with a pyrex filter under water cooling. In the initial 5 hours the reaction proceeded 
smoothly and 1H NMR analysis revealed that the conversion of 2,3-dimethylmaleic 
anhydride is over 60%. However the photoreaction became sluggish and lots of the 
starting 2,3-dimethylmaleic anhydride still remained even after irradiation for 20 
hours. We found that the photocycloaddition reaction could be accelerated greatly by 
means of the use of benzophenone as a photosensitizer. This method effectively 
promoted the photocycloaddition reaction and resulted in 100% conversion of 
2,3-dimethylmaleic anhydride in 20 hours. Needle crystals of photocycloaddition 
product 136 could be obtained via recrystallization from diethyl ether and hexane in 
94% isolated yield, thus avoiding silica gel column chromatography.  
The key intermediate cyclobutanone 94 was prepared from 136 via three 
straightforward steps. Firstly, reduction of 136 on a 10 gram scale with lithium 
aluminium hydride (LiAlH4) in diethyl ether furnished the diol 137 in quantitative 
yield (95% purity determined by 1H NMR experiment), which was then directly used 
in the next step. Secondly, protection of diol with BnBr using NaH in THF and a 
catalytic amount of nBu4NI was monitored by TLC until the the reaction was 
completed. Subsequently, the reaction was quenched carefully with water and then 
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the pH of the reaction mixture was adjusted to 1 by adding H2SO4 solution to remove 
the acetal group. This three-step sequence produced the cyclobutanone 94 in 89% 
yield after purification by silica gel chromatography.  
The advantage of this approach was that the challenging cis-methyl quaternary 
centres were set immediately by means of a [2+2] photocycloaddition reaction as the 
very first step in the synthesis. The key intermediate cyclobutanone 94 was 
accumulated on a large scale of around 30 grams in a short time via  the effective 
and robust approach, requiring only one silica chromatography purification. With 
sufficient cyclobutanone 94 in hand our synthesis advanced to the next ring 
expansion stage. 
2.3.2 Regioselective Tiffeneau-Demjanov ring expansion  
The classical Tiffeneau-Demjanov rearrangement (TDR) is the reaction[31] of 
1-aminomethyl cycloalkanols with nitrous acid to form an enlarged cycloketone. The 
TDR reaction was discovered by the Russian chemist Nikolai Demyanov and 
enlarged upon by Tiffeneau in 1903 and 1937, respectively. This reaction provides an 
easy way to expand a ring by one carbon. The starting ring can be between four and 
eight carbons giving good yields of product rings having five to nine carbons, while 
the yield decreases as initial ring size increases. The basic reaction mechanism is a 
diazotation of the amino group in 139 by nitrous acid followed by expulsion of 
nitrogen and formation of a carbocation 140. A rearrangement reaction with ring 
expansion forms a more stable oxonium ion which is deprotonated to produce ring 
expansion product 142 (Scheme 2-12).  
 
Scheme 2-12. Mechanism for the ring expansion reaction 
For the synthesis of merrilactone A, a ketone group rather than a -amino alcohol 
was present in the substrate and thus a modified TDR reaction has to be employed in 
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which ethyl diazoacetate is used as the ring expansion reagent[34]. Ethyl diazoacetate 
was preferred over diazomethane for several reasons: Firstly, ethyl diazoacetate is 
easy to handle compared to diazomethane which possesses the unpleasant traits of 
explosiveness and difficulty of preparation and preservation. Secondly, ethyl 
diazoacetaete affords a ring expanded -ketoester which was to be employed for 
further elaboration. Finally, literature precedent was found where a greater 
regioselectivity was obtained in the rearrangement step with ethyl diazoacetate 
compared to diazomethane. Several examples were reported where this methodology 






























a) N2CHCO2Et, BF3.Et2O, DCM, 0 ℃, 82% 
Scheme 2-13. Tiffeneau-Demjanov ring expansion reaction 
Due to the unsymmetrical nature of our substrate 94, the carbon atom migration 
could occur on ether side of the formed carbonyl motif, therefore giving two possible 
regioisomeric expansion products 145 and 144. Additionally, the newly formed 
carbon stereocentre between ketone and ester group, was created without 
stereocontrol, thus forming diastereomeric mixtures of 1,3-ketoesters. Initial 
experimental studies on Tiffeneau-Demjanov ring enlargement reaction were carried 
out with the use of boron trifluoride etherate as the Lewis acid. Nucleophilic attack 
of ethyl diazoacetate onto an activated carbonyl group followed by loss of nitrogen 
with simultaneous ring expansion rearrangement resulted in desired product 144 in 
82% yield (Scheme 2-13). A highly regioselective migration of the less-substituted 
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carbon atom centre was observed in this case. The byproduct suspected to be the 
undesired regioisomer 145 was collected in 10% yield but the structure was not 
confirmed due to the complicated 1H NMR signals.    
2.3.3 Transesterification reaction 
Transesterification is one of the classic organic reactions having enjoyed numerous 
laboratory uses and industrial applications. It is more advantageous than ester 
synthesis from carboxylic acids and alcohols which require either harsh condition at 
high temperature or a coupling reagent such as DCC. These reactions are often 
catalyzed by the addition of an acid or base catalyst, or with the help of enzymes 
such as lipases.  
A search of the literature revealed several pertinent example of transesterification of 
a -keto ester with an allylic alcohol proceding in good yield[10-12]. Mechanistic 
studies suggested that the transformation most likely proceeds via a ketene 
intermediate. In contrast to the model reaction (Scheme 2-14) in which substrate 103 
underwent transesterification reaction smoothly, subjecting 146 to the same 
conditions gave no product even in refluxing toluene for one day. This control 
experiment further confirms the proposed mechanism involving a ketene 
intermediate pathway (not possible from 146). 
 
Scheme 2-14. Transesterification reaction in model system 
This exceedingly simple, yet effective method was applied to our substrate 144. The 
transesterification procedure was extremely simple experimentally: a mixture of 144 
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and the allylic alcohol in toluene was merely heated to reflux, with a short tube in 
place of the usual condenser. The equilibrium was thus shifted to right due to the loss 
of the relatively volatile ethanol from the reaction mixture, furnishing the desired 

















a) toluene, reflux, 94% 
Scheme 2-15. Transesterification reaction 
Both ring expansion and transesterification reactions proceeded smoothly, thus 
sufficient materials could be accumulated in a short time to set the stage for the next 
alkylation and Tsuji-Trost reaction.  
2.3.4 Alkylation of 1,3-ketoester and Tsuji-Trost reaction 
2.3.4.1 Mechanism of Tsuji-Trost reactions 
The palladium-catalyzed decarboxylation-dehydrogenation of allyl -keto 
carboxylate to-substituted ,-unsaturated ketone was first reported by Jiro Tsuji 
in 1982.[13-15] Three competitive reaction pathways catalyzed by palladium with 
substrate 150 are outlined in Scheme 2-16, including path a, decarboxylation- 
dehydrogenation to give 2-alkylcyclopentenone 153 or 154, and path b, the 
decarboxylation-protonation to give 2-allyl-2-alkylcyclopentanone 155, and path c 
the decarboxylation-allylation to give 2-allyl-2-alkylcyclopentanone 156.  
The three reaction pathways could be selectively controlled by different reaction 
conditions shown in Scheme 2-16. The decarboxylation dehydrogenation reaction 
was possible to be carried out as a main path under certain conditions. In attempts to 
improve the selectivity of the desired enone formation, the molar ratio of 
phosphine/palladium was found to be the key parameter in this reaction. In MeCN 
and using dppe, the enone formation becomes predominant when the molar ratio of 
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phosphine/palladium becomes lower than 1.  
 
Scheme 2-16. Different pathway for the Tsuji-Trost reaction 
 
 
Scheme 2-17. Mechanism for the Tsuji-Trost reaction 
The mechanism of enone formation is explained in Scheme 2-17. Firstly the Pd(0) 
species is generated in situ from Pd(OAc)2, which undergoes oxidative addition to 
the allyl ester affording allylpalladium -keto carboxylate 158. Subsequently, 158 
undergoes decarboxylation to produce the allylpalladium enolate complex 159, 
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which is in equilibrium with the carbon-bonded complex 160. Then the enone is 
formed by means of the elimination of Pd-H from 160. Finally the reductive 
elimination of the allylpalladium hydride complex produces propene and thus 
regenerates the Pd(0) species for the next reaction cycle. 
2.3.4.2 Alkylation of 1,3-ketoester with protected 2-bromoethanol 
With the ring expansion product in hand, the introduction of a quaternary centre at 
the 2-position of the 1,3 ketoester needed to be addressed prior to Tsuji-Trost 
reaction. We envisaged a direct introduction of a two carbon fragment for the carbon 
segment of γ-lactone via alkylation with an alkyl halide.  
Initial attempts of such a transformation were carried out based on the TBS-protected 
2-bromoethanol 105, which was used in the model system successfully. 
Unfortunately, employing a range of conditions, no formation of the anticipated 
reaction product 162 from 149 could be achieved in our real synthesis (Scheme 2-18). 
This is likely due to increased steric hindrance between the two quaternary carbon 
centres and the TBS protecting group prevented the alkylation from occurring.  
 
a) K2CO3, acetone, reflux; b) Pd(OAc)2, PPh3, MeCN, reflux 
Scheme 2-18. Alkylation of 1,3-ketoester in the model system 
This result thus made us change our alkylation substrate from the bulky TBS group 
to less hindered protecting group such as 163 and 166[35]. Various conditions were 




Scheme 2-19. Alkylation of 1,3-ketoester with protected 2-bromoethanol 
 
Table 2-1. 
entry Substrate Conditions Results 
1 BnO
I
 K2CO3, Acetone, RT SM only 
2 BnO
I
 K2CO3, Acetone, reflux, 20h Trace product
3 BnO
I





 NaH, DMF, 120℃, 10h Decomposition
5 BnO
I
 K2CO3, Acetone, HMPA (5 eq), RT 168, 70% yield
6 Acetone, K2CO3, NaI, reflux, 40 h SM only 
7 MOMO
Br MeCN, K2CO3, NaI, 80℃, Trace product
8 DMF or DMSO, K2CO3, 120℃, 12h Decomposition
9 MOMO
Br Acetone, K2CO3, HMPA (5 eq), RT 165, 60% yield
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Br THF, NaH, NaI, HMPA (1 eq), RT 
164, 28% yield
165, 40% yield
12 n-Bu2O, NaH, 90℃, 12 h Trace product
When reaction proceeded in acetone or acetonitrile below 80 ℃ without additive, 
only trace product was observed (entry 1, 2, 6, 7). Further increasing reaction 
temperature to reflux over 20 hours produced desired 167 and undesired byproduct 
168 as an inseparable mixture (entry 3). This resulting mixture was subsequently 
treated with Pd(OAc)2 and PPh3 in refluxing MeCN to afford the desired product 
cyclopentanone 169 but in the very low yield of 10% after 2 steps. Carrying out the 
reaction in DMF or DMSO at high temperature over 120 ℃ gave no expected 
improvement but instead resulted in the decomposition of the starting materials 
(entry 4 and 8).  
Hexamethylphosphoramide (HMPA) was found in the pertinent literature[8,9] to be an 
effective additive to facilitate the alkylation reaction. In the presence of 5 equivalents 
of HMPA the alkylation reaction proceeded even at room temperature, however 
oxygen-alkylation pathway was found to occur predominantly over the desired 
carbon-alkylation pathway (entry 5 and 9). Decreasing loading of HMPA from 5 to 1 
equivalents improved the formation of desired C-alkylation product 164 but the 28% 
yield was still not satisfactory (entry 9, 10, 11).   
2.3.4.3 Alkylation with methyl 2-bromoacetate 
The disappointing result let us slightly modify the approach for the alkylation 
reaction. In the alternative approach, represented in Scheme 2-20, methyl 
2-bromoacetate was used as the alkylation reagent. Due to its high reactivity, the 
alkylation and Tsuji-Trost reaction preceded very well. Cyclopentanone 149 was 
treated with K2CO3 and methyl 2-bromoacetate in acetone, and the resulting 
suspension was stirred at room temperature for 24 h affording the alkylation product 
171 in 92% yield, with just a trace of undesired O-alkylation product. This then set 
the stage for Tsuji-Trost reaction: cyclopentanone 171 was treated with Pd(OAc)2 
and PPh3 in acetonitrile at 90 ℃ under an argon atmosphere. The resulting mixture 
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was then stirred for 3 h before being allowed to cool to room temperature furnishing 
cyclopentenone 172 in 90% yield. 
 
a) methyl 2-bromoacetate, K2CO3, acetone, 92%; b) Pd(OAc)2, PPh3, MeCN, 90% 
Scheme 2-20. Alkylation of 1,3-ketoester with methyl 2-bromoacetate 
However the further elaboration of this substrate 172 was found to be difficult 
(Scheme 2-21). Subsequent 1,2-addition of organometallics to the ketone group was 
accompanied by competitive addition to the ester group without selectivity. 
Numerous efforts have been carried out attempting to control these addition reactions, 
such as slow addition of the substrate at low temperature. But all attempts proved to 
be fruitless and only gave complex mixtures of several unidentified products. 
Similarly, attempted epoxidation of the alkene with H2O2 led to rapid decomposition 
of substrate 172.   
 
Scheme 2-21. Further elaboration of cyclopentenone 147 
To solve the chemoselectivity issue of having an ester and ketone group in the same 
molecule we reduced both moieties concurrently to diol 175 (Scheme 2-22). We 
envisaged that either the resulting allyl alcohol could be selectively oxidised to a 
ketone, or the less hindered primary alcohol group could be selectively protected. In 
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order to validate the viability of this redesigned route, a number of typical reducing 

















Scheme 2-22. Reduction of cyclopentenone 172 
 
Table 2-2 
Entry Reducing reagent 175a/b 177 178 
1 LAH 20-30% trace 20% 
2 DIBAL-H 0% 30-40% trace 
3 LiBH4   Mess on TLC 
4 NaBH4+CeCl3   No Reaction 
*the possible products 177 and 178 are not fully characterised 
Lithium aluminium hydride (LAH) is a commonly used reducing reagent[36,37] with 
good 1, 2 reduction selectivity for enones. Addition of LAH into the solution of 172 
in diethyl ether did furnish the favored diol albeit in low yield of 20-30%, combined 
with several over reduction byproducts such as 177 and 178. The structures of 177 
and 178 were unconfirmed due to complicated 1H NMR data. The byproduct 178 
was suspected to be derived from the lithium enolate (the side product from 1,4- 
reduction of enone system of 172), which resisted further reduction by LAH and 
delivered the ketone group after hydrolysis. Diisobutylaluminium hydride 
(DIBAL-H)[38] is another excellent 1,2-reduction reagent. However in this case, none 
of the desired product 175 was obtained, only the unwanted 177. It appears that the 
steric hindrance of the ketone group makes 1,4-reduction competitive over 
1,2-reduction, producing 177 as the major product.  
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Luche reduction[39-40] is famous for its excellent 1,2- selectivity in enone reduction, 
and would not be expected to reduce the ester group.When applied to our substrate, 
however, the formation of the expected product 175 was not observed. Instead, the 
starting materials were fully recovered (entry 4). Other reducing reagent such as 
lithium borohydride (LiBH4), aminoborohydrides or 9-borabicyclo(3.3.1)nonane 
(9-BBN) gave no improvement.  
2.3.4.4 Alkylation with allyl bromide and optimization of Tsuij-Trost reaction 
We turned our attention to alkylation of the -ketoester 149 with allyl bromide which 
possesses high reactivity. The alkene is known to be convertable into the alcohol 
group easily via a standard multi-step sequence of dihydroxylation, oxidative 
cleavage and subsequent reduction of the resulting aldehyde to alcohol. Alkylation 
with allyl bromide could be achieved in analogy with the substrate preparation with 
methyl 2-bromoacetate. The substrate 149 (10 gram scale) was treated with K2CO3 in 
acetone and 2 equivalents of allyl bromide were added. The resulting suspension was 
stirred at room temperature for 10 hours furnishing the alkylation product 179 in 
92% yield with only a trace of undesired O-alkylation product 180. This nicely set 
the stage for the Tsuji-Trost reaction.  
 
a) allyl bromide, K2CO3, acetone, 180, 5%,179, 95% 
Scheme 2-21. Alkylation of allyl bromide 
Initial attempts at the Tsuji-Trost for synthesis of 181 were carried out using the same 
method as for the preparation of 171. Treatment of 179 with catalytic Pd(OAc)2 and 
PPh3 in acetonitrile afforded the expected decarboxylation dehydrogenation product 
181 but in an average yield of ~50%. The reaction was accompanied with formation 
of a large amount of undentified byproduct, which was purified by column 
chromatography but the structure was unconfirmed due to a complex 1H NMR 
spectrum. Extensive screening of mono- and bidentate phosphine ligands and 
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palladium sources proved fruitless and gave no increase of the yield. However a 
significant improvement was eventually achieved when we decreased the substrate 
concentration and catalyst loading. The formation of the byproduct was also 
suppressed efficiently. A number of reaction conditions havs been screened and the 
results are presented in table 2-3.  
 
a) Pd(OAc)2, PPh3, MeCN 
Scheme 2-24. Optimization of Tsuij-Trost reaction 
 
Table 2-3 
entry Catalyst Loading Sub Concentration Reaction Time Yields 
1 10% 0.2 [M] 0.5 h 45-64% 
2 5% 0.2 [M] 1 h 76-82% 
3 5% 0.08 [M] 1 h 79-86% 
4 5% 0.04 [M] 2 h 87-92% 
5 3% 0.04 [M] > 4h N/A 
The reaction showed a remarkable dependence on the catalyst loading and substrate 
concentration. Under Tsuji’s original conditions (0.2 [M] solution of substrate) with 
10% catalyst loading, we were pleased to see the formation of desired product 181 
but containing a large amount (30%) of an undesired byproduct (entry 1). When 
employing 5% catalyst loading (entry 2), the reaction proceeded smoothly in one 
hour with significant improvement of the formation of the desired product 181 with 
less undesired byproduct (10%). Further optimization by carrying out the reaction 
using a 0.08 [M] solution of substrate 179 afforded 181 with a slightly better yield of 
86% after one hour (entry 3). The best yield was achieved using a 0.04 [M] solution 
of the starting material in MeCN, furnishing product 181 in 92% yield. Under these 
conditions the Tsuji-Trost reaction was proven to be reliable and effective, and could 
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be carried out on 5 gram scale of substrate furnishing the desired product smoothly in 
two hours combined with only trace amounts of byproduct. Further reducing catalyst 
loading from 5% mol to 3% mol was less efficient, with large amounts of substrate 
remaining even after several hours.  
2.4 Synthesis of the functionalized cyclopentaneone  
2.4.1 Transformation of alkene to primary alcohol 
At this stage, we had to prepare the substrate for the key radical chemistry, requiring 
the alkene in the enone system of 181 to be selectively oxidized to an epoxide. The 
combination of hydrogen peroxide solution in methanol in the presence of sodium 
hydroxide is well known for its efficient epoxidation of enone systems. However 
initial experiments indicated that no formation of the desired epoxide 182 was 
observed when 181 was subjected to this condition, even at high temperatures and 
longer times. Attempts to apply m-chloroperoxybenzoic as oxidizing agent led to 
rapid decomposition of 181. We felt that the terminal alkene in the side chain could 
be responsible for complications, so we decided to convert it into an alcohol. 
 
Scheme 2-25. Epoxidation of cyclopentenone 181 
Transformation of alkene to diol (Scheme 2-26) was effected by osmium tetroxide 
(OsO4) and N-methylmorpholine N-oxide (NMO)
[45-46] as cooxidant. A catalytic 
amount of OsO4 mediated mono-dihydroxylation
[41-44] of 181 with regioselectivity 
and led to a single diol 183 (precise stereochemistry of the 1,2-diol moiety not 
delineated). The excellent regioselectivity was probably derived from the stereo and 
electronic differences between the two alkenes. The terminal alkene was less 
hindered for access by osmium and was electronically rich compared to the alkene in 
the enone system. Accurate weighing of one equivalent of NMO was pivotal for this 
reaction since excess NMO led to double dihydroxylation of both alkene groups 
existing in the molecule. The resulting diol 183 was oxidatively cleavaged to 
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aldehyde by sodium metaperiodate in the solvent mixture of THF and water 
furnishing compound 184 with excellent yield. 
 
a) OsO4, NMO, H2O, acetone, 92%; b) NaIO4, THF, H2O, 92% 
Scheme 2-26. Transformation of alkene to primary alcohol 
We then protected the aldehyde (also the diol precursor) as the dioxolane and 
acetonide respectively, as shown in Scheme 2-27. Protection of diol[47] or aldehyde[48] 
proceeded smoothly under standard conditions and produced corresponding products 




















184 186  
a) (EtO)3CH, acetone, TsOH, 90%; b) TsOH, toluene, reflux, 99% 
Scheme 2-27. Protection in dioxolane form 
The advanced intermediates 185 and 186 were further functionalized into the 
substrates for the key radical cyclisation reaction in a reasonable number of steps. 
However these efforts were somewhat wasteful since the dioxolane group was found 
to be unstable and decomposed when subjecting to radical conditions. 
Attempts to reduce the aldehyde group were found to be somewhat problematic. 
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There were three potential reducible positions existing in this molecule (Scheme 
2-28), including the aldehyde group, C7 of enone for 1,4-reduction and C4 of ketone 
for 1,2-reduction. Thus the control of selectivity was pivotal for the reduction 
reaction. Selective reduction of the aldehyde in the presence of ketone should be 
readily achieved via careful control of the reactivity of the reducing reagent, because 
the ketone is hindered and more stable than the aldehyde. 1,4-Reduction should be 
suppressed by selecting a reducing reagent with good regio-selectivity. In the event, 











Scheme 2-28. Selectivity in reduction of 184 
At first glance, the problem seems to be readily resolved if we could control the 
selectivity between aldehyde and 1,4-reduction of enone. A hint on how to achieve 
this came from the previous reduction of intermediate 172 (Scheme 2-20), where the 
Luche reduction was employed but no reaction occurred (including no 1,4- 
reduction). On the other hand, Luche reduction is known for selectively reducing 
ketones in the presence of an aldehyde. Bearing all this in mind, we attempted 
reduction under Luche conditions of sodium borohydride in methanol in the presence 
of cerium(III) chloride.  
However three product spots appeared by TLC analysis: the aldehyde was reduced to 
a primary alcohol which was confirmed by HPLC-MS analysis and the 1H NMR 
spectrum. Careful collection and separation of the other two by-products by column 
chromatography followed by further NMR analysis determined the structure  to be 
the over reduced products 175a/b. Obviously the ketone group was reduced to the 
allylic alcohol, however no 1,4-reduction product was observed due to the presence 
































a) NaBH4, CeCl3, MeOH 
Scheme 2-29. Possible pathway of ketone reduction 
This result shown in Scheme 2-29 led us to a thorough investigation of the reduction. 
Firstly the aldehyde group was reduced to alcohol 176 in all cases. Nevertheless the 
reaction did not end at this stage and the product 175 appeared immediately after the 
primary alcohol 176 was formed. Various modifications of the system were made, 
such as changing the solvent to ethanol or iso-propanol, controlling the temperature 
at 0 ℃ , adding sodium borohydride carefully, but all proved unfruitful - the ketone 
group was always reduced. This result was quite surprising to us and was in contrast 
to the previous attempts to reduce 172, where the ketone group was intact due to 
steric hindrance when Luche reduction conditions were employed.  
A plausible account for this different activity may be derived from the presence of 
the free alcohol group contained in the molecule 176. Thus we might predict a 
possible pathway shown in Scheme 2-29 for this result. While the aldehyde was 
reduced, the resulting free alcohol would coordinate to the boron and deliver a 
hydride to the ketone group via an intramolecular coordinate 185. The presence of 
cerium(III) chloride could suppress the 1,4-reduction. 
These unsuccessful attempts still gave us some constructive ideas; we need to choose 
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a suitable reducing reagent processing good selectivity through controllable reducing 
ability. In the optimised reaction, the aldehyde could be reduced exclusively while 
the ketone group could survive. LAH, DIBAL-H or similar reagents processing 
strong reducing ability were excluded firstly. 9-BBN, aminoborohydrides and 
LiAlH(OtBu)3 also failed on this substrate. 
(Pyridine)(tetrahydroborato)zinc complex, Zn(BH4)2(Py) was reported by Behzad 
Zeynizadeh in 2003[49] as a new reagent having great 1,2-reduction selectivity in the 
enone system, along with remarkable selectivity for reducing aldehydes in the 
presence of ketones. More interestingly, this reagent revealed alterable reducing 












Table 2-4 presents the results of reduction reactions with Zn(BH4)2(Py). In THF or 
diethyl ether (entry 2), the reduction gave 175a/b as a major product. Then MeOH 
and EtOH were used as solvent and the reaction produced the desired 176 as major 
product with only trace formation of 175a/b (entry 3). Eventually, we found that 
iso-PrOH or tert-BuOH as solvent gave solely the desired product 176. The reaction 
was finished in 2 hours and then the excess Zn(BH4)2(Py) was quenched by several 
drops of HCl solution. Three steps (two pots) for the transformation of alkene to 
primary alcohol resulted in a 67% yield.  
  
Table 2-4. Zn(BH4)2(Py) in reduction of aldehyde 
entry Reagent Solvent 176 175a/b 
1 NaBH4, CeCl3 MeOH or EtOH trace major 
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2 Zn(BH4)2(Py) THF or Ether trace major 
3 Zn(BH4)2(Py) MeOH or EtOH major much 
4 Zn(BH4)2(Py) iso-PrOH or t-BuOH sole product N/A 
* products were determined by TLC analysis 
Obviously the direct alkylation of 1,3-ketoester 149 was the shortest pathway for the 
synthesis of 176. However, as this approach was unsuccessful, we had to redesign 
our route to develop an alternative approach to advance our synthesis. Alkylation 
with allyl bromide was smooth. Conversion of alkene 181 to alcohol 176 required an 
extra three steps but afforded a good yield of 67% over three steps. This approach 
was reliable and robust, enabling the key intermediate 176 to be accumulated 
efficiently and our synthesis could advance to the next stage.  
a) OsO4, NMO, H2O, acetone, 92% yield; b) i, NaIO4, THF, ii, Zn(BH4)2.py, i-PrOH, 76% over 2 steps 
Scheme 2-30. Transformation of alkene to alcohol 
2.4.2 Epoxidation and 1,2-organometallic addition 
With an efficient synthesis of cyclopentenone 176 established, we next investigated 
the stereoselective epoxidation and 1,2-nucleophilic addition reactions which were 
required to set up the substrate for radical epoxide opening and cyclisation. As is 
evident from our retrosynthetic analysis (Scheme 2-24), we required the 
1,2-nucleophilic addition to occur on the same face as the protected diol functionality 
of the cyclopentenone. This would set the correct stereochemistry at C4, eventually 




Scheme 2-24. Selectivity in Epoxidation and 1,2-organometallic addition 
2.4.2.1 Approach I, chelation controlled 1,2-addition 
A short synthetic plan is outlined in Scheme 2-32 that describes a chelation 
controlled addition strategy. We expected that benzyl-protected hydroxyl groups 
could behave as weak syn-directing participating groups in 1,2-addition reaction[50], 
thus creating the desired stereochemistry at C4. The nucleophile was chosen as an 
alkynyllithium, as sp3 organometallics were expected to create elimination problems 
with the product tertiary alcohol (vide supra). 
Scheme 2-32. Proposed chelation controlled 1,2-addition 
Oxidation of the alkene to an epoxide and subsequent hydrogenation of the alkyne 
side chain could provide 193. Deprotection and oxidation of the primary alcohol 
would result in an aldehyde which could be then converted consecutively to terminal 
alkyne 195 by Bestmann's reagent with potassium carbonate in methanol. This could 
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set the stage for radical cyclization. 
To testify the feasibility of the proposed selective 1,2-addition and epoxidation 
approach, pentyne was selected as simple model substrate in the addition to 186 
since it was commercially available as a liquid (Scheme 2-33). Deprotonation of the 
terminal alkyne using n-butyllithium and addition of cyclopentenone 186 afforded 
the tertiary alcohol 197 in excellent yield but only moderate selectivity (2.5-5.5 : 1). 
When exchanging the organolithium to the organocerium, the selectivity was 
improved to 12:1. Although the stereochemistry of the newly formed chiral centre C4 
could not be determined at this stage as the NOESY and 1H NMR proved 
non-conclusive, we advanced the material and attempted epoxidation of the alkene.  
 
Scheme 2-33. Selective 1,2-organometallic addition and epoxidation 
Exposure of 197 to m-chloroperoxybenzoic acid in dichloromethane afforded only 
low yields of the desired epoxidation product 198, with slow decomposition of the 
substrate into complex mixtures being observed. Modifications such as increasing the 
temperature or increasing oxidative reagent loading, were not successful and only 
trace product was formed, along with the gradual decomposition of starting 
materials. 
A number of reagents were screened for the epoxidation, e.g. buffered 
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trifluoroperoxyacetic acid, dimethyldioxirane, methyl(trifluoromethyl)dioxirane[51-53], 
the peroxycarboximidic acid derived from the combination of hydrogen peroxide and 
acetonitrile[54], none of which were successful. We suspected that the tertiary alcohol 
moiety in 197 might be unstable in both basic and acid conditions. A NOESY 
analysis of 198 revealed that the newly formed epoxide was on the opposite face to 
the two methyl groups. However the stereochemistry of C4 remained unclear since 
there were no positive NOESY cross peaks that allowed confident assignment. The 
low yield of the epoxide product, and significant decomposition of the substrate, 
prompted us to seek an improved method to introduce the epoxide. As a result we 
turned our attention to the second approach - steric controlled epoxidation.  
2.4.2.2 Approach II, steric controlled epoxidation 
Treatment of cyclopentenone 169 with alkaline hydrogen peroxide in methanol 
afforded a very clean epoxidation reaction in 84% yield, furnishing the two 
diastereomers in a 1.8:1 ratio of 200 and 199 (Scheme 2-34). The two isomers were 
readily separated through column chromatography and the stereochemistry was 
assigned based on NOESY analysis of the downstream intermediate 201. The key 




































Scheme 2-34. Epoxidation with hydrogen peroxide 
The facial selectivity apparent in the epoxidation reaction slightly favored the 
formation of undesired product 200, in which the epoxide is introduced on the same 
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face as the bis-benzyl protected diol. We did not know the origin of this facial 
selectivity, but speculated that it could arise from the weak interaction of hydrogen 
bonding between hydrogen peroxide and BnO group. The configuration at C7 of the 
epoxide was not felt to be critical in itself in terms of the overall synthesis, as it could 
be manipulated in a variety of ways further down the line. However, the influence of 
the epoxide configuration on the subsequent 1,2 addition to the neighbouring ketone 
was thought to be highly important (vide infra). We required the epoxide to be 
formed on the opposite face of the protected diol in this context, ie 199.  
Obviously an improvement in the diastereoselectivity of the epoxidation was still 
required. Common epoxidation reagents known to afford good stereoselectivity in 
epoxidation reaction failed to promote the reaction. Using mCPBA, t-BuOOH and 
VO(acac)2/t-BuOOH system
[55,56], no epoxidation product could be observed. This 
was speculatively attributed to the increased steric hindrance encountered by these 
larger epoxidation agents, preventing their approach, along with the electron-poor 
character of the carbon-carbon double bond of this system. 
Sodium hypochlorite (NaClO), commonly known as bleach, was reported as an 
effective oxidizer in epoxidation reactions for the enone system affording excellent 
diastereoselectivity in the preceding literature [57,58]. When sodium hypochlorite was 
used as epoxidation reagent in pyridine, the reaction worked well and furnished 
desired -epoxide 203 as the major product (203:204 = 2.2:1). The possible pathway 
for this reaction is shown in Scheme 2-35. In principle, the two BnO groups are 
larger than two methyl groups, and the epoxidation reagent attacks the enone from 
the less hindered face to produce corresponding epoxide 203. Further optimization of 
the reaction conditions, such as screening the solvent (toluene, MeCN, DCM) or 






























Scheme 2-35. Steric controlled epoxidation 
The efficiency of the overall transformation could be improved by recycling the 
unwanted minor -epoxide 204 through reductive deoxygenation. The deoxygenation 
of epoxides to alkenes is an important synthetic transformation in organic chemistry. 




[65] system. To our interest, the 
deoxygenation ability of Cp2TiCl2/Zn has also been extensively studied, due to its 
unique features of high oxophilicity and reducing power. The low-valent titanium(III) 
species were readily generated as previously by the in situ reduction of 
bis(cyclopentadienyl)-titanium(IV) dichloride (Cp2TiCl2) with activated zinc powder 
in tetrahydrofuran for 1 hour at room temperature. This system is particularly 
effective if the olefin formed is a conjugated one.  
 
a) TiCp2Cl2, Zn, THF, 70% 
Scheme 2-36. Recovery of unwanted minor -epoxide 204 
Application of this methodology on our substrate 204 proved efficient: to a solution 
of the titanium(III) reagent, the substrate in tetrahydrofuran was added dropwise and 
stirring was continued for 10 hours at room temperature under argon. The 
deoxygenation product 176 was isolated in 70% yield, while other methods, such as 
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treatment with Mo(CO)6 in refluxing benzene, only gave very low yields of the 
desired product. 
Protection of diols with bulky silyl protecting groups. 
A detailed investigation into stereocontrolled epoxidation was undertaken using 
bulkier protecting groups on the diol motif, which is briefly summarized below: if we 
could change the two OBn groups to bulkier protecting groups, such as silyl 
protecting groups, the diastereoselectivity of the epoxidation could possibly be 
improved. This proved to be the case. Debenzylation and subsequent protection of 
diols with a series of different size silyl groups worked well. The results of 




























206 207 208   
Scheme 2-37. Protection with different size silyl groups 
Table 2-5 
Entry Protection group (R) Ratio of 207 and 208 
1 Bn 1.2 : 1 
2  3.4 : 1 
3 TBS >10 : 1 
4 TPS SM decomposed 
5 TBDPS Sole product 207 
*The ratio was determined by 1H-NMR analysis 
The diastereoselectivity of the epoxidation increased from 3.4 : 1 to 10 : 1 when 
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 and TBS were used as protecting groups, respectively. TPS protection 
groups were found to be unstable in the epoxidation conditions and led to rapid 
decomposition of starting materials. Eventurally, when TBDPS was used as 
protecting group the desired epoxidation product 207 was achieved as the sole 
product.  
Unfortunately, the bulky TBDPS groups led to some problems in the following 1,2 
addition reaction. Treament of 208 with 221 produced the sole addition product 209 
in high yield, however the newly formed chiral centre at C4 could not be assigned by 
nOe experiments at this stage. We expected that the epoxide group would be the 
dominant element of stereocontrol in 1,2 addition in general for this system (vide 
infra), but in the case of the very bulky TBDPS groups this epoxide control might be 
overwhelmed. Treament of 209 with titanium(III) was fruitless and only the SM was 
fully recovered. Attempts to remove the TBDPS groups before 1,2-addition under 
various condition were also unsuccessful.  
 
a) Et2O, -78 ℃ 
Scheme 2-38. 
High selectivity (both regio and diastereo) of chemical reactions in total synthesis is 
certainly always preferred. In our case, using bulky TBDPS protection groups 
induced high diastereoselectivity for the epoxidation reaction, and we believed that 
the selectivity in the following 1,2-addition reaction and reactivity in the radical 
chemistry could possibly be solved by some method eventually. However, due to 
time restrictions and the fact that the benzyl groups were already proven as reliable 
in the synthesis (despite the moderate diastereoselectivity of the epoxidation 
reaction), under such circumstances we decided to advance our synthesis to the next 
step with benzyl groups. 
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2.4.2.3 Stereoselective orgaometallic addition 
With adequate quantities of -epoxide 203 in hand we intended to carry out the 
introduction of the C15-C1-C2-C3 side-chain via organometallic addition. The 
epoxide group is known to exert powerful stereocontrol in this reaction for simple 
five-membered ring systems, enforcing exclusive anti addition of organometallics to 
the carbonyl group to produce the cis-epoxyalcohol (Scheme 2-39) [66,67].  
 
Scheme 2-39. Stereoselective 1,2-addition in the simple model system 
A complex example in natural product synthesis could be found in the Corey’s total 
synthesis of Ginkgolide B[68]. Reaction of advanced intermediate 213 with 7 
equivlant of  the lithium enolate of tert-butyl propionate (from LDA) in 4:1 THF- 
hexamethyl-phosphoramide (HMPA), furnished the desired aldol adduct 215 in 60% 
yield combined with a small amount of C3 epimer (ca. 7%).  
Scheme 2-40. A complex example of stereoselective 1,2-addition 
The side chain to be introduced was prepared in two steps as is outlined in Scheme 
2-41. Treating 3-butyn-1-ol 216 with n-butyllithium and TMSCl furnished the 
intermediate alcohol 217 which was subsequently iodinated to afford 218 in good 
yield. Addition of tert-butyllithium to 218 would facilitate a lithium iodide exchange, 




a) nBuLi, THF, -78 ℃, then TMSCl, RT, 18 h; b) PPh3, Imidazole, I2, THF, RT, 1 h, 78% over 2 steps 
Scheme 2-32. Synthesis of side-chain 218 
We envisaged that the epoxide group would be the dominant element of stereocontrol 
in 1,2 addition to 219, presenting a sterically more accessible convex face of the 
bicycle to the incoming nucleophile, anti to the epoxide C-O bond (see Scheme 





a) TBSCl, Et3N, DCM, 91%; b) Et2O, -78 ℃, 94%; c) KOH, MeOH, 99%, d) TBAF, DCM; e) Ac2O, 
pyridine, DCM 67% 
Scheme 2-42. Stereoselective orgaometallic 1,2-addition 
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This proved to be the case – addition of excess homopropargyllithium reagent 221 to 
the highly hindered ketone proceeded in excellent yield and diastereoselectivity,[16] 
affording the tertiary alcohol 222 as essentially a single stereoisomer in 94% yield 
(Scheme 2-42). The product of the organometallic addition reaction was then treated 
with KOH in MeOH[19] or TBAF in DCM to remove the terminal alkyne protecting 
group and furnished 223 or 224 in 98% and 99% yield, respectively. The primary 
alcohol in 224 could be protected as an acetate when treated with Ac2O in pyridine.  
Once we successfully introduced the desired side-arm in excellent yield we set about 
demonstrating its relative stereochemistry. The use of X-ray crystallography proved 
unfeasible, as 225 was an oil. Nonetheless, the elucidation of the relative 
stereochemistry was achieved by means of extensive 1D and 2D-NMR spectroscopy 
(Scheme 2-43).  
  
Scheme 2-43. nOe-signals observed for 1,2-addition product 225 
The crucial stereochemical configuration to be assigned was the orientation of the 
tertiary alcohol at C4. If we could demonstrate its location to be on the same face as 
the methyl substituents at C8 and C13, we would confirm the incoming nucleophile 
of 1,2-addition was anti to the epoxide C-O bond, thus constructing the correct 
stereochemistry at C4. Such proof was found in the nOe effect observed between the 
proton signals of the methyl substituent C13 and the proton of the tertiary alcohol at 
C4 as well as the nOe effect between C3 and C10. Both interactions strongly support 
our stereochemical assignment as indicated above. Furthermore the nOe correlations 
observed between the protons C7 and C12 confirmed the epoxide to be located on 
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the same face as the two methyl substituents, C8 and C13. Thus the stereochemistry 
of the epoxide 225 is correct. 
2.5 Titanium(III)-Mediated Radical Cyclization   
2.5.1 Radical cyclization in the synthesis of BC core of merrilactone A 
As our successful preliminary reactions had been carried out on a model system 
(Scheme 2-9), initially we attempted this methodology on substrate 224 containing a 
free C11-OH group. The titanium(III) reagent was prepared via the following 
standard methods: to a flask containing titanocene dichloride (Cp2TiCl2) and excess 
activated zinc powder as the reducing agent was simply added anhydrous and 
degassed THF under a constant purge of argon. The resulting suspension was 
vigorously stirred for 60 min under an argon atmosphere with rigorous exclusion of 
oxygen, and the color changed from a dark red to a bright green, confirming the 
formation of the desired titanium(III) species. After the precipitation of unreacted 
zinc, the solution of titanium(III) was then transferred into a solution of substrate 224 
in THF. The concentration of resulting substrate solution is [0.2] M. The reagent side 
product of ZnCl2 contained in the reaction system appeared to have no detrimental 



































a) TiCp2Cl2, Zn, THF 
Scheme 2-44. Preliminary study of radical cyclisation 
After 20 hours the reaction was quenched by adding several drops of water and the 
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excess titanium reagent was removed by filtration through a short silica pad. The 
crude product was purified by careful flash column chromatography to afford the 
major products 226 and 227 as a mixture of colourless oils in 50% yield. We were 
delighted to observe the successful formation of desired cyclization product 226, 
accompanied with the formation of tricyclic product 227 in1:1 ratio. Both structures 
were confirmed by 1H NMR and 13C NMR analysis (Scheme 2-44). Interestingly, the 
desired bicyclic product 226 underwent cyclization reaction to tricyclic 227 in CDCl3 
in the NMR tube after a period of several weeks. The formation of the minor 
byproduct was suspected to be 228 via a deoxygenation pathway. However the 
structure was not fully characterized due to the scarcity of materials and the unstable 
nature of this compound.  
 
a) TiCp2Cl2, Zn, THF 
Scheme 2-45. Possible pathway for the formation of byproduct 
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Scheme 2-45 outlines the proposed mechanistic pathway for these radical 
tranformations. Firstly, the titanium(III) mediated epoxide opening via regioselective 
C9-O homolysis generated the relative stable tertiary radical intermediate 229, which 
underwent subsequent 5-exo-dig cyclization onto the pendant alkyne producing 
desired the bicyclic product 226 containing exo-alkene. Meanwhile the highly 
congested C9 quaternary stereo center was formed. It seemed that the steric 
conformation of 226 was appropriate for the consecutive alkene etherification 
reaction with free primary alcohol to produce 227. The etherification was also 
possibly promoted by trace acid existing in the reaction system. Additionally, the 
etherification product 227 was very interesting to us as it possesed the fully carbon 
skeleton of the anislactone sesquiterpenes, thus 227 could possibly be converted into 
anislactones in a several-step sequence. This part will be discussed in detail in the 
following chapter of this thesis, The mechanism for the formation of byproduct 228 
could be accounted for by the tertiary radical intermediate 229 reacting with a 
secondary titanium(III) equivalent to produce transient intermediate 231, which 
subsequently lost one “TiO” to afford deoxygenation byproduct 228.[20] An 
analogous approach to deoxygenation has been employed by us earlier in the 
synthesis in recycling undesired epoxide 204 (Scheme 2-36).  
Although the desired bicyclic product 226 was achieved in only 25% yield and the 
reaction was accompanied by several unexpected pathways, this result still validated 
the feasibility of the radical epoxide opening and cyclisation methodology on our 
advanced complex intermediate 133. Based on the understanding of the mechanism 
of the reaction, several modifications of the reaction condition could be made. Firstly, 
to circumvent the alkene etherification pathway we protected the primary alcohol as 
a TBS ether thus preventing the attack of free alcohol on the exo-alkene. Secondly, 
dilute conditions along with dropwise addition of titanium(III) reagent to epoxide, 
were found to be essential in minimizing the formation of deoxygenation product 




a) TiCp2Cl2, Zn, THF, 67-73%, 10% SM recovered 
Scheme 2-46. Titanium(III) induced radical cyclization 
Applying the modified conditions under dilute concentrations [60,61] ([0.04] M) of the 
substrates 223 and 225, we were delighted to find that the reaction proceeded 
smoothly and furnished the bicyclic products 232 and 233 in 73% and 65% yield 
respectively, with the recovery of 10% starting materials over 20 hours. As before, 
the reaction was carried out under strict exclusion of oxygen throughout the course of 
the transformation. Initial formation of the low valent titanium reagent was achieved 
via treatment of titanocene with zinc dust and consecutive transfer of this reagent 
into a THF solution of substrate 223 and 225, which resulted in the formation of the 
desired products 232 and 233, respectively. 
 
Scheme 2-47. nOe-signals observed for radical cyclisation product 233 
Once we had successfully employed the pivotal radical epoxide opening and 
cyclization strategy to our substrate 225 to afford the advanced bicyclic 233, we set 
about demonstrating its relative stereochemistry (Scheme 2-47). The radical 
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cyclization product 233 could be fully characterizd via 1D NMR spectroscopy 
techniques, however its relative stereochemistry proved difficult to elucidate by 
crystallographic methods, as it was an oil. Thus we turned our attention to 2D-NMR 
spectroscopy. Assignment of all 1H NMR signals could be determined by COSY and 
HMQC experiments. Shown in Scheme 2-44 are the nOe interactions observed in the 
NOESY spectrum of 233. Strong correlation peaks indicated a close spatial 
arrangement between the single proton at C7 and C12, suggesting that the secondary 
alcohol was on the same face as the bis-benzyl protected diol. Both nOe interactions 
between C8 and C10, C3 and C14 indicated that the newly formed B ring bearing an 
exo-alkene group was also on the same face as the bis-benzyl protected diol. These 
results were in accordance with our expectation and confirmed the stereochemistry of 
233 to be as predicted.  
It is worth noting that these nOe interactions outlined in Scheme 2-47 also confirmed 
the newly formed secondary alcohol at C7 to be on the opposite face of ring C with 
respect to the benzyl protected diol, as expected. This incorrect orientation of the 
hydroxyl group for merrilactone A required an inversion of stereochemistry, which 
would be achievable via an oxidation/reduction sequence.  
2.6 Total synthesis of merrilactone A 
With the radical cyclization product 232 in hand, we were well placed to complete 
the synthesis as all C-C bond forming steps are complete. Considerable 
redox-adjustments were still required, however. The transformations shown in 
Scheme 2-48 were planed as the synthetic endgame: (i) inversion of the 
stereochemistry of the secondary alcohol at C7 of 236, (ii) desilylation of TBS group 
and lactonization to form the left-hand -lactone A of 237, (iii) debenzylation and 
Fetizon oxidation of the diol to form right-hand-lactone D of 9. Finally we 
anticipated to employ the known procedure of stereoselective epoxidation and 




Scheme 2-48. Synthesis plan for merrilacone A 
2.6.1 Synthesis of -lactone A in merrilactone A  
Several attempts to synthesize the -lactone A via different pathways were 
investigated in our synthesis (Scheme 2-49). Desilylation of 232 was straightforward, 
affording 239 in high yield. Subsequent oxidation with tetrapropylammonium 
perruthenate (TPAP) produced a mixture of several products based on TLC analysis. 
The lactonization reaction could undergo two competitive pathways with either the 
secondary alcohol at C7 or the tertiary alcohol at C4. Thus we decided to oxidize the 
secondary alcohol at C7 into a ketone to avoid the undesired lactonization pathway.  
a) TBAF, THF; b) TPAP, DCM. 
Scheme 2-49. Synthesis of -lactone A 
Treatment of 232 with TPAP and excess NMO in dry DCM in the presence of 
molecular sieves afforded the ketone 241 smoothly (Scheme 2-50). Oxidation of 232 
with Dess-Martin periodinane (DMP) also produced the desired ketone 241 but in 
low yield. At this stage we hoped to create the correct stereochemistry at the C7 
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secondary alcohol by means of reduction. A highly selective reduction had been 
achieved on an analogous structure in both Hirama and Metha’s total synthesis of 
merrilactone A, where the bulky reducing reagent DIBAL-H demonstrated good 
selectivity in the reduction of ketone of 48 and 76 (Scheme 1-16 and 1-24). In turn 
we expected that Fetizon’s oxidation could construct the -lactone A of 244 in the 
presence of secondary alcohol functionality (outlined in Scheme 2-50).  
 
a) TPAP (50% mol), NMO (10 eq), DCM, 10 h, 76%; b) DIBALH or LiBH4; c) TBAF, THF; d) TPAP (10 % 
mol), NMO (5 eq), 86% over 2 steps 
Scheme 2-50. Synthesis of -lactone A 
However, to our surprise, slow addition of DIBAL-H into substrate 241 in toluene or 
dichloromethane at -78 ℃ only led to the recovery of the secondary alcohol 232. 
No expected formation of secondary alcohol 242 was observed. We assumed that the 
benzyl ether groups could act as syn-directing participating groups via coordination 
with DIBAL-H, and then DIBAL-H delivered the hydride to the ketone from the 
same face of the benzyl group. Reduction with LiBH4 produced the same product 232. 
Other reduction reagents were investigated, including NaBH4, Zn(BH4)2, and 
samarium(II) iodide (SmI2), however the ketone group remained intact under such 
conditions indicating significant steric hindrance.  
Currently we do not have an accurate explanation for the stereoselectivity of this 
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reduction reaction. As a result, we decided to employ an alternative synthetic 
approach based on compound 243 shown in Scheme 2-50. The -lactone A would be 
constructed first (243), then debenzylation and stereoselective reduction of ketone 
would occur concurrently under dissolving metal conditions, a transformation based 
on precedent from Hirama’s synthesis. The correct stereochemistry at C7 could be 
expected during the course of dissolving metal reduction. Treatment 241 with TBAF 
led to desilylation smoothly and subsequent lactonization with TPAP and excess 
NMO furnishing the -lactone A 243 in 86% yield over two steps. (Scheme 2-50) 
Attempts at the debenzylation of substrate 243 containing exo-alkene motif under 
dissolving metal condition were investigated subsequently at this stage. Accordingly, 
applications of Hirama’s protocol of sodium in ammonia (vide infra) on 243 were 
carried out. Unfortunately these efforts were fruitless, as 1H-NMR spetrum indicated 




As all of these attempts via different pathways to synthesize merrilactone 
investigated above were unsuccessful, we directed our attention to the alkene 
isomerization reaction, in which the exo-alkene would be moved to an internal 
pattern. 
2.6.2 Alkene isomerization  
It was necessary to isomerize the exo-cyclic alkene into the B ring at this stage. The 
alkene isomerization reaction had been carried out by Danishefsky in the course of 
his merrilactone synthesis, albeit on a substrate differing in C-ring functionality. 
Using Danishefsky’s conditions of p-toluenesulfonic acid in refluxing toluene for 4 
hours afforded one major product accompanied by trace amounts of byproducts. The 
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major product, which was separated by silica column chromatography and 
characterized by 1H NMR spectrum, however was not the desired olefin 
isomerization product 246, and was suspected to be 247. Mass spectrometry 
indicated that one benzyl protecting group had been removed in the reaction. The 
lability of the benzyl groups was confirmed by O-debenzylation products being 
observed even in refluxing dichloromethane with 1 equivalent p-toluenesulfonic acid. 
Debenzylation is known to be promoted by strong Bronsted acid or Lewis acid such 
as trifluoromethanesulfonic acid (TfOH), iron(III) chloride[69,70] or tin(IV) chloride; 
[71] however, O-debenzylation by TsOH is unusual in the literature[72]. In order to 
access the desired olefin isomerization product, a number of modifications of the 
reaction conditions were made and the results are presented in the Table 2-6. 
 
Scheme 2-52. Alkene isomerization 
Table 2-6 
Entry condition results 
1 TfOH, CH2Cl2 product 248    
2 MsOH, CH2Cl2 two unidentified byproducts 
3 TsOH, benzene, reflux product 247 
4 TsOH, CH2Cl2, reflux or 40 ℃ product 246 and 247 
5 TsOH, CH2Cl2, 30℃ product 246, reaction is slow 
6 TsOH, AcOH, CH2Cl2, 30 ℃   2 days, product 246, 92% yield 
7 TFA, CH2Cl2 No Reaction 
8 Rh(Ph3)3Cl, toluene, reflux   20h, product 246, 10% conversion 
 *possible product 247 and 248 were not fully characterized 
As shown in Table 2-6, treatment of substrate 243 with trifluoromethanesulfonic acid 
(TfOH) in dichloromethane produced rapid alkene isomerisation even at -78 ℃. 
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However, deprotection of the benzyl ether group was followed by intramolecular SN2 
reaction immediately affording the cyclic ether 248 as the major product (entry 1). 
Exchanging to methanesulfonic acid (MsOH) led to two unidentified byproducts 
(entery 2). When p-toluenesulfonic acid was employed as catalyst for alkene 
isomerization in refluxing benzene, it only led to the formation of unexpected 
product 247 (entry 3). When reaction was carried out in refluxing dichloromethane, 
we did observe the formation of the expected product 246 albeit in low yield (entry 
4). Further decreasing the temperature to 30 ℃  suppressed the unwanted 
debenzylation pathway and led to the formation desired product 246 (entry 5), but 
the reaction processed extremely slowly - probably due to the poor solubility of 
p-toluenesulfonic acid in dichloromethane at low temperature. Finally, using a 
solvent mixture of acetic acid and dichloromethane at 30 ℃ with p-toluenesulfonic 
acid was found to be effective for the alkene isomerization. The internal alkene 246 
was obtained in high yield after 2 days while the O-debenzylation reaction was 
suppressed (entry 6). Transition metal rhodium-catalyzed alkene isomerization 
reaction was also investigated and the conversion was less than 10% even after 20 h 
(entry 8).  
The detailed mechanism of the O-debenzylation etherification reaction remained 
unclear. However, the mild conditions using p-toluenesulfonic acid as catalyst at 30 
℃ led us to consider the mechanism of this reaction. Highly selective removal of the 
two benzyl protecting groups indicated some additional factor at work in this 
transformation; we suspected that the adjacent ketone group could participate in 




























a) TsOH, DCM 
Scheme 2-53. Proposed chelation mechanism for selective debenzylation reaction 
The ketone oxygen could be capable of chelating the proton from p-toluenesulfonic 
acid which therein facilitated the acid-mediated debenzylation via a six-menbered 
cyclic intermediate 249, as proposed in Scheme 2-53. A similar chelated intermediate 
has been put forward by Steven Fletcher to account for the trifluoroacetic acid 
mediated rapid O-debenzylation of ortho-substituted phenols[73]. Another analogous 
intermediate was also proposed by Baldwin for the MgBr2-mediated debenzylation 
reaction[74]. Following debenzylation, the free alcohol 250 attacked the exo-alkene to 
produce the stable six-membered cyclic ether. 
Due to the the limited quantities of material and time restrictions, no further 
experiments were done to reinvestigate the mechanism for the formation of the 
products 247 and 248. However, based on the results and preceding literature we 
believe that the account for this transformation is reasonable.  
2.6.3 Formal total synthesis of merrilactone A 
Compound 246 is very similar to a late-stage intermediate 254 in Inoue and Hirama’s 
synthesis, differing only slightly in the protecting group at C14 (benzyl vs. 




a) Na, NH3, EtOH/THF, -78 ℃; b) Ag2CO3, toluene, reflux,  41% over 2 steps; c) mCBPA, DCM, 91%; d) 
TsOH, DCM, 96%. 
Scheme 2-54. Hirama’s synthesis of merrilactone A 
Accordingly, application of Hirama’s two-step protocol (Scheme 2-55) of sodium in 
ammonia followed by Fetizon’s reagent affected three transformations: first, the 
dissolving metal reduction effects debenzylation and subsequent stereoselective 
reduction of the hindered ketone at C7 to the -hydroxy group, presumably via 252 
through a six-membered chelate. It is likely that the lactone A ring is also reduced to 
a lactol at this stage. Second, the mixture of lactols 253a/b is oxidized with Fetizon’s 
reagent[75,76] – the weak oxidizing agent is selective for the sterically most accessible 
C12 primary alcohol – to produce the desired bis--lactone 9 as a single isomer. This 
selectivity in the oxidative lactonization step is crucial to the success for the 
synthesis and was precedented in Hirama’s work – molecular models of 246 shows 
that the C14 position is quite occluded by the sp3 C3 atom on the other side of the 
molecule. We were very happy to replicate the stereo- and regio-selectivity of this 
transformation. Unfortunately the isolated yield over the two steps was a poor 28% - 
considerably lower than that reported by Hirama, and we did not have the material to 
optimise this reaction further in our hands. Tetracycle 9 is the antepenultimate 
compound in all merrilactone A syntheses to date and the 1H NMR, 13C NMR, IR, 
and HRMS spectra of 9 matches those reported in the previous literatures, thus 










































a) Na, NH3, EtOH/THF, -78 ℃; b) Ag2CO3, toluene, reflux, 28% over 2 steps; c) mCBPA, DCM; d) TsOH, 
DCM  
Scheme 2-55. Formal total synthesis of merrilactone A 
2.7 Conclusion 
We have achieved a formal total synthesis of the complex, neurotrophic 
sesquiterpenoid merrilactone A following the approach shown in Scheme 2-56. 
The synthesis towards natural products began with [2+2] photocycloaddition of 
4,5-dimethylmaleic anhydride 135 and dimethylketene acetal 20. Reduction of the 
resulting anhydride, benzyl protection and ketal hydrolysis gave the cyclobutanone 
94 in 83% yield over 4 steps. The required cyclopentanone 144 was achieved via a 
highly regioselective Tiffeneau-Demjanov rearrangement reacting with ethyl 
diazoacetate in the presence of BF3·Et2O. The ethyl ester group in 144 was then 
transesterified with allyl alcohol, followed by C-alkylation of the -keto-ester with 
allyl bromide to set up a Tsuji-Trost decarboxylation-dehydrogenation sequence. 
Treatment with catalytic Pd(OAc)2 and PPh3 worked smoothly and gave the enone 
181 in 90% yield. Oxidative cleavage of the terminal alkene followed by 
immediately reduction of the aldehyde with Zn(BH4)2(Py) complex gave the 
cyclopentanone 176 in 72% yield over 3 steps. The required -epoxide 219 was 
prepared through NaOCl treatment of enone 176, then addition of excess 
homopropargyl lithium reagent to the highly hindered ketone 219 proceeded in 
excellent yield and diastereoselectivity, affording the tertiary alcohol 223 as a single 
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stereoisomer in 94% yield. Treament of 223 with Cp2TiCl2 and excess zinc promoted 
a reductive epoxide cleavage with titanium(III) and subsequent 5-exo-dig cyclisation 
onto the pendant alkyne resulted in successful formation of the BC bicycle 232 in 
69% yield (79% brsm). Oxidation of the hindered secondary alcohol of 232, 
desilylation and oxidative lactonization with TPAP afforded the tricyclic compound 
243 in 71% yield over 3 steps. Careful treatment 243 with a mixture of TsOH and 
AcOH in DCM at 30 ℃ over 2 days afforded the internal alkene 246 in high yield. 
Compound 246 was very similar to a late stage intermediate in Inoue and Hirama’s 
synthesis. Accordingly, application of Hirama’s two step protocol of sodium in 
ammonia followed by Fetizon’s reagent provided the tetracycle 9.  
 
a) h, pyrex, MeCN/acetone (9:1), 96%; b) LiAlH4, Et2O, 0 ℃, 97%; c) BnBr, TBAI, NaH, THF; d) H2SO4 
(aq), MeCN, 90% (two steps); e) N2CHCO2Et, BF3·Et2O (2.5 equiv), DCM, 0 ℃, 88%; f) allyl alcohol, 
toluene, reflux, 93%; g) allyl bromide, K2CO3, acetone, 89%; h) Pd(OAc)2 (5 mol%), PPh3 (5 mol%), 
MeCN, reflux, 90%;i) OsO4 (2 mol%), NMO (1 equiv), acetone / H2O (4:1), 96%; j) NaIO4, THF/H2O (1:1), 
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k) ZnBH4·py, isopropanol, 0 ℃, 76% (2 steps). l) NaOCl (aq), pyridine, 0 ℃, 90%, dr = 2.2:1; m) TBSCl, 
imidazole, DCM, 0 ℃, 98%; n) 186, t-BuLi, Et2O, -78 ℃, 94%; o) KOH, MeOH, 98%; p) Cp2TiCl2 (3 
equiv), Zn (9 equiv), THF, ~69%,10% SM recovered; q) TPAP (0.5 equiv), NMO, MS 4 Å, DCM, 82%; r) 
TBAF, THF; s) TPAP (0.1 equiv), NMO, MS 4 Å, DCM, 90% (2 steps); t) TsOH, AcOH/DCM (1:1), 30 ℃, 
78% (5% SM recovered); u) Na, liq NH3, THF / EtOH (5:1), -78 ℃; v) Ag2CO3 on celite, toluene, 130 ℃, 
28% (two steps); 
Scheme 2-56 
The key intermediate 9 was achieved via a 22 steps synthetic route with overall 2.4% 
yield. Tetracycle 9 is also the common intermediate in all merrilactone A syntheses to 
date, and represents a formal total synthesis of this natural product. 
The novel synthetic route conceptualized here offers many avenues of diversity 
creation around the framework of this bioactive natural product. The strategy is also 
amenable towards accessing a pair of epimeric sesquiterpene, anislactone A and B 
via a regio- selective lactonization pathway. Detailed synthesis of anislactones will 
be discussed in the next chapter. 
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3 Total synthesis of Anislactone A and B 
3.1 Introduction and background of Anislactone A 
In 1989 Kouno reported the isolation of anislactones A and B[1], two novel 
sesquiterpene lactones that were isolated from the pericarps of Illicium anisatum. 
The structure of anislactone A was established from spectral data and X-ray 
crystallographic analysis. Anislactone B is an isomer of anislactone A, and its 
structure was determined by spectral data compared with those of anislactone A. 
Furthermore, anislactones A and B have an unique carbon skeleton, which consists of 
two consecutive five-membered ring frameworks fused with two -lactones.  
Interestingly, Fukuyama has shown that anislactone B can be converted into 
merrilactone A using a simple three-step sequence, suggesting that anislactones may 
be biogenetic precursors to merrilactone A. Anislactones A and B, by contrast to 
merrilactone A have received little attention from synthetic chemists with only a 
single report from Hong et al. on an approach to the tricyclic framework.[2] This is 
presumably due to the lack of biological activity reported for the molecule, which 
was not subjected to any assay in Kuono’s orginal report. 
 
Scheme 3-1. Chemical conversion of anislactone B to merrilactone A 
3.2 Aluminium triflate catalyzed intramolecular hydroalkoxylation reaction 
In order to access the anislactones it was necessary to install the regioisomeric 




Scheme 3-2. Regio- selective lactonization for merrilactone A and anislactone A 
A hint on how to achieve this transformation came from our development of the 
earlier epoxide fragmentation/cyclization, where we observed a small amount of 
alkene etherification product being formed from substrates having a free C11-OH 
group. The etherification was possibly mediated by traces of acid existing in the 
reaction system and the resulting five-membered cyclic ether could be further 
oxidized to the -lactone D of anislactones.  
As for merrilactone A, we prepared the titanium(III) reagent via the treatment of 
titanocene dichloride with activated zinc powder in anhydrous and degassed THF. 
The resulting suspension was vigorously stirred under argon atmosphere with 
rigorous exclusion of oxygen, and the color changed from dark red to bright green, 
confirming the formation of the desired titanium(III) species. The resulting 
titanium(III) complex was then transferred into a solution of 224, containing the free 
primary alcohol, in THF and the resulting mixture was stirred for further 20 hours. 
Excess titanium reagent was removed using a silicon pad and the resulting reaction 
mixture was purified by column chromatography to furnish the radical cyclized 
products bicyclic 226 and tricyclic 227 as a mixture. Separation proved difficult by 
silica gel chromatography. 1H NMR spectral data indicated that the ratio of the two 
products was roughly 1:1. Interestingly, bicyclic 226 underwent spontaneous 
etherification reaction in the NMR tube (in chloroform-d) and gradually transformed 




Scheme 3-3.  
In order to optimise the etherification reaction we screened various acid catalysts. 
Whilst strong Brønsted acids (TfOH, MsOH, TFA) all led to rapid decomposition, 
treatment of 226 with TsOH in DCM at 0 ℃ provided 227 but in low yield. Due to 
the unstable nature of the substrate 226 in the presence of Brønsted acids, we turned 
our attention to metal-catalyzed etherification reactions. Transition-metal catalysts 
such as CeIII/NaI[4], RuIII/AgI[5-7] and AuI/AgI[8,9] systems, as well as PtII complexes, 
have recently been used as catalysts for the intramolecular etherification of 
unactivated alkenes to form cyclic ethers. Very recently, Elisabet Dunach et al. 
reported aluminium triflate as an efficient catalyst for the highly regioselective 
intramolecular hydroalkoxylation of unactivated olefins to afford the corresponding 
cyclic ether in excellent yield.[10] This catalyst system provided one of the most 
straightforward routes to cyclic ethers with Markovnikov-type regioselectivity under 
very mild conditions.  
 
a) TBAF, DCM; b) Al(OTf)3, DCM, 92% over 2 steps 
Scheme 3-4. Al(OTf)3 catalyzed intromolecular hydroalkoxylation reaction 
Application of aluminium triflate on our substrate proved to be highly effective. We 
found it more efficient to effect radical cyclisation with the TBS-protected substrate 
as for Merrilactone A. Desilylation with tetra-n-butylammonium fluoride (TBAF) 
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afforded 245, the substrate for intramolecular hydroalkoxylation. The crude product 
245 was redissolved in dichloromethane and treated with 0.05 equivalents of 
aluminium triflate. The resulting solution was stirred for 10 h at room temperature 
affording desired cyclic ether 227 in 88% yield over two steps, while the 
decomposition of substrate 245 was not observed.   
3.3 Lactonization and total synthesis of anislactones 
Removal of the benzyl protecting groups by hydrogenolysis was straightforward, 
setting the stage for two selective lactonizations (Scheme 3-5). First, the -lactone D 
was installed by regioselective oxidation of 246 with Fetizon’s reagent. As 
previously found in this transformation, it appeared that the reactivity of the hydroxy 
group at C12 towards oxidation was higher than the one at C14. Molecular modeling 
(shown in Scheme 3-5a for an MM2-minimised structure of 246) suggested that the 
steric hindrance between the protons at C3 and C14 impeded the attack of the bulky 
Fetizon’s reagent, thus the weak 
oxidising agent was selective for the 
sterically most accessible C12 primary 
alcohol[4b]. The secondary alcohol at 
C7 was intact and survived under 
these conditions due to the steric 
hindrance around C7 existing in the 






























227 246 247  
a) Pd/C, MeOH, H2; b) Ag2CO3, toluene, 73% over 2 steps 
Scheme 3-5. Selective lactonization of anislactones 
The remaining -lactone A was anticipated to arise through oxidation at C11 of the 
cyclic ether. Using catalytic ruthenium tetroxide (RuO4) and excess NaIO4 in carbon 
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tetrachloride (CCl4), the oxidation of 247 to 248 proved to be efficient. The reaction 
required several hours for completion with concomitant oxidation of the secondary 
alcohol to a ketone. Attempts to protect the secondary alcohol before oxidation were 
fruitless. Acetylation of 247 with 4-dimethylaminopyridine (DMAP), acetic 
anhydride and pyridine for three days yielded a tertiary alcohol protected monoacetyl 
derivative with the recovery of 247. Similarly silylation with TMSCl or TMSOTF in 
the DCM was also unsuccessful, only furnishing mono-protected teriary alcohol 
derivative, indicating the strongly hindered environment around the secondary 
alcohol group. Using harsh conditions, such as Ac2O/Sc(OTf)3/MeCN, or Ac2O/cat. 
TMSOTf/DCM led to the rapid decomposition of the starting materials 247. 
 
a) RuO4, NaIO4, MeCN/CCl4/H2O, 75%; b) NaBH4, THF, 98%, ratio 5:1 
Scheme 3-6. Completion of anislactone A 
In the event, reduction of the ketone 248 with NaBH4 was found to be efficient, 
delivering hydride from the more accessible -face and producing anislactones A and 
B in 95% yielded as a 5:1 mixture, from which anislactone A could be purified. 
Synthetic 2a matches 1H NMR, 13C NMR, IR and HRMS spectra to the natural 
product, and the structure was confirmed unambiguously through X-ray 





Scheme 3-7. X-Ray structure of Anislactone A 
3.4 Conclusion 
We have finished the first total synthesis of complex sesquiterpenoids anislactone A 
and B successfully in total 21 synthetic steps with an overall 5.6% yield.  
 
a) TBAF, DCM/THF (5:1); b) Al(OTf)3 (5 mol%), DCM, 88% (two steps); c) H2, Pd/C, MeOH; d) Ag2CO3 
on celite, toluene, 130 ℃, 73% (two steps); e) RuCl3 (0.5 equiv), NaIO4, MeCN/CCl4/H2O (1:1:1), 73%; f) 
NaBH4, THF, 95% (dr = 5:1) 
Scheme 3-8. Total synthesis of anislactone A / B 
Access to the anislactones was achieved from the common intermediate 232 via a 
regioselective lactonization pathway. A intramelecular etherification reaction 
catalyzed by Al(OTf)3 in DCM at room temperature afforded 227 in 88% yield. 
Hydrogenolysis of the benzyl protecting groups then region-selective oxidation with 
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Fetizon’s reagent constructed the right-part -lactone D in 247. The remaining 
-lactone A was then synthesised through RuO4 oxidation at C11 of the cyclic ether, 
with concomitant oxidation of the secondary alcohol to a ketone. Reduction of this 
ketone with NaBH4 delivered anislactones A and B in 95% yield as a 5:1 mixture. 
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4 Conclusions  
We have successfully achieved a formal total synthesis of the complex, neurotrophic 
sesquiterpenoid merrilactone A and the first total synthesis of anislactone A in the 
overall 2.2% yield (24 steps) and 5.6 % (21 steps), respectively. Our synthetic route 
is highly competitive with the four previous total syntheses of merrilactone A.  
Table 4-1 
2002 Danishefsky 20 steps 11% 
2003 Hirama 27 steps 1% 
2006 Mehta 27 steps 0.4% 
2007 Frontier 20 steps 10% 
2010 Greaney 24 steps 2.2% 
One advantage of our synthetic route is that both natural products anislactone A / B 
and merrilactone A could be synthesized from the common intermediate 232. We 
developed a concise and efficient route in 16 steps to the advanced BC intermediate 
232 in overall 15.2% yield. The key transformations in our synthesis are shown in 
scheme 4-1. 
 
a) h, pyrex, MeCN/acetone (9:1), 96%; b) LiAlH4, Et2O, 0 ℃ 97%; c) BnBr, TBAI, NaH, THF; d) H2SO4 
(aq), MeCN, 90% (two steps); e) N2CHCO2Et, BF3·Et2O (2.5 equiv), DCM, 0 ℃, 88%; f) allyl alcohol, 
toluene, reflux, 93%; g) allyl bromide, K2CO3, acetone, 89%; h) Pd(OAc)2 (5 mol%), PPh3 (5 mol%), 
MeCN, reflux, 90%;i) OsO4 (2 mol%), NMO (1 equiv), acetone / H2O (4:1), 96%; j) NaIO4, THF/H2O (1:1), 
k) ZnBH4·py, isopropanol, 0 ℃, 76% (2 steps). l) NaOCl (aq), pyridine, 0 ℃, 90%, dr = 2.2:1; m) TBSCl, 
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imidazole, DCM, 0 ℃, 98%; n) 186, t-BuLi, Et2O, -78 ℃, 94%; o) KOH, MeOH, 98%; p) Cp2TiCl2 (3 
equiv), Zn (9 equiv), THF, ~69%,10% SM recovered 
Scheme 4-1 
Cyclobutane 94 was achieved from a [2+2] photocycloaddition reaction. The 
five-membered C-ring 187 at the heart of the approach was synthesized through 
regionselective ring-expansion of cyclobutane 94. The tertiary alcohol at C4 raised 
via a stereoselective epoxidation and organometallic 1,2-addition to the ketone in 219. 
Reductive epoxide opening of 223 and radical cyclisation onto the pendant alkyne 
installed B/C bi-cyclic system 232 containing the highly congested C9 quaternary 
stereocenter. Compound 232 has the complete carbon skeleton of both anislactone A / 
B and merrilactone A and was directed to either one by orthogonal lactonization 
sequences.  
 
a) TPAP (0.5 equiv), NMO, MS 4 Å, DCM, 82%; b) TBAF, THF; c) TPAP (0.1 equiv), NMO, MS 4 Å, DCM, 
90% (2 steps); d) TsOH, AcOH/DCM (1:1), 30 ℃, 78% (5% SM recovered); e) Na, liq NH3, THF / EtOH 
(5:1), -78 ℃; f) Ag2CO3 on celite, toluene, 130 ℃, 28% (two steps); g) TBAF, DCM/THF (5:1); h) 
Al(OTf)3 (5 mol%), DCM, 88% (two steps); i) H2, Pd/C, MeOH; j) Ag2CO3 on celite, toluene, 130 ℃, 73% 
(two steps); k) RuCl3 (0.5 equiv), NaIO4, MeCN/CCl4/H2O (1:1:1), 73%; l) NaBH4, THF, 95% (dr = 5:1) 
Scheme 4-2 
-Lactone A was achieved via a standard three-step-sequence from 232 as shown in 
Scheme 4-2. Careful treatment 243 with a mixture of TsOH and AcOH in DCM at 30 
℃ afforded the internal alkene 246 in high yield. Application of Hirama’s two step 
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protocol of sodium in ammonia followed by Fetizon’s reagent provided the tetracycle 
9. Tetracycle 9 is the common intermediate in all merrilactone A syntheses to date, 
and represents a formal total synthesis of this natural product. Access to the 
anislactones was achieved via a pivotal intramelecular etherification reaction 
catalyzed by Al(OTf)3 in DCM at room temperature affording 227 in 88% yield. The 
remaining two -lactones were synthesized via Fetizon’s oxidation and RuO4 
oxidation respectively.  
High regio- and stereoselectivity in the chemical reaction is always desired in total 
syntheses as it directly affects the synthetic efficiency and overall yield of the final 
product. Our syntheses generally feature very high selectivities in the key steps, e.g. 
regioselective Tiffeneau-Demjanov ring expansion, stereoselective 1,2-addition to an 
epoxycyclopentanone and regioselective lactonization with Fetizon’s reagent. 
Although the moderate diastereoselectivity (2.2 : 1) of the epoxidation reaction is not 
very satisfactory, the overall transformation is still very efficient as the undesired 
minor -epoxide 204 could be recycled readily. Whilst we did solve this 
stereocontrol issue at the reaction level, we were unable to integrate the solution of 
using bulky silyl protecting groups to improve diastereoselectivity into the total 
synthesis as a whole. This was largely due to time restrictions, and it is possible that 
further work on this alternative route would improve the overall yield of the total 
synthesis. 
In several events, the reactions proved more difficult than anticipated due to the 
complexity of the molecule, such as alkylation of 1,3-ketoester (scheme 2-19), 
Tsuij-Trost reaction (scheme 2-24), the reduction of aldehyde 184 (scheme 2-28), 
alkene isomerization (scheme 2-52) and intramolecular hydroalkoxylation (scheme 
3-4). These challenges were surmounted eventually by careful optimization of 
reaction conditions and extensive screening of various reagents.  
Our synthetic strategy is also amenable towards accessing both the enantiomers of 


















250 251 252 253  
a) chiral amine, MeOH; b) I2, THF, NaHCO3; c) LAH 
Scheme 4-3. proposed asymmetric synthetic route 
Treatment of the known anhydride 205 with chiral amine would lead to optically 
pure acid 251. The resultant acid subjected to iodolactonization would produce 
iodolactone 252. Reduction of iodolactone with LAH would afford triol 253 and the 
iodine atom would be removed cocurrently. The resulting secondary alcohol would 
be selectively oxidised to a ketone in several steps and produce enantiopure 
intermediate 94.  
In summary, there were many surprises, disappointments and unexpected results that 
required more efforts to resolve. However, it was a great joy and learning experience 



















5 Experimental  
5.1 General Procedures  
General Methods: 1H and 13C NMR spectra were recorded on a Bruker 360 MHz, 
500 MHz or 600 MHz instrument and are calibrated to residual solvent peaks (CDCl3 
7.26 ppm and 77.0 ppm).  The data is reported as chemical shift (ppm) followed by 
peak signal shape with relevant coupling constants quoted to the nearest 0.1 Hertz.  
Infra-red spectra were recorded on a JASCO FT/IR-460 using sodium chloride disks 
or a PerkinElmer Spectrum One FT-IR Universal ATR sampling accessory 
instrument as a thin film. Electrospray high resolution mass spectrometry was 
performed by the EPSRC National Mass Spectrometry Service Centre, Swansea, 
using a Finigan MAT 900 XTL double focusing mass spectrometer. EI HRMS was 
carried out by the University of Edinburgh using a Kratos MS50 instrument.  The 
data is recorded as the ionization method followed by the calculated and measured 
masses. T.L.C. was performed on Merck 60F254 aluminium backed silica plates and 
visualized by UV light (both 254 nm and 365 nm).  Final compounds were purified 
by wet flash chromatography using Merck Kieselgel 60 (particle size 35-70) silica 
under a positive pressure. All chemicals were purchased from a chemical supplier 
and used as received unless otherwise stated.  




Ethyl 2-oxocyclopentanecarboxylate 103 (3.12 g, 20.0 mmol, 1 equiv) was dissolved 
in toluene (100 mL) and allyl alcohol (11.6 mL, 200.0 mmol, 10 equiv) added. The 
resulting solution was heated to reflux for 20 h. After cooling to RT, the solvent was 
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evaporated under reduced pressure and the crude product 104 was used in the next 
step without further purification. Allyl 2-oxocyclopentanecarboxylate 104 (3.30 g, 
20.0 mmol, 1 equiv) was dissolved in acetone (50 mL) and K2CO3 (5.40 g, 40.0 
mmol, 2 equiv) and TBS-protected 2-bromoethanol 105 (9.6 g, 40.0 mmol, 2 equiv) 
were added. The suspension was refluxed for 24 h. After cooling down to RT the 
K2CO3 was removed by filtration through a short silica pad, the solvent removed in 
vacuo and the crude product then purified by flash column chromatography (SiO2, 
hexanes:EtOAc 20:1) to afford the product 106 as a colourless oil 3.0 g (46% yield 
for 2 steps). 106: 1H NMR (500 MHz, CDCl3) δ 5.92-5.83 (1 H, m), 5.30 (1 H, dq, J 
= 17.2, 1.4, Hz), 5.22 (1 H, dd, J = 10.4, 1.2 Hz), 4.59 (1 H, dd, J = 5.6, 1.2 Hz), 
3.74-3.64 (2 H, m), 2.55-2.49 (1 H, m), 2.43-2.32 (2 H, m), 2.21-2.15 (1 H, m), 
2.10-1.88 (4 H, m), 0.86 (9 H, s), 0.02 (6 H, s); 13C NMR (125 MHz, CDCl3) δ 214.4, 
170.7, 131.6, 118.4, 65.7, 59.5, 58.7, 37.7, 36.3, 32.6, 25.8, 19.7, 18.2, -5.5, -5.5; IR 
(thin film) νmax 2956, 2929, 2886, 2857, 1755, 1728, 1471, 1464, 1256, 1223, 1099, 
837, 777 cm-1; HRMS (ES) m/z calcd for C17H31O4Si [M+H]




A solution of cyclopentanone 106 (3.0 g, 9.1 mmol, 1 equiv) in acetonitrile (20 mL) 
was slowly added to a solution of Pd(OAc)2 (101 mg, 0.455 mmol, 0.05 equiv) and 
PPh3 (119 mg, 0.455 mmol, 0.05 equiv) in acetonitrile at 90 ℃ under Ar. The 
reaction mixture was then stirred at 90 ℃ for 3 h before being allowed to cool to RT. 
Filtration through a plug of silica, removal of solvent and flash column 
chromatography (SiO2, Hexanes/EtOAc 20:1) furnished cyclopentenone 107 1.7 g, 
(77 % yield) as a colourless oil. 107: 1H NMR (500 MHz, CDCl3) δ 7.43 (1 H, tt, J 
= 2.6, 1.1, Hz), 3.71 (2 H, t, J = 6.4 Hz), 2.58-2.54 (2 H, m), 2.42-2.36 (4 H, m), 
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0.86 (9 H, s), 0.02 (6 H, s); 13C NMR (125 MHz, CDCl3) δ 209.8, 159.4, 143.2, 61.0, 
34.3, 28.3, 26.6, 25.8, 18.2, -5.3; IR (thin film) νmax 3419, 2925, 2694, 1629, 1442, 
1348, 1253, 1048, 791 cm-1; HRMS (ES) m/z calcd for C13H25O2Si [M+H]
+ 
241.1618, found 241.1620. 
1-(2-((Tert-butyldimethylsilyl)oxy)ethyl)-6-oxabicyclo[3.1.0]hexan-2-one (108) 
 
Cyclopentanone 107 (1.0 g, 4.1 mmol, 1 equiv) in MeOH (10mL) was added 
dropwise to H2O2 aqueous solution (1 mL, ~2 equiv) at 0 
oC then NaOH (1 M) 
aqueous solution (0.5 mL) was added. The resulting solution was stirred for 10h after 
reaction was completed. Saturated NaHCO3 solution (10 mL) was added, and the 
phase was extracted with ether (2 X 10 mL). The combined organic phase was 
removed under reduced pressure and flash column chromatography (SiO2, 
Hexanes/EtOAc 2:1) furnished epoxide product 108 as colourless oil 0.9 g (88 % 
yield). 108: 1H NMR (500 MHz, CDCl3) δ 3.90 (1 H, s), 3.75 (1 H, ddd, J = 10.2, 
7.1, 5.3 Hz), 3.66 (1 H, ddd, J = 10.2, 6.4, 5.6 Hz), 2.39-2.19 (3 H, m), 2.13-2.06 (1 
H, m), 2.01-1.95 (1 H, m), 1.94-1.85 (1 H, m), 0.86 (9 H, s), 0.03 (3 H, s), 0.02 (3 H, 
s); 13C NMR (125 MHz, CDCl3) δ 210.6, 63.4, 61.7, 58.3, 31.4, 27.5, 25.8, 22.3, 
18.1, -5.4, -5.5; IR (thin film) νmax 2955, 2930, 2884, 2875, 1742, 1472, 1256, 1105, 
838, 777 cm-1; HRMS (ES) m/z calcd for C13H25O3Si [M+H]







A solution of 109 (385 mg, 1.50 mmol, 1.5 equiv) in dry Et2O 10 mL at -78 
oC was 
treated with tBuli (2.02 mL, 1.7M solution in pentane, 3.45 mmol, 3.45 equiv). The 
resulting mixture was stirred under Ar for 1 h before warming to RT and stirred for a 
further 2 h. After re-cooling to -78 oC, the mixture was transferred into an Et2O 
solution of epoxide 108 (251 mg, 1.0 mmol, 1 equiv) at -78 oC via a double tipped 
needle. The reaction mixture was then stirred for 30 min and quenched with several 
drops water before warming up to RT. Filtration through a plug of silica to removed 
salt, removal of Et2O under reduced pressure, the crude product as a colourless oil. 
The crude product obtained above was dissolved in MeOH 10 mL and treated with 
K2CO3 70 mg. The resulting mixture was stirred for 10 h until reaction finished. The 
solvent was evaporated under reduced pressure and the crude product was purified 
by flash column chromatography (SiO2, hexanes/EtOAc 20:1) to afford the product 
110 as a colourless oil 120 mg (40% yield). 110: 1H NMR (500 MHz, CDCl3) δ  
4.18 (1 H, s), 3.92 (1 H, dt, J = 10.4, 2.5 Hz), 3.76 (1 H, td, J = 10.4, 4.1 Hz), 3.29 
(1 h, s), 2.48-2.33 (2 H, m), 2.23 (1 H, dddd, J = 16.7, 10.7, 5.6, 2.6 Hz), 2.05-1.97 
(2 H, m), 1.94 (1 H, t, J = 2.6, 2.6 Hz), 1.78-1.56 (3 H, m), 1.52-1.46 (2 H, m), 0.92 
(9 H, s), 0.12 (3 H, s). 0.11 (3 H, s); 13C NMR (125 MHz, CDCl3) δ 84.6, 78.8, 68.2, 
68.0, 63.7, 60.2, 35.7, 30.8, 29.8, 25.8, 25.4, 18.2, 12.8, -5.4, -5.6; IR (thin film) νmax 
3426, 3313, 2954, 2884, 2857, 1471, 1256, 1099, 837, 626 cm-1; HRMS (ES) m/z 
calcd for C17H31O3Si [M+H]






Cp2TiCl2 (176 mg, 0.70 mmol, 2 equiv) and Zn dust (65.0 mg, 2.13 mmol, 6 equiv) 
were placed in a dried round bottom flask and THF 5 mL was added under rigorous 
exclusion of air by means of an Ar atmosphere. The resulting suspension was stirred 
at RT for 1 h, during which the colour of the mixture was changed from red to green, 
indicating the formation of a low valent titanium complex. The suspension of Ti 
complex was then cannuled under Ar into a solution of the 110 (110 mg, 0.35 mmol, 
1 equiv) in THF 5 mL and the resulting green solution was stirred at RT under an Ar 
for 2h. Then the excess Ti complex was removed by filtrated through a short silica 
pad and the solvent was evaporated under reduced pressure. The crude product was 
purified by flash column chromatography (SiO2, hexanes/EtOAc 20:1) to afford the 
product 111 as a colourless oil 90 mg (83% yield). 111: 1H NMR (500 MHz, CDCl3) 
δ 4.98 (1 H, t, J = 1.9 Hz), 4.75 (1 H, t, J = 2.3 Hz), 4.10 (1 H, m), 3.83 (1 H, ddd, J 
= 10.8, 9.0, 1.9 Hz), 3.74 (1 H, ddd, J = 10.2, 6.4, 2.5 Hz), 3.15 (1 H, s), 3.10 (1 H, d, 
J = 4.6 Hz), 2.46-2.40 (1 H, m), 2.31-2.24 (1 H, m), 2.09-2.03 (2 H, m), 1.89-1.77 (5 
H, m), 1.65 (1 H, ddd, J = 15.2, 6.4, 1.9 Hz), 0.92 (9 H, s), 0.11 (3 H, s), 0.10 (3 H, 
s); 13C NMR (125 MHz, CDCl3) δ 154.8, 108.1, 89.5, 80.7, 61.5, 59.6, 38.8, 35.6, 
31.4, 31.1, 29.5, 25.8, 18.1, -5.6, -5.6; IR (thin film) νmax 3383, 2952, 1716, 1652, 
1455, 1214, 1033, 890 cm-1; HRMS (ES) m/z calcd for C17H33O3Si [M+H]
+ 





A solution of 2,3-dimethylmaleic anhydride 20 (2.00 g 15.8 mmol, 1 equiv), 
dimethylketene acetal 135 (5.57 g, 63.2 mmol, 4 equiv) and benzophenone (287 mg, 
1.58 mmol, 0.1 eq) in a mixed solvent of acetone (50 mL) and acetonitrile (350 mL) 
was degassed under a stream of N2 for 30 min. The mixture was irradiated using a 
400 W medium pressure mercury lamp with a pyrex filter for 24 h under water 
cooling. Solvent removal under reduced pressure followed by flash column 
chromatography (SiO2, EtOAc/hexane 1:9) gave cyclobutane 136 as a pale yellow oil. 
Crystallization from Et2O / hexane afforded the pure product (3.24 g, 15.1 mmol, 
96% yield) as white needles. 136: 1H NMR (360 MHz, CDCl3): δ 3.24 (3 H, s), 3.22 
(3 H, s), 2.67 (1 H, d, J = 13.4, Hz), 2.24 (1 H, d, J = 13.4, Hz), 1.36 (3 H, s, Hz), 1.32 
(3 H, s, Hz). 13C NMR (90 MHz, CDCl3) δ 175.8, 171.9, 99.6, 59.2, 50.2, 50.1, 41.2, 
41.0, 15.7, 10.2; IR (thin film) νmax 2949, 2841, 1846, 1779, 1448, 1385, 1272, 1255, 
1144, 1094, 1060, 1029, 918, 834, 793, 752 cm-1; HRMS (ES) m/z calcd for 
C10H15O5 [M+H]
+ 215.0914, found 215.0915. 
(3,3-Dimethoxy-1,2-dimethylcyclobutane-1,2-diyl)dimethanol (137) 
 
Anhydride 136 (7.00 g, 32.8 mmol, 1 equiv) in Et2O (300 mL) was cooled to 0 ˚C 
and LiAlH4 powder (2.20 g, 58.0 mmol, 2 equiv) careful added in portions. The 
reaction mixture was then stirred for 5 h at 0 ˚C. The resulting suspension was 
quenched by addition of H2O (2.2 mL), NaOH solution (1.0 M, 2.2 mL) and then 
H2O (5 mL). Filtration and removal of solvent under reduced pressure afforded diol 
137 as a colourless oil (6.5 g, 97% yield), which was used in the next step without 
further purification. 137: 1H NMR (360 MHz, CDCl3) δ 4.07-3.94 (2 H, m), 
3.57-3.48 (2 H, m), 3.45-3.42 (1 H, m), 3.32-3.26 (1 H, m), 3.17 (3 H, s), 3.12 (3 H, s), 
1.81 (1 H, d, J = 12.6 Hz), 1.71 (1 H, d, J = 12.6 Hz), 1.14 (3 H, s), 1.12 (3 H, s); 13C 
NMR (90 MHz, CDCl3) δ 102.8, 68.8, 65.7, 52.6, 50.0, 49.2, 37.6, 36.4, 20.6, 15.9; 
IR (thin film) νmax 3854, 3745, 3333, 2940, 2833, 1653, 1448, 1380, 1253, 1195, 
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1111, 1065, 973, 916, 867, 826, 665 cm-1; HRMS (ES) m/z calcd for C10H20O4Na 




NaH (2.7 g, 60% in mineral oil, 70 mmol, 2.5 equiv) was added slowly to a solution 
of 137 (6.2 g, 30 mmol, 1 equiv) and Bu4NI (1.1 g, 3.0 mmol, 0.1 equiv) in THF 
(200 mL) at 0 ˚C, followed by the addition of benzyl bromide (7.2 mL, 6.2 mmol, 2.1 
equiv). The reaction mixture was stirred at RT for 20 h and subsequently the excess 
NaH was quenched by addition of H2O (50 mL). Following extraction with EtOAc 
(2), the organic layers were combined, washed with brine and dried over MgSO4. 
Filtration and removal of solvent under reduced pressure afforded 138 as a yellow oil, 
which was used directly in the next step. 138: 1H NMR (360 MHz, CDCl3) δ 
7.40-7.29 (10 H, m), 4.57-4.45 (4 H, m), 3.60-3.50 (4 H, m), 3.25 (1 H, s), 3.15 (3 H, 
s), 2.14 (1H, d, J = 12.6 Hz), 1.77 (1H, d, J = 12.6 Hz), 1.25 (3 H, s, Hz), 1.175 (3 H, 
s); 13C NMR (90 MHz, CDCl3) δ 139.0, 138.8, 128.2, 128.1, 127.4, 127.3, 127.2, 
102.8, 75.4, 73.1, 71.1, 52.1, 50.2, 48.9, 37.5, 35.8, 19.8, 15.8; IR (thin film) νmax 




Compound 138 （12.1g， 31.5 mmol） was dissolved in MeCN (50 mL), H2SO4 (0.5 
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M, 15 mL) added and the reaction stirred at RT for 5 h. The reaction was quenched 
with saturated NaHCO3 solution, extracted with DCM, and the combined organic 
extracts dried with MgSO4. Filtration and removal of solvent under reduced pressure 
afforded a yellow oil, which was purified by flash column chromatography (SiO2, 
EtOAc/hexane 1:9) to give ketone 94 as a colourless oil (9.2 g, 90% yield for 2 steps). 
94: 1H NMR (360 MHz, CDCl3) δ 7.36-7.23 (10 H, m), 4.46 (1H, d, Jab= 12.2 Hz), 
4.42 (1H, d, Jab= 12.2 Hz), 4.37 (2 H, s), 3.76 (1 H, d, Jab= 9.0 Hz), 3.57 (2 H, s), 
3.55 (1 H, d, Jab= 9.0 Hz), 3.06 (1 H, d, J = 16.6 Hz), 2.58 (1 H, d, J = 16.6 Hz), 1.25 
(3 H, s), 1.13 (3 H, s); 13C NMR (90 MHz, CDCl3) δ 211.9, 138.3, 137.9, 128.2, 
127.5, 127.4, 74.8, 73.1, 73.1, 71.5, 66.0, 54.2, 36.0, 21.0, 15.3; IR (thin film) νmax 
2871, 1775, 1496, 1454, 1378, 1273, 1095, 1028, 739, 699, 665 cm-1; HRMS (ES) 
m/z calcd for C22H30O3N [M+NH4]














94 144  
Cyclobutanone 94 (5.15g, 15.2 mmol, 1 equiv) in DCM (200 mL) was cooled to 0 
℃ and BF3.OEt2 (4.87 mL, 38.0 mmol, 2.5 equiv) added dropwise. After stirring for 
5 min, ethyl diazoacetate (4.0 mL, 38 mmol, 2.5 equiv) was added dropwise and the 
resulting solution was stirred at 0 ℃ for 2 h. Following addition of saturated 
NaHCO3 solution, the organic phase was separated, dried over MgSO4, and the 
solvent removed under reduced pressure. Flash column chromatography (SiO2, 
hexanes/EtOAc 20:1) afforded cyclopentanone 144 as a colourless oil (mixture of 
diastereoisomers and tautomers, 5.60g, 88% yield). Major isomer 144: 1H NMR 
(360 MHz, CDCl3) δ 7.39-7.17 (10 H, m), 4.42-4.05 (6 H, m), 3.59 (1 H, t, J = 9.8 
Hz), 3.54-3.49 (2 H, m), 3.35 (1 H, d, J = 8.9 Hz), 3.24 (1 H, d, J = 8.9 Hz), 
2.27-2.13 (2 H, m), 1.27 (3 H, t, J = 7.1 Hz), 1.19 (3 H, s), 1.08 (3 H, s); 13C NMR 
(90 MHz, CDCl3) δ 212.8, 169.9, 138.2, 137.6, 128.3, 128.1, 127.5, 127.4, 127.2, 
73.2, 73.1, 72.6, 61.2, 54.1, 53.3, 43.8, 36.1, 20.3, 17.1, 14.0; IR (thin film) νmax 
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3030, 2981, 1719, 1495, 1454, 1367, 1207, 1097, 737, 698 cm-1; HRMS (ES) m/z 
calcd for  C26H36NO5 [M+NH4]




Cyclopentanone 144 (5.80 g, 13.6 mmol, 1 equiv) was dissolved in toluene (100 mL) 
and allyl alcohol (9.23 mL, 136 mmol, 10 equiv) added. The resulting solution was 
heated to reflux for 10 h. After cooling to RT, the solvent was evaporated under 
reduced pressure and the crude product was purified by flash column 
chromatography (SiO2, hexanes/EtOAc 20:1) to afford 149 as a colourless oil (5.5 g, 
93% yield, mixture of diastereoisomers and tautomers). Major isomer 149: 1H NMR 
(360 MHz, CDCl3) δ 7.36-7.16 (10 H, m,), 5.95-5.83 (1 H, m), 5.33 (1 H, qd, J = 
17.2, 1.5 Hz), 5.22 (1 H, dd, J = 10.5, 2.3 Hz), 4.66-4.57 (2 H, m), 4.41-4.27 (2 H, 
m), 4.24 (2 H, m), 3.64 (1 H, t, J = 9.9 Hz), 3.50 (2 H, m), 3.34 (1H, d, Jab = 9.0 Hz), 
3.24 (1 H, d, Jab = 9.0 Hz), 2.61-1.83 (2 H, m), 1.19 (3 H, s), 1.08 (3 H, s); 
13C NMR 
(90 MHz, CDCl3) δ 212.5, 169.6, 138.2, 137.5, 131.7, 118.2, 77.3, 73.2, 73.1, 72.6, 
65.7, 54.1, 53.2, 43.8, 36.1, 20.3, 17.2; IR (thin film) νmax 2861, 1749, 1724, 1454, 
1097 cm-1; HRMS (ES) m/z calcd for C27H36NO5 [M+NH4]







Cyclopentanone 149 (1.20 g, 2.74 mmol, 1 equiv) was dissolved in acetonitrile (5 
mL) and K2CO3 (760 mg, 5.50 mmol, 2 equiv) and (2-iodoethoxymethyl) benzene 
166 (1.44 g, 5.50 mmol, 2 equiv) were added. The suspension was stirred under N2 at 
95 ℃ for 26 h, cooled to RT and EtOAc (10 mL) was added. Following washes 
with saturated NH4Cl solution and brine, the organic layer was dried over MgSO4, 
filtered and the solvent removed under reduced pressure. Flash column 
chromatography (SiO2, DCM 100%) afforded 167 as a pale yellow oil (928 mg, 76% 
yield, mixture of diastereoisomers, ratio = 2 : 1). Major isomer 167: 1H NMR (360 
MHz, CDCl3) δ 7.34-7.20 (15 H, m), 5.82 (1 H, m), 5.34-5.16 (2 H, m), 4.62-4.21 (8 
H, m), 3.71-3.28 (6 H, m), 2.53 (1 H, d, J=13.7 Hz), 2.39 (1 H, m), 2.04 (1 H, d, 
J=13.7 Hz), 1.98 (1 H, m), 1.08 (3 H, s), 1.04 (3 H, s); 13C NMR (90 MHz, CDCl3) δ 
215.9, 171.3, 138.4, 138.0, 137.9, 131.7, 128.3, 128.2, 127.8, 127.7, 127.6, 127.5, 
118.4, 76.7, 74.6, 73.4, 73.2, 72.7, 66.9, 65.9, 57.9, 55.3, 42.5, 40.7, 36.0, 22.1, 17.9; 
IR (thin film) ν 2857, 1749, 1725, 1454, 1100 cm-1; HRMS (ES) m/z calcd for 
C36H46O6N [M+NH4]




An acetonitrile solution (2.5 mL) of cyclopentanone 167 (106 mg, 0.18 mmol, 1 
equiv) was added to a solution of Pd(OAc)2 (5.00 mg, 0.02 mmol, 0.1 equiv) and 
PPh3 (5.00 mg, 0.02 mmol, 0.1 equiv) in acetonitrile (2.5 mL) at 50 ℃ under a N2 
atosphere. The reaction mixture was then stirred at 95 ℃ for 5.5 h before allowing 
to cool to RT. Filtration through a plug of silica, removal of solvent and flash column 
chromatography (SiO2, hexanes/EtOAc 9:1) furnished cyclopentenone 169 as a 
colourless oil (17 mg, 20% yield). 1H NMR (360 MHz, CDCl3) δ 7.33-7.18 (15 H, 
m), 7.05 (1 H, s), 4.44 (2 H, s), 4.38-4.29 (2 H, m), 4.31 (2 H, s), 3.61-3.47 (6 H, m,), 
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2.49 (2 H, dt, J= 1.0, 6.7 Hz), 1.14 (3 H, s), 1.12 (3 H, s); 13C NMR (90 MHz, 
CDCl3) δ 211.3, 162.3, 139.2, 138.4, 138.3, 128.3, 128.2, 128.1, 127.6, 127.4, 127.3, 
127.2, 74.8, 73.5, 73.2, 72.8, 72.7, 68.1, 54.1, 49.6, 25.3, 20.1, 19.9; IR (thin film) ν 






Cyclopentanone 149 (100 mg, 0.23 mmol, 1 equiv) was dissolved in acetonitrile (1 
mL) and K2CO3 (65.0 mg, 0.46 mmol, 2 equiv) and 1-bromo-2-(methoxymethoxy)- 
ethane 166 (76.0 m g, 0.46 mmol, 2 equiv) were added. The suspension was stirred 
under N2 at 95 ℃ for 26 h, cooled to RT and EtOAc (2 mL) was added. Following 
washes with saturated NH4Cl solution and brine, the organic layer was dried over 
MgSO4, filtered and the solvent removed under reduced pressure. Flash column 
chromatography (SiO2, DCM 100%) afforded 164 as a pale yellow oil (12 mg, 10% 
yield, mixture of diastereoisomers, ratio = 2 : 1) and 165 (18 mg, 15% yield). Major 
isomer 164: 1H NMR (360 MHz, CDCl3) δ 7.36-7.22 (10 H, m), 5.95-5.84 (1H, m), 
5.36-5.31 (1H, m), 5.24-5.21 (1H, m), 4.62-4.57 (2H, m), 4.47 (2H, m), 4.34-4.27 
(4H, m), 3.52-3.46 (4H, m), 4.34-4.31 (2H, m), 3.82 (3H, s), 2.52 (1 H, d, J = 13.6 
Hz), 2.37 (1 H, td, J = 13.8, 6.8 Hz), 2.04 (1 H, d, J = 13.7 Hz), 1.96 (1 H, m), 1.08 (3H, 
s), 1.04 (3H, s); 13C NMR (90 MHz, CDCl3) δ 215.7, 171.2, 137.9, 137.8, 131.6, 
128.6, 128.2, 128.1, 127.7, 127.6, 127.5, 127.5, 127.2, 118.4, 96.3, 96.1, 74.5, 73.3, 
73.1, 73.0, 65.9, 64.1, 57.9, 55.2, 55.0, 42.4, 40.5, 35.8, 22.0, 17.8; IR (thin film) 
νmax 3448, 2937, 2879, 1724, 1454, 1200, 1153, 1109, 1045, 918, 698 cm
-1; HRMS 
(ES) m/z calcd for C31H44O7N1 [M+NH4]
+ 542.3112, found 542.3113. 165: 1H NMR 
(360 MHz, CDCl3) δ 7.34-7.29 (10 H, m), 6.04-5.85 (1 H, m), 5.31 (1 H, qd, J = 17.2, 
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1.6 Hz), 5.21 (1 H, qd, J = 10.4, 1.3 Hz), 4.62-4.60 (4H, m), 4.54 (1 H, ddd, J = 11.4, 
5.7, 3.3 Hz), 4.40 (2 H, d, J = 6.2 Hz), 4.34 (2 H, d, J = 11.7 Hz), 4.21 (1 H, ddd, J = 
11.4, 5.9, 3.3 Hz), 3.75-3.62 (2 H, m), 3.59 (1 H, d, J = 8.8 Hz), 3.44 (2 H, d, J = 3.1 
Hz), 3.35 (1 H, d, J = 8.8 Hz), 3.33 (3 H, d, J = 0.4 Hz), 2.67 ( 1 H, d, J = 14.0 Hz), 
2.16 ( 1 H, d, J = 14.0 Hz), 1.14 ( 3 H, s), 1.05 (3H, s); 13C NMR (90 MHz, CDCl3) δ 
170.3, 164.7, 138.8, 138.5, 132.6, 128.1, 127.2, 117.4, 104.0, 96.3, 75.5, 74.0, 73.4, 
73.0, 72.8, 66.6, 64.3, 55.0, 54.5, 43.0, 40.5, 22.2, 16.3; IR (thin film) νmax 3423, 
2933, 2860, 1703, 1624, 1454, 1373, 1321, 1267, 1227, 1200, 1171, 1153, 1111, 
1028, 920, 737, 698 cm-1; HRMS (ES) m/z calcd for C31H44O7N1 [M+NH4]
+ 




Cyclopentanone 149 (5.00 g, 11.4 mmol, 1 equiv) was dissolved in acetone (100 mL) 
and K2CO3 (3.10 g, 22.4 mmol, 2 equiv) and methyl 2-bromoacetate (3.30 g, 22.4 
mmol, 2 equiv) were added. The suspension was stirred at RT for 24 h. The K2CO3 
was removed by filtration through a short silica pad, the solvent removed under 
reduced pressure and the crude product then purified by flash column 
chromatography (SiO2, hexanes/EtOAc 20:1) to afford the product 171a/b as a 
colourless oil (5.2 g, 89% yield, mixture of diastereoisomers (ratio 2:1). Major 
isomer 171a: 1H NMR (360 MHz, CDCl3) δ 7.35-7.18 (10 H, m), 5.86 (1 H, tdd, J = 
17.2, 10.5, 5.6, 5.6 Hz), 5.29 (1 H, qd, J = 17.2, 1.53 Hz), 5.20 (1 H, ddd, J = 10.4, 2.6, 
1.2 Hz), 4.60-4.59 (1 H, m), 4.59 (2 H, td, J = 5.6, 1.3 Hz), 4.35 (1 H, d, J = 11.9 Hz), 
4.25 (3 H, m), 3.60 (3H, s), 3.47 (1 H, d, J = 3.6 Hz), 3.28 (1 H, d, J = 1.5 Hz), 3.15 (1 
H, d, J = 16.9 Hz), 2.85 (2 H, m), 1.97 (1 H, d, J = 14.4 Hz),  1.14 (3 H, s), 1.12 (3 H, 
s); 13C NMR (90 MHz, CDCl3) δ 213.7, 172.0, 170.1, 137.8, 137.3, 131.6, 128.3, 
128.2, 128.2, 128.1, 127.9, 127.8, 127.6, 127.5, 118.2, 77.1, 73.6, 73.3, 73.2, 66.2, 
 110
 
57.7, 55.1, 51.5, 42.6, 41.4, 40.4, 21.5, 18.0; IR (thin film) νmax 3030, 2949, 2862, 
1732, 1455, 1417, 1358, 1267, 1206, 1098, 1058, 1029, 925, 738, 699 cm-1; HRMS 
(ES) m/z calcd for C30H40O7N1 [M+NH4]
+ 526.2799, found 526.2800. Minor isomer 
171b: 1H NMR (360 MHz, CDCl3) δ 7.39-7.30 (10 H, m), 5.89-5.78 (1 H, m), 5.29 (1 
H, qd, J = 17.2, 1.53, 1.38 Hz), 5.18 (1 H, ddd, J = 10.4, 2.4, 1.1 Hz), 4.53-4.41 (5 H, 
m), 4.31 (1 H, d, J = 12.2 Hz), 3.75 (1 H, d, J = 9.0 Hz), 3.69 (3 H, s), 3.49-3.42 (3 H, 
m), 3.37 (1 H, d, J = 9.1 Hz,), 3.18 (1 H, d, J = 14.5 Hz), 2.48 (1 H, d, J = 16.3 Hz), 
1.84 (1 H, d, J = 14.5 Hz), 1.23 (3 H, s), 1.09 (3 H, s); 13C NMR (90 MHz, CDCl3) δ 
211.8, 170.9, 168.7, 138.0, 131.7, 128.2, 128.1, 127.4, 127.3, 127.2, 117.9, 75.5, 73.1, 
72.8, 71.9, 66.1, 56.8, 56.7, 51.7, 42.6, 42.1, 39.8, 22.4, 16.9; IR (thin film) νmax 
3030, 2951, 2862, 1739, 1454, 1414, 1355, 11275, 1205, 1098, 1029, 738, 698 cm-1; 
HRMS (ES) m/z calcd for C30H40O7N1 [M+NH4]




An acetonitrile solution (2.5 mL) of cyclopentanone 171 (91.0 mg, 0.18 mmol, 1 
equiv) was added to a solution of Pd(OAc)2 (5.00 mg, 0.02 mmol, 0.1 equiv) and 
PPh3 (5.00 mg, 0.02 mmol, 0.1 equiv) in acetonitrile (2.5 mL) at 50 ℃ under a N2 
atosphere. The reaction mixture was then stirred at 95 ℃ for 2 hours before 
allowing to cool to RT. Filtration through a plug of silica, removal of solvent and 
flash column chromatography (SiO2, hexanes/EtOAc 9:1) furnished cyclopentenone 
172 as a colourless oil (71 mg, 90% yield). 172: 1H NMR (360 MHz, CDCl3) δ 
7.39-7.23 (11 H, m), 4.43 (1 H, Jab = 10.8 Hz), 4.38 (1 H, Jab = 10.8 Hz), 4.37 (2 H, s), 
3.70 (3H, s), 3.65 (1 H, Jab = 10.8 Hz), 3.61 (1 H, Jab = 10.8 Hz), 3.55 (2 H, s), 
3.33-3.21 (2 H, m), 1.23 (3 H, s), 1.21 (3 H, s); 13C NMR (90 MHz, CDCl3) δ 210.0, 
170.7, 163.2, 138.2, 138.1, 135.0, 128.1, 127.9, 127.3, 127.3, 127.1, 74.6, 73.1, 72.8, 
54.0, 51.8, 49.9, 30.0, 19.9, 19.6; IR (thin film) νmax 2951, 2859, 1741, 1708, 1454, 
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1436, 1376, 1361, 1305, 1257, 1204, 1167, 1094, 738, 698 cm-1; HRMS (ES) m/z 
calcd for C26H31O5 [M+H]




Cyclopentanone 149 (5.00 g, 11.4 mmol, 1 equiv) was dissolved in acetone (100 mL) 
and K2CO3  (3.10 g, 22.4 mmol, 2 equiv) and allyl bromide (2.68 g, 22.4, 2 equiv) 
were added. The suspension was stirred at RT for 24 h. The K2CO3 was removed by 
filtration through a short silica pad, the solvent removed under reduced pressure and 
the crude product then purified by flash column chromatography (SiO2, 
hexanes/EtOAc 20:1) to afford the product 179 as a colourless oil (4.8 g, 89% yield, 
mixture of diastereoisomers (ratio 2.5 : 1). Major diastereoisomer 179: 1H NMR 
(360 MHz, CDCl3) δ 7.33-7.23 (10 H, m,), 5.87 (1 H, tdd, J = 17.0, 10.6, 5.7 Hz), 
5.62 (1 H, dddd, J = 17.0, 10.3, 7.9, 6.8 Hz), 5.32 (1 H, qd, J = 17.2, 1.5 Hz), 5.21 (1 H, 
dd, J = 10.4, 1.3 Hz), 4.94 (1 H, dd, J = 10.1, 2.0 Hz), 4.84 (1 H, dd, J = 17.0, 1.8 Hz), 
4.59-4.56 (2 H, m), 4.36 (1 H, d, Jab = 11.9 Hz), 4.29 (1 H, d, Jab = 11.9 Hz), 4.27 (2 
H, s), 3.50-3.46 (2 H, m), 3.40 (1 H, d, J = 8.9 Hz), 3.28 (1H, d, J = 8.9 Hz), 2.75 (1 H, 
dd, J = 13.8, 6.8 Hz), 2.41 (1 H, d, J = 13.8 Hz), 2.34 (1 H, dd, J = 13.7, 8.0 Hz), 1.96 
(1 H, d, J = 13.8 Hz), 1.06 (3 H, s), 1.03 (3 H, s); 13C NMR (90 MHz, CDCl3) δ 
215.4, 171.0, 137.9, 137.8, 133.4, 131.6, 128.2, 127.8, 127.7, 127.5, 127.5, 118.5, 
118.0, 76.7, 74.5, 73.3, 73.2, 65.9, 59.4, 55.3, 42.4, 40.5, 39.9, 22.1, 17.8; IR (thin 
film) νmax 3064, 3030, 2979, 2939, 2860, 1726, 1454, 1201, 1147, 1095, 920, 739, 
698 cm-1; HRMS (ES) m/z calcd for C30H37O5 [M+H]





A solution of cyclopentanone 179 (5.00 g, 10.5 mmol, 1 equiv) in acetonitrile (20 mL) 
was slowly added to a solution of Pd(OAc)2 (117 mg, 0.52 mmol, 0.05 equiv) and 
PPh3 (37.0 mg, 0.52 mmol, 0.05 equiv) in acetonitrile at 90 ℃ under Ar. The 
reaction mixture was then stirred at 90 ℃ for 3 h before being allowed to cool to RT. 
Filtration through a plug of silica, removal of solvent and flash column 
chromatography (SiO2, Hexanes/EtOAc 20:1) furnished cyclopentenone 181 (3.6 g, 
90% yield) as a colourless oil. 181: 1H NMR (360 MHz, CDCl3) δ 7.31-7.17 (10 H, 
m), 6.97 (1 H, t, J = 1.4 Hz), 5.83 (1 H, tdd, J = 16.8, 10.1, 6.6 Hz), 5.10-5.01 (2 H, m), 
4.38 (1 H, d, Jab = 11.9 Hz), 4.33 (1 H, d, Jab = 11.9 Hz), 4.33 (2 H, s), 3.59 (1 H, d, 
Jab = 9.4 Hz), 3.56 (1 H, d, Jab = 9.4 Hz), 3.50 (1 H, d, Jab = 9.0 Hz), 3.48 (1 H, d, 
Jab = 9.0 Hz), 2.91 (1 H, ddd, J = 6.6, 2.7, 1.3 Hz), 1.15 (3 H, s), 1.13 (3 H, s); 
13C 
NMR (90 MHz, CDCl3) δ 210.9, 161.4, 140.6, 138.3, 138.2, 134.4, 128.2, 128.1, 
127.4, 127.3, 127.1, 116.4, 74.7, 73.5, 73.1, 72.8, 54.2, 49.5, 29.0, 20.1, 19.8; IR 
(thin film) νmax 3064, 3030, 2979, 2858, 1705, 1454, 1360, 1093, 914, 737, 698 cm
-1; 
HRMS (ES) m/z calcd for C36H31O3 [M+H]




To a solution of cyclopentenone 181 (1.29 g, 3.30 mmol, 1 equiv) in water / acetone 
(7 mL / 28 mL) was added OsO4 solution (0.67 mL of a 4 wt.% solution in water, 
0.06 mmol, 0.02 equiv) and NMO (401 mg, 3.30 mmol, 1 equiv) at 0 ℃. The 
reaction mixture was then stirred at RT for 20 h. A 5% aqueous solution of Na2S2O5 
 113
 
(7 mL) was then added and the resulting mixture was stirred for a further 2 h. The 
solution was extracted with DCM (4  30 mL), and the combined organic phases 
were dried over MgSO4 and concentrated under reduced pressure. The residue was 
purified by flash column chromatography (SiO2, Hexanes/EtOAc 1:1) to give diol 
183 (1.35 g, 96% yield, mixture of diastereoisomers) as a colourless oil (ratio = 1 : 1). 
183: 1H NMR (360 MHz, CDCl3) δ 7.40-7.22 (20H, m), 7.10 (1 H, m), 7.04 (1 H, m, 
C=CH), 4.44-4.39 (2 H, m), 4.33-4.21 (6 H, m), 3.77 (1 H, m), 3.67 (1 H, m), 
3.59-3.45 (9 H, m), 3.41 (1 H, m), 3.31 (1 H, m),  3.10 (1 H, d, J = 4.2 Hz), 2.93 (1 H, 
d, J = 6.2 Hz), 2.69 (1 H, t, J = 6.1, 6.1 Hz), 2.57-2.27 (6 H, m), 1.20 (6 H, s), 1.19 (6 
H, s); 13C NMR (90 MHz, CDCl3) 213.3, 212.4, 164.8, 164.1, 138.7, 138.4, 137.9, 
137.7, 137.4, 137.3, 128.3, 128.3, 128.3, 128.1, 127.9, 127.8, 127.8, 127.7, 127.6, 
127.4, 73.7, 73.5, 73.4, 73.3, 73.2, 72.9, 70.3, 69.5, 65.5, 65.1, 54.1, 54.1, 50.0, 49.83, 
29.8, 28.9, 20.2, 20.0, 19.9, 19.7; IR (thin film) ν 3408, 2922, 2862, 1701, 1454, 
1361, 1090, 1028, 737, 698 cm-1; HRMS (ES) m/z calcd for C26H33O5 [M+H]
+ 




Compound 183 (150 mg, 0.35 mmol, 1 equiv) was dissolved in 
1,1,1-trimethoxyethane (1 mL) and acetone (1 ml) and TsOH (6.0 mg, 0.1 equiv) was 
added. The solution was stirred for 10 h. The reaction mixture was then poured into a 
saturated aqueous solution of NaHCO3 and extracted with DCM. The organic phase 
was washed with brine and concentrated under reduced pressure. The crude product 
was purified by flash column chromatography (SiO2, hexanes/EtOAc 5:1) to afford 
185 as a colourless oil (149 mg, 98% yield, mixture of diastereoisomers, ratio = 1 : 
1). 185: 1H NMR (360 MHz, CDCl3) δ 7.38-7.24 (20 H, m), 7.14 (1 H, s), 7.12 (1 H, 
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s), 4.44-4.34 (8 H, m), 4.30-4.17 (2 H, m), 3.92 (1 H, dd, J = 8.2, 5.9 Hz), 3.83 (1 H, 
dd, J = 8.1, 5.9 Hz), 3.65-3.50 (10 H, m), 2.63-2.54 (2 H, m), 2.47-2.38 (2 H, m), 
1.44 (3 H, s), 1.43 (3 H, s), 1.36 (3 H, s), 1.35 (3 H, s), 1.21 (3 H, s), 1.20 (3 H, s), 1.18 
(3 H, s), 1.17 (3 H, s); 13C NMR (90 MHz, CDCl3) δ 212.3, 212.3, 164.2, 164.1, 
139.3, 139.2, 139.2, 139.1, 129.3, 129.1, 128.9, 128.6, 128.6, 128.5, 128.4, 128.3, 
109.9, 78.4, 78.2, 78.0, 77.8, 77.7, 75.6, 75.5, 75.5, 74.9, 74.5, 74.5, 74.3, 73.9, 70.0, 
69.8, 55.1, 50.8, 50.8, 30.0, 29.6, 28.0, 27.9, 26.6, 26.6, 21.1, 21.1, 21.0, 20.9; IR 
(thin film) νmax 3062, 3030, 2985, 2933, 2871, 1703, 1454, 1367, 1211, 1155, 1074, 
1028, 737, 698 cm-1; HRMS (ES) m/z calcd for C29H37O5 [M+H]





To a solution of diol 183 (1.00 g, 2.35 mmol, 1 equiv) in THF (10 mL) was added a 
solution of NaIO4 (1.0 g in water (10 mL), 2.7 mmol, 2 equiv), dropwise at 0 ℃. The 
resulting mixture was stirred for 5 h, then extracted with EtOAc (2  50 mL). The 
combined organic phases were dried over MgSO4 and concentrated under reduced 
pressure to give aldehyde 184 as a colourless oil. This crude product was used in the 
next step without further purification. 184: 1H NMR (360 MHz, CDCl3) δ 9.60 (1 H, 
t, J = 1.8 Hz), 7.34-7.18 (11 H, m), 4.37 (1 H, d, Jab = 12.2 Hz), 4.32 (1 H, d, Jab = 
12.2 Hz), 4.31 (1 H, s), 3.60 (1 H, d, Jab = 9.4 Hz), 3.57 (1 H, d, Jab = 9.4 Hz), 3.52 
(1 H, d, Jab = 9.0 Hz), 3.50 (1 H, d, Jab = 9.0 Hz), 3.28 (2 H, m), 1.19 (3 H, s), 1.16 
(3 H, s); 13C NMR (90 MHz, CDCl3) δ 210.5, 197.8, 164.4, 138.1, 138.0, 133.7, 
128.2, 128.2, 127.5, 127.4, 127.2, 74.3, 73.2, 73.2, 72.8, 53.9, 50.3, 39.3, 19.9, 19.86; 







Compound 184 (100 mg, 0.25 mmol, 1 equiv) was dissolved in DCM (2 mL) and 
ethane-1,2-diol (155 mg, 10 equiv) and TsOH (4.3 mg, 0.1 equiv) was added. The 
solution was refluxed for 10 h. After cooling down to room temperature the reaction 
mixture was then poured into a saturated aqueous solution of NaHCO3 and extracted 
with DCM. The organic phase was washed with brine and concentrated under 
reduced pressure. The crude product was purified by flash column chromatography 
(SiO2, hexanes/EtOAc 5:1) to afford 186 as a colourless oil (112 mg, 98% yield). 186: 
1H NMR (360 MHz, CDCl3) δ 7.38-7.25 (10 H, m), 7.22 (1 H, s), 5.03 (1 H, t, J = 
4.8 Hz,), 4.43 (1 H, Jab = 10.8 Hz), 4.38 (2 H, s), 4.39 (1 H, Jab = 14.4 Hz), 4.00-3.94 (2 
H, m), 3.87-3.81 (2 H, m), 3.65 (1 H, Jab = 10.8 Hz), 3.61 (1 H, Jab = 7.8 Hz), 3.54 (1 H, 
Jab = 9.0 Hz), 3.54 (1 H, Jab = 9.0 Hz), 2.59 (2 H, dd, J = 4.8, 0.7 Hz), 1.21 (3 H, s), 
1.09 (3 H, s); 13C NMR (90 MHz, CDCl3) δ 211.0, 163.3, 138.4, 138.3, 136.8, 128.2, 
128.2, 127.4, 127.3, 127.2, 102.5, 74.8, 73.4, 73.2, 72.8, 64.8, 54.0, 49.8, 29.4, 19.9; 
IR (thin film) νmax 3480, 3030, 2874, 1704, 1496, 1454, 1362, 1271, 1206, 1092, 
1028, 738, 698 cm-1; HRMS (ES) m/z calcd for C27H33O5 [M+H]





The crude product 184 from the previous step was dissolved in iso-propanol (5 mL), 
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cooled to 0 ℃ and freshly prepared1 Zn(BH4)2 / pyridine complex (400 mg, ~ 2.35 
mmol, 1 equiv) added in one portion. The reaction mixture was stirred at 0 ℃ for 2 
h and then quenched with saturated NH4Cl aqueous (5 mL). The solution was 
extracted with EtOAc (2  10 mL), and the combined organic phases dried by 
MgSO4 and concentrated under reduced pressure. The crude product was purified by 
flash column chromatography (SiO2, Hexanes:EtOAc 1:1) to afford 176 (0.70 g, 76% 
yield for 2 steps) as a colourless oil. 176: 1H NMR (600 MHz, CDCl3) δ 7.32-7.16 
(10 H, m), 6.98 (1 H, s), 4.34 (1 H, d, J = 12.0 Hz), 4.26 (1 H, d, J = 11.9 Hz), 4.25 
(1 H, d, J = 11.9 Hz), 4.20 (1H, d, J = 11.9 Hz), 3.57 (2 H, dd, J = 11.1, 6.3 Hz), 
3.53 (1 H, d, Jab = 9.0 Hz), 3.51 (1 H, d, Jab = 9.0 Hz), 3.45 (1 H, d, Jab = 9.0 Hz), 
3.41 (1 H, d, Jab = 9.0 Hz), 2.49-2.45 (1 H, m), 2.41 (1 H, t, J = 6.2 Hz), 2.38-2.33 (1 
H, m), 1.13 (3 H, s), 1.27 (3 H, s); 13C NMR (150 MHz, CDCl3) δ 212.0, 163.4, 
139.5, 137.9, 137.6, 128.3, 127.8, 127.7, 127.6, 73.8, 73.5, 73.3, 72.9, 60.0, 54.2, 
49.7, 29.2, 20.1, 19.8; IR (thin film) νmax 3423, 2871, 1701, 1454, 1361, 1074, 737, 
698 cm-1; HRMS (ES) m/z calcd for C25H31O4 [M+H]




(Ratio = 1 : 1) 175a: 1H NMR (600 MHz, CDCl3) δ 7.37-7.22 (10 H, m), 5.18 (1 H, 
s), 4.48 (1 H, d, J = 12.1 Hz), 4.38 (1 H, d, J = 11.5 Hz), 4.32 (1 H, d, J = 12.1 Hz), 
4.29 (1 H, d, J = 11.5 Hz), 4.05 (1 H, d, J = 10.8 Hz), 3.80 (1 H, d, J = 9.9 Hz), 
3.77-3.72 (1 H, m), 3.59-3.53 (3 H, m), 3.44-3.41 (2 H, m), 3.11 (1 H, d, J = 9.3 Hz), 
2.49 (1 H, ddd, J = 14.4, 5.1, 3.2 Hz), 2.32 (1 H, m), 1.07 (3 H, s), 0.96 (3 H, s); 13C 
NMR (150 MHz, CDCl3) δ 143.0, 138.8, 136.6, 136.1, 128.5, 128.2, 128.1, 128.1, 
127.6, 127.4, 85.6, 74.0, 73.3, 72.9, 62.0, 51.9, 48.7, 34.0, 22.4, 18.7; IR (thin film) 
νmax 3405, 3029, 2858, 1495, 1454, 1362, 1073, 736, 698 cm
-1; HRMS (ES) m/z 




calcd for C25H32O4Na [M+Na]
+ 419.2193, found 419.2192. 175b: 1H NMR (600 
MHz, CDCl3) δ 7.38-7.26 (10 H, m), 5.30 (1 H, s), 4.68 (1 H, s), 4.46 (1H, d, Jab = 
12.0 Hz), 4.42 (1H, d, Jab = 12.0 Hz), 4.36 (2 H, d, J = 1.4 Hz), 3.70 (1 H, td, J = 
9.72, 4.71 Hz), 3.63 (1 H, m), 3.57 (1 H, d, J = 8.5 Hz), 3.51 (1 H, d, J = 8.5 Hz), 
3.27 (1 H, d, J = 9.1 Hz), 3.20 (1 H, d, J = 9.1 Hz), 2.47 (1 H, td, J = 14.0, 3.8 Hz), 
2.36 (1 H, ddd, J = 14.1, 9.4, 4.7 Hz), 1.07 (3 H, s), 1.04 (3 H, s); 13C NMR (150 
MHz, CDCl3) δ 141.3, 138.4, 138.0, 134.6, 128.3, 128.3, 127.7, 127.5, 82.1, 75.7, 
75.2, 73.4, 73.0, 60.6, 51.2, 51.2, 31.8, 20.0, 15.26; IR (thin film) νmax 3375, 3029, 
2857, 1495, 1454, 1362, 1206, 1073, 1028, 734, 697 cm-1; HRMS (ES) m/z calcd for 
C25H32O4Na [M+Na]














186 197  
Pent-1-yne (272 mg, 4.01 mmol, 2.5 equiv) in THF (20 mL) was cooled to -42 ℃ 
and n-butyllithium (2.50 mL, 1.6 M solution in hexane, 4.01 mmol, 2.5 equiv) was 
added dropwise. The resulting solution was stirred for 45 min at -42 ℃. After 
warming to RT, the solution was slowly added to cyclopentenone 186 (460 mg, 1.60 
mmol, 1 equiv) in THF (20 mL) at -42 ℃ via a cannula. The reaction mixture was 
stirred at -42 ℃ for 1 h, then warmed to RT over a further 1 h and quenched by 
addition of a saturated solution of NH4Cl. The aqueous layer was extracted with 
EtOAc and the resulting organic layer was washed with brine, dried over MgSO4, 
filtered and evaporated. Flash column chromatography (SiO2, hexanes/EtOAc 9:1) 
afforded tertiary alcohol 197 as a colourless oil (645 mg, 80 % yield). 197: 1H NMR 
(360 MHz, CDCl3) δ 7.39-7.31 (10 H, m), 5.56 (1 H, s), 5.14 (1 H, t, J = 4.8 Hz), 
4.50-4.49 (4 H, m), 4.06-4.02 (2 H, m), 3.94-3.80 (2 H, m), 3.82 (1 H, d, J = 9.1 Hz), 
3.72 (1 H, d, J = 7.0 Hz), 3.70 (1 H, d, J = 6.5 Hz), 3.57 (1 H, d, J = 8.6 Hz), 3.36 (1 
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H, s), 2.65 (2 H, dd, J = 4.8, 1.0 Hz), 2.17 (2 H, t, J = 6.9 Hz), 1.50 (2 H, dd, J = 
14.4, 7.2 Hz), 1.23 (3 H, s), 1.14 (3 H, s), 1.00 (3 H, t, J = 7.3 Hz); 13C NMR (90 
MHz, CDCl3) δ 138.9, 138.8, 138.6, 136.1, 128.1, 128.0, 127.3, 127.2, 127.1, 103.6, 
86.5, 82.5, 81.9, 75.0, 74.7, 73.3, 73.0, 64.9, 64.7, 54.6, 51.2, 31.7, 22.1, 20.7, 20.4, 
16.2, 13.5; IR (thin film) νmax 3445, 2962, 2932, 2872, 1722, 1454, 1361, 1272, 1207, 
1074, 1029, 737, 698 cm-1; HRMS (ES) m/z calcd for C32H40O5Na1 [M+Na]
+ 


















197 198  
Compound 197 (50 mg, 0.1 mmol, 1 equiv) was dissolved in DCM (2 mL) and 
mCPBA (156 mg, 10 equiv) was added. The solution was stirred for 2 days. The 
reaction mixture was then poured into a saturated aqueous solution of NaHCO3 and 
extracted with DCM. The organic phase was washed with brine and concentrated 
under reduced pressure. The crude product was purified by flash column 
chromatography (SiO2, hexanes/EtOAc 5:1) to afford 198 as a colourless oil (5 mg, 
10% yield). 198: 1H NMR (360 MHz, CDCl3) δ 7.40-7.30 (10 H, m), 5.13-5.11 (1 H, 
m), 4.57 (1 H, d, J = 12.4 Hz), 4.52 (1 H, d, J = 11.9 Hz), 4.45 (1 H, d, J = 5.5 Hz), 
4.41 (1 H, d, J = 4.9 Hz), 4.07-4.02 (2 H, m), 3.94-3.90 (2 H, m), 3.74 (1 H, d, J = 
8.6 Hz), 3.58 (1 H, d, J = 8.9 Hz), 3.53 (1 H, s), 3.46 (1 H, d, J = 8.5 Hz), 3.46 (1 H, 
s), 3.42 (1 H, d, J = 8.9 Hz), 2.75 (1 H, dd, J = 14.7, 5.6 Hz), 2.13-2.07 (3 H, m), 
1.52-1.42 (2 H, m), 1.29 (3 H, s), 1.28 (3 H, s), 0.98 (3 H, t, J = 7.3 Hz); 13C NMR 
(90 MHz, CDCl3) δ 138.3, 137.6, 128.2, 128.2, 127.5, 127.5, 127.3, 101.8, 89.3, 81.2, 
80.8, 75.2, 73.2, 72.8, 67.3, 66.6, 64.8, 64.5, 48.6, 46.4, 32.1, 21.9, 20.8, 18.6, 18.1, 
13.5; IR (thin film) νmax 3446, 2962, 2931, 2873, 1722, 1454, 1411, 1362, 1093, 































Cyclopentenone 169 (272 mg, 0.56 mmol, 1 equiv) in MeOH (20 mL) was treated 
with H2O2 (190 µL, 30% wt solution in H2O, 1.68 mmol, 3 equiv) and 1 M NaOH 
solution (1.68 mL, 1.68 mmol, 3 equiv) at 0 ℃. The resulting solution was warmed 
to RT, stirred for 18 h and poured into a saturated NH4Cl solution. The mixture was 
extracted with Et2O, dried over MgSO4, filtered and the solvent removed in vacuo. 
Flash column chromatography (SiO2, hexanes/EtOAc 9.5:0.5) afforded two 
diastereomers of the epoxide product (200 - 85 mg, 197 – 150 mg, 235 mg overall, 
84% yield, 1.8:1 ratio of diastereomers). 200: 1H NMR (360 MHz, CDCl3) δ 
7.36-7.21 (15 H, m), 4.53 (1 H, d, Jab= 12.9 Hz), 4.47 (1 H, d, Jab= 12.9 Hz), 4.45 (2 
H, s), 4.39 (1 H, d, JabB= 12.2 Hz), 4.34 (1 H, d, Jab= 12.2 Hz), 3.74 (1 H, s), 
3.63-3.50 (4 H, m), 3.47 (1 H, d, Jab= 8.8 Hz), 2.36 (1 H, m), 2.01 (1 H, m), 1.08 (3 
H, s), 1.00 (3 H, s); 13C NMR (90 MHz, CDCl3) δ 211.2, 138.4, 138.2, 138.0, 128.3, 
128.2, 127.6, 127.4, 127.3, 74.4, 73.4, 73.0, 72.9, 72.0, 67.4, 65.6, 62.1, 52.0, 43.6, 
25.1, 18.8, 16.3; IR (thin film) ν 2859, 1740, 1454, 1097, 697 cm-1; HRMS (ES) m/z 
calcd for C32H40O5N [M+NH4]
+ 518.2901, found 518.2903. 197: 1H NMR (360 
MHz, CDCl3) δ 7.34-7.23 (13 H, m), 7.13-7.01 (2 H, m), 4.42 (1 H, d, Jab= 12.0 Hz), 
4.32 (2 H, s), 4.25 (1 H, d, Jab= 12.0 Hz), 3.57-3.40 (5 H, m), 3.28 (1 H, d, Jab= 12.0 
Hz), 2.21 (1 H, m,), 2.06 (1 H, m), 1.31 (3 H, s), 1.13 (3 H, s); 13C NMR (90 MHz, 
CDCl3) δ 212.1, 138.4, 138.3, 137.6, 138.3, 127.7, 127.6, 127.5, 127.4, 74.3, 73.5, 
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73.4, 73.0, 72.6, 68.8, 65.5, 62.8, 49.3, 43.8, 24.7, 21.6, 16.2; IR (thin film) ν 2860, 
1737, 1454, 1099, 697 cm-1; HRMS (ES) m/z calcd for C32H40O5N [M+NH4]
+ 























A solution of cyclopentanone 176 (1.0 g, 2.5 mmol, 1 equiv) in pyridine (10 mL) was 
treated with NaClO (14% active chlorine, 3 mL, ca. 10 equiv), dropwise, at 0 ℃. 
The resulting solution was stirred for 5 h after which time the reaction was 
completed. Filtration through a plug of silica, removal of pyridine under reduced 
pressure and flash column chromatography (SiO2, Hexanes/EtOAc 2:1) furnished 
two diastereomeric epoxides 203 (633 mg, 62% yield) and 204 (276 mg, 27% yield), 
each as colourless oils. (dr = 2.2:1). Diastereomer 203:  1H NMR (600 MHz, 
CDCl3) δ 7.33-7.13 (10 H, m), 4.39 (1 H, d, J = 12.0 Hz), 4.17 (1 H, d, J = 12.2 Hz,), 
4.16 (1 H, d, Jab = 11.4 Hz), 4.12 (1 H, d, Jab = 11.4 Hz), 3.57-3.54 (4 H, m), 3.49 (1 
H, d, J = 9.3 Hz), 3.40 (1 H, d, J = 9.2 Hz), 3.35 (1 H, d, J = 9.4 Hz), 2.91 (1 H, dd, 
J = 7.4, 5.1 Hz), 2.20 (1 H, td, J = 14.5, 3.2, 3.2 Hz), 1.75 (1 H, ddd, J = 14.5, 9.5, 
4.9 Hz), 1.30 (3 H, s), 1.11 (3 H, s); 13C NMR (150 MHz, CDCl3): δ 212.2, 138.0, 
136.0, 128.4, 128.3, 128.2, 128.2, 127.6, 127.5, 127.3, 74.2, 73.3, 73.2, 73.1, 68.5, 
62.9, 58.1, 49.4, 43.6, 28.9, 21.7, 16.2; IR (thin film) νmax 3462, 3063, 3030, 2875, 
1738, 1454, 1361, 1094, 739, 699 cm-1; HRMS (ES) m/z calcd for C25H31O5 [M+H]
+ 
411.2166, found 411.2162. Diastereomer 204: 1H NMR (500 MHz, CDCl3) δ 
7.34-7.22 (10 H, m), 4.53 (1 H, d, Jab = 12.0 Hz), 4.49 (1 H, d, Jab = 12.2 Hz,), 4.38 
(2 H, d, J = 1.9 Hz), 3.75 (1 H, s), 3.78-3.71 (2H, m), 3.60 (1 H, d, J = 9.0 Hz,), 3.58 
(1 H, d, J = 9.0 Hz), 3.56 (1 H, d, J = 9.0 Hz), 3.49 (1 H, d, J = 9.0 Hz), 2.17-2.05 (2 
H, m), 1.11 (3 H, s), 1.06 (3 H, s); 13C NMR (125 MHz, CDCl3): δ 212.2, 138.2, 
138.1, 128.3, 128.2, 127.5, 127.5, 127.4, 127.4, 74.1, 73.4, 73.0, 71.8, 67.5, 63.0, 
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58.8, 52.1, 43.6, 28.1, 18.9, 16.3; IR (thin film) νmax 3460, 3030, 2862, 1739, 1496, 
1454, 1361, 1272, 1073, 738, 698 cm-1; HRMS (ES) m/z calcd for C25H31O5 [M+H]
+ 
















To a solution of 200 (150 mg, 0.36 mmol) in MeOH (5 mL) was added Pd/C (15 mg) 
and the resulting mixture purged with H2 for 5 min. The reaction mixture was then 
stirred under a hydrogen balloon at RT for 2 h, then filtered through a pad of silica 
and concentrated under reduced pressure. Purification by flash column 
chromatography (SiO2, EtOAc) gave 201 as a colourless oil (63 mg, 80% yield). 201: 
1H NMR (500 MHz, CDCl3) δ 4.16 (1 H, dd, J = 11.7, 4.0 Hz), 4.11 (1 H, dd, J = 10.9, 
4.7 Hz), 3.79-3.71 (2 H, m), 3.65 (1 H, dd, J = 11.7, 8.5 Hz), 3.59 (1 H, s), 3.42 (1 H, 
dd, J = 10.8, 5.5 Hz), 3.26 (1 H, dd, J = 8.5, 4.2 Hz), 2.84 (1 H, t, J = 5.2, Hz), 
2.13-2.10 (3 H, m), 1.12 (3 H,s), 1.11 (3 H, s); 13C NMR (125 MHz, CDCl3): δ 212.4, 
67.9, 67.9, 66.2, 61.9, 58.5, 53.8, 44.6, 27.6, 19.2, 16.9; IR (thin film) νmax 3365, 2938, 
1738, 1457, 1031, 879 cm-1; HRMS (ES) m/z calcd for C11H22O5N1 [M+NH4]
 + 




Cp2TiCl2 (58.0 mg, 0.24 mmol, 2 equiv) and Zn dust (47 mg, 0.7 mmol, 6 equiv) 
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were placed in a dried round bottom flask and THF (2 mL) was added under an argon 
atmosphere. The resulting suspension was stirred at RT for 1 h, then cannulated 
under argon into a solution of epoxide 204 (50.0 mg, 0.13 mmol, 1 equiv) in THF (2 
mL). The resulting green solution was stirred at RT under an argon atmosphere for 2 
h. Then the catalyst was then removed by filtering through a short silica pad and the 
solvent was removed under reduced pressure. The crude product was purified by 
flash column chromatography (SiO2, hexanes/EtOAc 2:1) to afford the product 176 
as a colourless oil (36 mg, 70% yield). 176: 1H NMR (600 MHz, CDCl3) δ 7.32-7.16 
(10 H, m), 6.98 (1 H, s), 4.34 (1 H, d, J = 12.0 Hz), 4.26 (1 H, d, J = 11.9 Hz,), 4.25 
(1 H, d, J = 11.9 Hz), 4.20 (1H, d, J = 11.9 Hz), 3.57 (2 H, dd, J = 11.1, 6.3 Hz), 
3.53 (1 H, d, Jab = 9.0 Hz), 3.51 (1 H, d, Jab = 9.0 Hz), 3.45 (1 H, d, Jab = 9.0 Hz), 
3.41 (1 H, d, Jab = 9.0 Hz), 2.49-2.45 (1 H, m), 2.41 (1 H, t, J = 6.2 Hz), 2.38-2.33 (1 
H, m), 1.13 (3 H, s), 1.27 (3 H, s); 13C NMR (150 MHz, CDCl3) δ 212.0, 163.4, 
139.5, 137.9, 137.6, 128.3, 127.8, 127.7, 127.6, 73.8, 73.5, 73.3, 72.9, 60.0, 54.2, 
49.7, 29.2, 20.1, 19.8; IR (thin film) νmax 3423, 2871, 1701, 1454, 1361, 1074, 737, 
698 cm-1; HRMS (ES) m/z calcd for C25H31O4 [M+H]




Compound 205 (1.0 g, 4.7 mmol, 1 equiv) in DCM (5 mL) was treated with 
TBDPSCl (2.80 g, 10.3 mmol, 2.2 equiv) and imidazole (958 mg, 14.1 mmol, 3.0 
equiv) at 0 ℃. The resulting solution was stirred for 5 h. Filtration through a plug of 
silica, removal of DCM under reduced pressure and flash column chromatography 
(SiO2, hexanes/EtOAc 5:1) furnished product 206 (3.16g, 98% yield) as a colourless 
oil. 206: 1H NMR (600 MHz, CDCl3) δ 7.56-7.24 (20 H, m), 6.83 (1 H, s), 5.83-5.76 
(1 H, m), 5.07-5.04 (2 H, m), 3.99 (1 H, d, J = 10.4 Hz), 3.90 (1 H, d, J = 9.7 Hz), 
3.76 (1 H, d, J = 3.3 Hz), 3.74 (1 H, d, J = 4.2 Hz), 2.85 (2 H, dddd, J = 46.0, 16.7, 
6.8, 1.2 Hz), 1.16 (3 H, s), 1.08 (3 H, s), 0.99 (9 H, s), 0.96 (9 H, s); 13C NMR (150 
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MHz, CDCl3) δ 210.7, 161.2, 140.7, 135.7, 135.6, 135.5, 134.3, 133.2, 133.1, 129.6, 
129.5, 127.5, 116.6, 68.6, 66.6, 55.3, 50.8, 29.3, 26.9, 26.7, 20.4, 19.2, 19.1, 19.0; IR 
(thin film) νmax 3072, 2930, 2857, 1708, 1471, 1472, 1113, 1080, 823, 739, 701 cm
-1; 
HRMS (ES) m/z calcd for C44H55O3Si2 [M+H]





A solution of cyclopentanone 206 (50.0 mg, 0.07 mmol, 1 equiv) in pyridine (1 mL) 
was treated with NaClO (14% active chlorine, 0.1 mL, ca. 10 equiv) dropwise, at 0 
℃. The resulting solution was stirred for 5 h after which time the reaction was 
completed. Filtration through a plug of silica, removal of pyridine under reduced 
pressure and flash column chromatography (SiO2, Hexanes/EtOAc 2:1) furnished a 
mixture of two diastereomeric epoxides 207 (46 mg, 95% yield, ratio > 20 : 1) as 
colourless oils. 207: 1H NMR (600 MHz, CDCl3) δ 7.55-7.24 (20 H, m), 5.58-5.51 
(1 H, m), 5.02-4.99 (2 H, m), 3.89-3.87 (2 H, m), 3.76 (1 H, d, J = 10.2 Hz), 3.65 (1 
H, d, J = 10.6 Hz), 3.53 (1 H, s), 2.64 (1 H, dd, J = 15.3, 6.2 Hz), 2.37 (1 H, dd, J = 
15.3, 7.6 Hz), 1.26 (3 H, s), 1.22 (3 H, s), 1.00 (18 H, s); 13C NMR (150 MHz, 
CDCl3) δ 212.40, 135.87, 135.80, 135.74, 135.59, 133.12, 133.04, 132.98, 132.57, 
131.09, 129.88, 129.84, 129.67, 129.62, 127.72, 127.55, 118.56, 68.12, 66.48, 63.78, 
50.63, 44.61, 28.45, 26.93, 26.76, 21.73, 19.13, 16.05; IR (thin film) νmax 2930, 2858, 
1735, 1427, 1113, 1075, 997, 822, 701 cm-1; HRMS (ES) m/z calcd for 
C44H58O4Si2N1 [M+NH4]


















Epoxide 203 (1.0 g, 2.4 mmol, 1 equiv) in DCM (5 mL)  was treated with TBSCl 
(432 mg, 2.88 mmol, 1.2 equiv) and imidazole (353 mg, 5.28 mmol, 2.2 equiv) at 0 
℃. The resulting solution was stirred for 5 h. Filtration through a plug of silica, 
removal of DCM under reduced pressure and flash column chromatography (SiO2, 
hexanes/EtOAc 2:1) furnished product 219 (1.26g, 98% yield) as a colourless oil. 
187: 1H NMR (500 MHz, CDCl3) δ 7.34-7.14 (10 H, m), 4.40 (1 H, d, J = 12.0 Hz,), 
4.23 (1 H, d, J = 12.0 Hz), 4.22 (1 H, d, Jab = 11.9 Hz), 4.16 (1 H, d, J = 11.9 Hz,), 
3.68 (1 H, td, J = 10.1, 6.6 Hz), 3.63-3.60 (1 H, m), 3.58 (1 H, s), 3.55 (1 H, d, J = 
9.5 Hz), 3.53 (1 H, d, J = 9.3 Hz), 3.42 (1 H, d, J = 9.3 Hz), 3.30 (1 H, d, J = 9.3 
Hz), 2.05 (2 H, t, J = 7.0, Hz), 1.31 (3 H, s), 1.42 (3 H, s), 0.86 (9 H, s), 0.01 (3 H, s), 
-0.01 (3 H, s); 13C NMR (125 MHz, CDCl3): δ 212.2, 138.3, 137.5, 128.3, 128.2, 
127.6, 127.6, 127.5, 74.3, 73.5, 73.3, 73.0, 68.8, 62.7, 58.4, 49.2, 43.7, 27.6, 25.8, 
21.6, 18.1, 16.1, -5.4; IR (thin film) νmax 3031, 2928, 2856, 1739, 1454, 1361, 1254, 








A solution of (4-iodobut-1-ynyl)trimethylsilane 218 (254 mg, 0.95 mmol, 5 equiv) in 
dry Et2O (3 mL) at -78 ℃ was treated with 
tBuli (1.23 mL, 1.7 M in pentane, 2.09 
mmol, 11 equiv) and stirred under argon for 1 h before warming to RT and stirring 
for a further 2 h. After re-cooling to -78 ℃, the mixture was transferred into a 
solution of epoxide 219 (100 mg, 0.19 mmol, 1 equiv) in Et2O at -78 ℃ via a 
double tipped needle. The reaction mixture was then stirred for 30 min and quenched 
with several drops of water before warming up to RT.  The reaction mixture was 
filtered through a plug of silica, concentrated under reduced pressure and then 
purified by flash column chromatography (SiO2, hexanes/EtOAc 20:1) to afford the 
product 222 as a colourless oil (116 mg, 94% yield). Product 222 (100 mg, 0.15 
mmol, 1 equiv) was dissolved in MeOH (1 mL) and treated with KOH (10 mg). The 
resulting mixture was stirred for 10 h, then concentrated under reduced pressure. The 
crude product was purified by flash column chromatography (SiO2, hexanes/EtOAc 
20:1) to afford 223 as a colourless oil (89 mg, 98% yield). Product 223: 1H NMR 
(500 MHz, CDCl3) δ 7.36-7.24 (10 H, m), 4.36 (1 H, d, Jab = 12.0 Hz), 4.34 (1 H, d, 
Jab = 12.0 Hz), 4.28 (1 H, d, Jab = 11.5 Hz), 4.23 (1 H, d, Jab = 11.5 Hz), 3.54 (1 H, 
ddd, J = 9.6, 7.7, 5.9 Hz), 3.45-3.75 (3 H, m), 3.27 (1 H, d, Jab = 9.5 Hz), 3.25 (1 H, 
s), 3.23 (1 H, d, Jab = 9.5 Hz), 2.77 (1 H, s), 2.37 (1 H, dt, J = 8.4, 2.6 Hz), 2.11-1.92 
(4 H, m), 1.95 (1 H, t, J = 2.6, 2.6 Hz), 1.10 (3 H, s), 0.879 (12 H, m), 0.02 (6H, s); 
13C NMR (125 MHz, CDCl3): δ 138.1, 137.6, 128.3, 128.3, 128.0, 127.7, 127.6, 85.4, 
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81.3, 74.3, 74.1, 73.3, 73.2, 71.6, 71.3, 67.8, 59.0, 45.4, 32.4, 30.5, 25.9, 18.2, 18.2, 
13.6, -5.3; IR (thin film) νmax 3308, 2928, 2856, 1455, 1361, 1255, 1091, 837, 698 
cm-1; HRMS (ES) m/z calcd for C35H51SiO5 [M+H]




Compound 222 (100 mg, 0.15 mmol, 1 equiv) was dissolved in DCM (2 mL) and 
treated with a solution of TBAF (0.76 mL, 1 M in THF, 5 equiv). The resulting 
mixture was stirred for 5 h. The solvent was evaporated under reduced pressure and 
the crude product was purified by flash column chromatography (SiO2, 
hexanes/EtOAc 20:1) to afford the product 224 as a colourless oil (68 mg, 95% 
yield). This compound decomposed over time so was immediately taken on to the 
next step.  
2-(3,4-Bis((benzyloxy)methyl)-2-(but-3-yn-1-yl)-2-hydroxy-3,4-dimethyl-6-oxabi
cyclo[3.1.0]hexan-1-yl)ethyl acetate (225) 
 
Compound 224 (129 mg, 0.28 mmol, 1 equiv) in DCM (2 mL) was treated with 
Ac2O (142 mg, 1.40 mmol, 5 equiv) and pyridine (79 mg, 2.8 mmol, 10 equiv) at 0 
℃. The resulting solution was stirred for 5 h. Filtration through a plug of silica, 
removal of DCM under reduced pressure and flash column chromatography (SiO2, 
Hexanes/EtOAc 10:1) furnished product 225 (140 mg, 90% yield) as a colourless oil. 
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225: 1H NMR (600 MHz, CDCl3) δ 7.37-7.21 (10H, m), 4,41 (1 H, d, Jab = 12.0 Hz,), 
4,36 (1 H, d, Jab = 12.0 Hz), 4,24 (1 H, d, Jab = 11.4 Hz), 4,16 (1 H, d, Jab = 11.4 Hz,), 
3.85-3.81 (1 H, m), 3.68-3.64 (1 H, m), 3.44 (1 H, d, Jab = 9.0 Hz), 3.36 (1 H, d, Jab = 
9.0 Hz), 3.32 (1 H, d, Jab = 9.6 Hz), 3.22 (1 H, d, Jab = 9.6 Hz), 3.20 (1 H, s), 2.67 (1 H, 
m), 2.45-2.39 (1 H, m), 2.34-2.28 (1 H, m), 2.14-2.08 (2 H m), 2.02-1.99 (1 H, m), 
1.98 (3 H, s), 1.96-1.92 (2 H, m), 1.12 (3H, s), 0.84 (3H, s); 13C NMR (125 MHz, 
CDCl3) 170.6, 138.0, 137.4, 128.4, 128.3, 128.3, 127.8, 127.7, 127.7, 127.6, 127.5, 
85.2, 81.2, 74.3, 74.1, 73.4, 73.3, 70.7, 68.0, 60.3, 45.1, 31.9, 26.0, 20.9, 18.3, 13.5; 
IR (thin film) ν 3505, 3294, 3029, 2862, 1739, 1454, 1365, 1245, 1089, 738, 699 
cm-1; HRMS (ES) m/z calcd for C31H39O6 [M+H]




Cp2TiCl2 (373 mg, 1.50 mmol, 3 equiv) and Zn dust (292 mg, 4.50 mmol, 9 equiv) 
were placed in a dried round bottom flask and THF (10 mL) was added under 
rigorous exclusion of air by means of an Ar atmosphere. The resulting suspension 
was stirred at RT for 1 h, during which time the colour of the mixture changed from 
red to green, indicating the formation of a low valent titanium complex. The 
suspension of Ti complex was then cannulated under Ar into a solution of 223 (250 
mg, 0.44 mmol, 1 equiv) in THF (20 mL) and the resulting green solution was stirred 
at RT under an Ar for 30 h. The excess Ti complex was then removed by filtration 
through a short silica pad and the solvent removed under reduced pressure. The crude 
product was purified by flash column chromatography (SiO2, hexanes/EtOAc 20:1) 
to afford the product 232 (contaminated with a small amount of an unidentified 
by-product – suspected to be a deoxygenation product) as a colourless oil (180 mg, 




ropentalen-3a-yl)ethyl acetate (233) 
 
Using the same procedure as above for TBS-protected 225, Ac-protected 233 (80.0 
mg, 0.16 mmol) was subjected to the radical cyclisation reaction to afford 233 (52 
mg, 65% yield) as a colourless oil. In this case, the minor side-product could be 
easily removed by chromatography. 233: 1H NMR (500 MHz, CDCl3) δ 7.34-7.24 
(10H, m), 4.94 (1 H, m), 4.87 (1 H, m), 4.43-4.32 (5 H, m), 4.11 (1 H, ddd, J = 10.7, 
9.4, 5.2 Hz), 3.85 (1 H, d, J = 4.1 Hz), 3.52 (1 H, d, J = 8.9 Hz), 3.77-3.32 (3 H, m), 
2.63-2.55 (1 H, m), 2.38-2.32 (1 H, m), 2.25 (1 H, s), 2.14 (1 H, d, J = 4.17 Hz), 
2.11-2.04 (2 H, m), 2.03 (3 H, s), 2.00-1.98 (1 H, m), 1.61-1.57 (1 H, m), 1.24 (3H, s), 
1.16 (3H, s); 13C NMR (125 MHz, CDCl3) 171.0, 157.3, 138.1, 138.1, 128.3, 128.2, 
128.2, 127.5, 127.4, 127.4, 105.8, 92.5, 82.6, 77.3, 74.7, 73.4, 73.4, 63.3, 59.9, 50.7, 
50.4, 37.2, 31.4, 28.7, 21.1, 17.7, 16.5; IR (thin film) ν 3522, 3064, 2935, 1733, 1454, 






The BC bicycle 232 (180 mg, ca. 0.30 mmol, ca. 1 equiv) in dry DCM (5 mL) was 
treated with TPAP (54.0 mg, 0.15 mmol, 0.5 equiv), NMO (181 mg, 1.55 mmol, 5 
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equiv) and MS 4Å (360 mg). The resulting solution was stirred for 5 h at RT. The 
sieves and catalyst were removed by filtration through a short silica pad and the 
solvent was evaporated under reduced pressure. The crude product was purified by 
flash column chromatography (SiO2, hexanes/EtOAc 20:1) to afford the ketone 241 
as a colourless oil (142 mg, 0.24 mmol, 82% yield). 241: 1H NMR (500 MHz, 
CDCl3) δ 7.31-7.17 (10 H, m) 4.94 (1 H, m), 4.73 (1 H, m), 4.36 (1 H, d, J = 12.1 
Hz), 4.30 (1 H, s), 4.24-4.21 (2 H, m), 4.14 (1 H, d, J = 11.9 Hz), 3.77 (1 H, dt, J = 
10.4, 1.9 Hz), 3.67 (1 H, td, J = 10.4, 3.7 Hz), 3.53 (1 H, d, J = 9.5 Hz), 3.45 (1 H, d, 
J = 9.6 Hz), 3.42 (1 H, d, J = 9.5 Hz), 3.35 (1 H, d, J = 9.6 Hz), 2.43-2.37 (2 H, m), 
2.29-2.22 (1 H, m), 2.13 (1 H, ddd, J = 14.2, 10.5, 3.4 Hz), 1.94 (1 H, ddd, J = 14.7, 
4.1, 1.9 Hz), 1.71 (1 H, ddd, J = 14.4, 10.9, 7.9 Hz), 1.42 (3 H, s), 1.38 (3 H, s), 0.90 
(9 H, s), 0.08 (3 H, s), 0.07 (3 H, s); 13C NMR (125 MHz, CDCl3) δ219.8, 152.4, 
138.5, 137.6, 128.1, 128.0, 127.7, 127.6, 127.3, 107.4, 89.8, 74.2, 73.6, 73.2, 73.0, 
66.2, 60.3, 56.0, 49.9, 39.8, 35.7, 31.4, 25.9, 19.9, 18.3, 15.4, -5.5, -5.5; IR (thin film) 
νmax 3408, 2929, 2858, 1731,1456, 1361, 1258, 1076, 697 cm
-1; HRMS (ES) m/z 
calcd for C35H51SiO5 [M+H]
















241 243  
To the solution of 243 (142 mg, 0.24 mmol) in DCM (5 mL) was added a solution of 
TBAF (0.48 mL, 1.0 M in THF, 2 equiv) and the resulting solution was stirred for 1h . 
The solvent was then evaporated under reduced pressure and the solution filtered 
through a short silica pad (hexanes/EtOAc 1:1). The crude product was redissolved 
in DCM (5 mL) and treated with TPAP (9.0 mg, 24 μmol, 0.1 equiv), NMO (56.0 mg, 
0.48 mmol, 2 equiv) and MS 4Å (200 mg). The resulting solution was stirred for 1 h 
at RT, then filtered through a short silica pad and the solvent evaporated under 
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reduced pressure. The crude product was purified by flash column chromatography 
(SiO2, hexanes/EtOAc 10:1) to afford 243 as a colourless oil (102 mg, 90% yield for 
2 steps). 243: 1H NMR (500 MHz, CDCl3) δ 7.35-7.18 (10 H, m), 5.08 (1 H, m), 
4.41 (1 H, d, Jab = 12.5 Hz), 4.39 (1 H, d, Jab = 12.5 Hz), 4.37 (2 H, s), 3.54 (1 H, d, 
Jab = 9.2 Hz), 3.51 (1 H, Jab = 9.2 Hz), 3.34 (1 H, d, Jab = 9.0 Hz), 3.32 (1 H, d, Jab = 
9.0 Hz), 2.96-2.92 (1 H, m), 2.68 (1 H, d, Jab = 19.0 Hz), 2.63-2.59 (1 H, m), 2.59 (1 
H, d, Jab = 19.0 Hz), 1.62 (3 H, m), 1.19 (3 H, s), 1.05 (3 H, s); 
13C NMR (125 MHz, 
CDCl3) δ 215.2, 175.1, 150.8, 137.4, 137.3, 128.3, 127.9, 127.9, 127.7, 127.7, 107.6, 
102.9, 73.6, 73.4, 73.2, 72.5, 63.2, 58.4, 49.2, 42.4, 32.8, 32.8, 18.5, 17.5; IR (thin 
film) νmax 2953, 2858, 1777, 1739, 1454, 1230, 1202, 1029, 946 cm
-1; HRMS (ES) 
m/z calcd for C29H36O5N1 [M+NH4]




Compound 243 (10 mg, 21.7 μmol, 1 equiv) was dissolved in DCM (1 mL) and 
AcOH (1 mL) and TsOH (40 mg, 20 equiv) was added. The solution was stirred for 2 
days, the temperature being carefully controlled below 30 ℃. The reaction mixture 
was then poured into a saturated aqueous solution of NaHCO3 and extracted with 
DCM. The organic phase was washed with brine and concentrated under reduced 
pressure. The crude product was purified by flash column chromatography (SiO2, 
hexanes/EtOAc 5:1) to afford unreacted starting material (0.5 mg, ~ 5%) and 246 as 
a colourless oil (7.8 mg, 78% yield, 82% brsm). 246: 1H NMR (500 MHz, CDCl3) δ 
7.35-7.18 (10 H, m), 5.08 (1 H, m), 4.41 (1 H, d, Jab = 12.5 Hz), 4.39 (1 H, d, Jab = 
12.5 Hz), 4.37 (2 H, s), 3.54 (1 H, d, Jab = 9.2 Hz), 3.51 (1 H, Jab = 9.2 Hz2, 3.34 (1 H, 
d, Jab = 9.0 Hz,, 3.32 (1 H, d, Jab = 9.0 Hz), 2.96-2.92 (1 H, m), 2.68 (1 H, d, Jab = 
19.0 Hz), 2.63-2.59 (1 H, m), 2.59 (1 H, d, Jab = 19.0 Hz), 1.62 (3 H, m), 1.19 (3 H, 
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s), 1.05 (3 H, s); 13C NMR (125 MHz, CDCl3) δ 214.14 175.22 138.33 137.7, 137.4, 
128.3, 128.3, 127.8, 127.7, 127.6, 127.6, 125.3, 99.4, 73.4, 73.3, 73.1, 72.3, 69.0, 
59.2, 50.0, 42.2, 36.5, 17.9, 17.4, 12.9; IR (thin film) νmax 2953, 2858, 1777, 1739, 
1454, 1230, 1202, 1029, 946 cm-1; HRMS (ES) m/z calcd for C29H36O5N1 
[M+NH4]




To a solution of 246 (20 mg, 43 μmol) in THF (1.38 mL) and EtOH (0.36 mL) at -78
℃ was added liquid ammonia (4.0 mL) followed by sodium (96.0 mg, 0.23 mmol) 
and the mixture stirred at -78 ℃ for 30 min. The reaction mixture was then 
quenched with ammonium chloride, stirred at -78 ℃ for 40 min, and then allowed 
to warm to RT. After the ammonia had boiled off, the resultant solution was filtered 
through a pad of silica to give the crude triol intermediate. This was taken into 
toluene (6 mL) and treated with Ag2CO3 on Celite (181 mg, 50%, 0.32 mmol) then 
heated to 130 ℃ for 4 h. The suspension was filtered through Celite, concentrated, 
and purified by flash column chromatography (hexane/EtOAc 2:1) to give 
bis-lactone 9 (2.9 mg, 28% for 2 steps). 9: 1H NMR (500 MHz, CDCl3) δ 5.39 (1 H, 
m), 4.20 (1 H, d, J = 8.7 Hz), 4.12 (1 H, d, J = 5.6 Hz), 3.95 (1 H, d, J = 8.7 Hz), 2.83 
(1 H, d, J = 19.0 Hz), 2.78 (1 H, d, J = 5.6 Hz), 2.65 (1 H, d, J = 19.0 Hz), 2.57-2.46 
(2 H, m), 1.82 (1 H, m), 1.23 (3 H, s), 1.23 (3 H, s); 13C NMR (125 MHz, CDCl3) δ 
178.3, 175.0, 141.0, 125.1, 104.4, 86.6, 73.6, 69.6, 61.9, 55.2, 41.0, 40.0, 16.7, 15.9, 
15.1; 1H NMR (500 MHz, Methanol-d4) δ 5.34 (1 H, m), 4.17 (1 H, dd, J = 8.6, 0.7 
Hz), 4.09 (1 H, s), 3.98 (1 H, d, J = 8.6 Hz), 2.89 (1 H, d, J = 19.3 Hz), 2.59-3.55 (1 H, 
m) 2.39-2.34 (1 H, m), 1.80 (3 H, dd, J = 2.2, 3.8 Hz), 1.20 (3 H, d, J = 0.7 Hz), 1.15 
(3 H, s); 13C NMR (125 MHz, Methanol-d4) δ 180.2, 177.9, 143.8, 125.1, 106.5, 
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87.0, 74.4, 71.5, 64.0, 57.0, 41.9, 40.5, 16.9, 16.0, 15.0; HRMS (ES) m/z calcd for 
C15H18O5 [M]




To the solution of 232 (65.0 mg, 0.12 mmol, 1 equiv) in DCM (1 mL) was added a 
solution of TBAF (0.24 mL, 1.0 M in THF, 2 equiv) and the resulting solution stirred 
for 1 h. The solvent was then evaporated under reduced pressure and the residue 
filtrated through a short silica pad using hexanes/EtOAc (1:1). The crude product 
was redissolved in DCM (5 mL) and treated with Al(OTf)3 (2.5 mg, 5.0 μmol, 0.05 
equiv), then stirred for 10 h at RT. The reaction mixture was filtered through a short 
silica pad and the solvent was evaporated under reduced pressure. The crude product 
was purified by flash column chromatography (SiO2, hexanes/EtOAc 1:1) to afford 
the product 227 as colourless oil 44 mg (88% yield). 227: 1H NMR (500 MHz, 
CDCl3) δ 7.34-7.23 (10 H, m), 4.48 (1 H, d, Jab = 12.0 Hz), 4.41 (1 H, d, Jab = 12.0 
Hz), 4.33 (1 H, d, Jab = 11.5 Hz), 4.31 (1 H, d, Jab = 11.5 Hz), 4.08 (1 H, d, J = 2.3 
Hz), 3.89-3.85 (1 H, m), 3.81-3.76 (1 H, m), 3.61 (1 H, d, J = 8.4 Hz), 3.44 (1 H, d, J 
= 8.4 Hz), 3.38 (1 H, d, J = 9.8 H), 3.29 (1 H, d, J = 9.8 Hz) 2.65 (1 H, d, J = 2.5 
Hz), 2.35 (1 H, td, J = 12.8, 9.0 Hz), 2.57-2.15 (2 H, m), 1.86 (1 H, ddd, J = 13.2, 
7.5, 3.9 Hz), 1.72-1.66 ( 1H, m), 1.52 (1 H, ddd, J = 13.5, 9.9, 7.6 Hz), 1.44 (1 H, s, ), 
1.21(3 H, s), 1.06 (3 H, s), 0.98 (3 H, s); 13C NMR (125 MHz, CDCl3) δ 138.0, 137.7, 
128.4, 128.3, 127.6, 127.6, 127.4, 92.8, 91.1, 77.7, 74.9, 73.6, 73.1, 67.1, 66.5, 50.94, 
50.1, 37.9, 36.5, 35.1, 26.9, 21.2, 16.1, 15.0; IR (thin film) νmax 3436, 2929, 2871, 
1713, 1454, 1362, 1275, 1207, 1072, 882 cm-1; HRMS (ES) m/z calcd for 
C29H38O5Na [M+Na]






To a solution of 227 (230 mg, 0.50 mmol) in THF (5 mL) was added Pd/C (32 mg) 
and the resulting mixture purged with H2 for 5min. The reaction mixture was then 
stirred under a H2 atmosphere (balloon) at RT for 3 h. The reaction mixture was 
filtered through a pad of silica and concentrated under reduced pressure to give the 
crude triol intermediate. This was taken into toluene (7.0 mL) and treated with 
Ag2CO3 on Celite (50%, 2.1 g) and heated to 130 ℃ for 4 h. The suspension was 
then filtered through Celite, concentrated under reduced pressure and purified by 
flash column chromatography (hexane/EtOAc 2:1) to give 247 as a white solid (102 
mg, 73% yield for 2 steps). 247: 1H NMR (500 MHz, CDCl3) δ 4.25 (1 H, d, J = 9.6 
Hz), 3.98 (1 H, s), 3.92-3.86 (2 H, m), 3.84 (1 H, d, J = 9.6 Hz), 2.46 (1 H, ddd, J = 
12.9, 9.6, 7.5 Hz), 2.21 (1 H, ddd, J = 12.8, 8.1, 4.6 Hz), 2.13 (1 H, ddd, J = 14.3, 
8.2, 2.9 Hz), 1.89 (1 H, ddd, J = 14.1, 8.6, 3.0 Hz), 1.77 (1 H, ddd, J = 14.1, 10.0, 
8.2 Hz), 1.60 (1 H, ddd, J = 14.3, 9.9, 8.8), 1.23 (3 H, s), 1.15 (3 H, s), 1.12 (3 H, s). 
13C NMR (125 MHz, CDCl3) δ 181.24, 92.57, 89.05, 74.17, 74.06, 70.06, 66.89, 
56.50, 54.06, 37.56, 36.56, 25.66, 19.94, 17.42, 10.87; IR (KBr) νmax 3445, 2926, 
1750, 1459, 1387, 1082, 1002, 846 cm-1; Mp: 218-220 ℃, HRMS (ES) m/z calcd 
for C15H23O5 [M+H]






To a solution of 247 (15.0 mg, 52.8 μmol, 1 equiv) in a mixture of MeCN (0.8 mL), 
CCl4 (0.8 mL), and H2O (0.8 mL) was added NaIO4 (60.0 mg, 0.25 mmol, 5 equiv) 
followed by RuCl3.H2O (5.46 mg, 26.0 μmol, 0.5 equiv). The reaction mixture was 
stirred at RT for 20 h, then the reaction mixture was filtered through a pad of silica. 
Concentration under reduced pressure followed by flash column chromatography 
(hexane/EtOAc 1:1) gave the ketone 248 as a white solid (11.0 mg, 75% yield). 248: 
1H NMR (500 MHz, CDCl3) δ 4.58 (1 H, d, J = 10.1 Hz), 4.01 (1 H, d, J = 10.1 Hz), 
3.04 (1 H, d, J = 17.7 Hz), 2.78 (1 H, d, J = 17.7 Hz), 2.34 (1 H , ddd, J = 13.6, 8.9, 
7.7 Hz), 2.23 (1 H, ddd, J = 14.5, 9.0, 7.6 Hz), 2.09 (1 H, ddd, J = 14.5, 7.4, 5.5 Hz), 
2.00 (1 H, ddd, J = 13.3, 6.6, 3.4 Hz), 1.40 (3 H, s), 1.34 (3 H, s), 1.14 (3 H, s). 13C 
NMR (125 MHz, CDCl3) δ 207.4, 173.6, 173.5, 95.6, 87.5, 73.3, 66.7, 62.1, 52.3, 
38.2, 36.7, 36.1, 22.4, 16.2, 15.3, IR (KBr) νmax 3484, 2952, 1774, 1713, 1456, 1394, 
1232, 1215, 1086, 1052, 1012 cm-1; Mp: 202-204 ℃, HRMS (ES) m/z calcd for 
C15H19O6 [M+H]
+ 295.11761, found 295.11809. 
Anislactones 
 
To a solution of 248 (5.0 mg, 17 μmol) in THF (2 mL) was added NaBH4 (5.0 mg, 
0.13 mmol). After 2 h, TLC indicated complete consumption of the starting materials. 
The reaction was quenched with several drops of saturated NH4Cl solution and the 
suspension filtered through a Celite pad. Concentration under reduced pressure 
followed by flash column chromatography (CHCl3/MeOH 100:3) gave a mixture of 
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anislactones A and B (4.6 mg, dr = 5:1, 95% yield). Further chromatographic 
purification of the two natural products enabled separation of anislactone A, 
containing a trace amount of the B epimer, as a colourless film. A small single crystal 
of anislactone A formed on standing that was suitable for X-ray crystallography. 
Anislactone A:  1H NMR (500 MHz, C5 D5N) δ 4.65 (1 H, d, J = 6.1 Hz), 4.54 (1 H, 
d, J = 9.5 Hz), 3.97 (1 H, d, J = 9.5 Hz), 3.65 (1 H, d, J = 17.2 Hz) , 3.36 (1 H, d, J = 
17.1 Hz), 2.41-2.37 (1 H, m), 2.16-2.01 (3 H, m) , 1.65 (3 H, s), 1.45 (3 H, s), 1.31 (3 
H, s). 13C NMR (125 MHz, C5D5N) δ 181.0, 176.9, 95.9, 88.4, 73.7, 72.7, 68.3, 57.6, 
55.5, 37.8, 36.4, 31.8, 21.0, 17.8, 11.1,  1H NMR (500 MHz, CD3OD) δ 4.34 (1 H, d, 
J = 9.8 Hz), 4.15 (1 H, s), 3.92 (1 H, d, J = 9.7 Hz), 3.07 (1 H, d, J = 17.3 Hz), 2.75 (1 
H, d, J = 17.3 Hz), 2.30-2.58 (1 H, m), 1.99-1.94 (2 H, m) , 1.79-1.74 (1 H, m), 1.46 
(3 H, s), 1.12 (3 H, s), 1.04  (3 H, s). 13C NMR (125 MHz, CD3OD) δ 182.6, 179.3, 
98.1, 89.0, 74.7, 73.4, 68.9, 58.2, 56.1, 38.2, 36.6, 32.0, 20.9, 17.4, 10.8, IR (KBr) 
νmax 3398, 2926, 1736, 1458, 1270, 1084, 1009, 936 cm
-1 HRMS (ES) m/z calcd for 
C15H21O6 [M+H]


















COSY correlation spectroscopy 
Cp cyclopentadiene 







DCC N, N-dicyclohexylcarbodiimide 
DCM dichloromethane 
DEPT distortionless enhancement by polarisation transfer 









ee enantiomeric excess 
EI electron impact ionisation 
EOM ethoxymethyl 
ES electrospray ionisation 
Et ethyl 




HMPA hexamethylphosphoric acid triamide 
hr hour(s) 
HRMS high resolution mass spectrometry 
HSQC heteronuclear single quantum coherence 
Hz Hertz 
IBX 2-iodoxybenzoic acid 
IR infrared 
J coupling constant 
LDA lithium diisopropylamine 
LDBB lithium di-tert-butylbiphenylide 
LHMDS lithium hexamethyldisilazide 
M molar (moles per litre) 
m multiplet 
m/z mass to charge ratio 
mCPBA meta-chloroperbenzoic acid 
Me methyl 
min minute(s) 
MMPP magnesium monoperoxyphthalate hexahydrate 
MOM methoxymethyl 
mp melting point 
Ms mesyl 
MS molecular sieves 
NaHMDS sodium hexamethyldisilazide 
NMO N-methylmorpholine 
NMR nuclear magnetic resonance 
NOESY Nuclear overhauser effect spectroscopy 
NTF neurotrophic factor 
℃ degree(s) celsius 








ppm parts per million 
q quartet 
RT/rt room temperature 
SEM β-trimethylsilylethoxymethyl 
Sia sialic acid 
TBAF tetrabutylammonium fluoride 
TBAI tetrabutylammonium iodide 
TBS t-butyldimethylsilyl 
Tf trifluoromethanesulfonyl 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
TLC/tlc thin layer chromatography 
TMS trimethylsilyl 




δ chemical shift 
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7 Appendix: Spectroscopic Data 
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